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Abstract
Introduction
Enhanced recovery after surgery was developed to optimise peri-operative care in an 
attempt to accelerate recovery, reduce morbidity and shorten hospital stay. The use of 
epidural analgesia is considered fundamental in Enhanced Recovery Protocols (ERP). 
However its value in the peri-operative management of laparoscopic colorectal 
surgical patients is unclear, and current analgesic regimens vary. Previous studies 
addressing this issue have not been conducted within a full ERP and have not ensured 
that patients are fluid optimised. The aim of this study was to examine the effects of 
different analgesic regimes on outcomes following laparoscopic colorectal surgery in 
fluid optimised patients treated within an ERP.
Methods
Two studies were performed. In the first study, ninety-nine patients undergoing 
laparoscopic colorectal segmental resections that did not involve the formation of a 
defunctioning stoma were randomised to receive epidural, spinal or patient controlled 
analgesia (PCA). Intra-operatively, all patients were fluid optimised using an 
oesophageal Doppler to guide fluid replacement according to the modified Wakeling 
protocol. All patients were treated within a full ERP. The primary end points were 
time until medically fit and the length of hospital stay. The secondary end points 
included the return of bowel function, pain scores and a quality of life assessment 
using the SF-36 questionnaire. The second study used the analgesic modality with the 
best results fi*om the study above and assessed the safety and feasibility of patients 
being discharged within 23 hours fi*om the start of laparoscopic colorectal surgery.
Results
Ninety-one patients completed the study with the main exclusions being for open 
conversion and epidural failure. There were no differences in the patient 
demographics other than patient weight, which was higher in the PCA group. The use 
of epidural analgesia resulted in a significantly longer time until medically fit for 
discharge, a longer hospital stay and a slower return of bowel function than spinal and 
PCA. Pain scores were higher in the PCA group than the spinal and epidural group 
although this did not affect the quality of life scores, which were similar for all 
analgesic modalities. Using spinal analgesia, 10 patients were safely discharged home 
within 23 hours of their surgery without any compHcations or re-admissions.
Discussion
The ERP has increasingly been used for laparoscopic surgery in its un-modified form 
with thoracic epidural use being a key feature. Many of the outcomes in the epidural 
analgesia group were significantly worse than the spinal and PCA groups suggesting 
that either of these two modalities could replace epidural analgesia. Although the 
results of the spinal and PCA groups were very similar, the pain scores and the return 
of bowel function were shghtly better in the spinal group thereby lending itself to the 
analgesic modality of choice for patients treated along 23-hour stay pathway. In order 
to safely discharge patients home within 23 hours from the commencement of 
surgery, it is essential to ensure that patients are optimized at every point of their care 
pathway and fluid therapy appears to play a major factor in patient outcome.
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Introduction
1.1 Introduction to laparoscopic colorectal surgery
The first laparoscopic appendectomy was performed on May 30, 1980 by a German 
gynaecologist called Kurt Semm. During the early 1980s, news of Semm's 
laparoscopic appendicectomy spread throughout the world. Erich Mühe was 
particularly interested in the possibility of performing additional operations using the 
laparoscopic technique and by 1984, Mühe had worked out the details of an operative 
laparoscope that he called the "Galloscope". On September 12, 1985, he carried out 
the first laparoscopic cholecystectomy and the concept of “minimally invasive 
surgery” was bom (Litynski, 1998).
Unfortunately Eric Mühe did not publish his work and consequently was not 
recognised for performing the first laparoscopic cholecystectomy. Phillipe Mouret, 
who was a gynaecologist, documented the first laparoscopic cholecystectomy in 1987 
(Mouret, 1996). Finally in 1999, Eric Mühe was recognized for his pioneering work 
and was invited by the Society of American Gastrointestinal Surgeons (SAGES) to 
give the Storz Lecture which he titled “The First Laparoscopic Cholecystectomy” 
(Reynolds, 2001).
The acceptance of the “laparoscopic cholecystectomy” resulted in marked 
improvements in laparoscopic equipment. With increasingly refined technology, it 
became possible to perform more complex procedures that consequently led to the 
first report of a laparoscopic colorectal operation being performed in 1991.
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The initial enthusiasm for laparoscopic colorectal surgery was soon followed with 
reservations that could have significantly affected its development. An early report 
raised major concerns regarding the safety of laparoscopic colorectal surgery due to 
the development of métastasés occurring at the port sites. Although the number of 
patients in this study was small, 20% of the patients developed port site métastasés 
(Berends et al., 1994). The cause for this very alarming rate of wound métastasés has 
never been identified, although the follow up of a large series of patients undergoing 
open surgery has shown that this problem was not unique to laparoscopic colorectal 
surgery, with an incidence of tumour recurrence at the wound site of open surgery 
found to be 0.6% (Reilly et al., 1996). Further studies have demonstrated the safety of 
laparoscopic surgery in terms of port site recurrence (Vukasin et al., 1996, Stocchi 
and Nelson, 2000).
Three later studies; the Conventional versus Laparoscopically assisted Surgery in 
Colorectal Cancer (CLASSIC) (Guillou et al., 2005); the Colon Cancer, Laparoscopic 
or Open (COLOR) (Hazebroek, 2002); and the Clinical Outcomes of Surgical 
Therapy Study Group (COST) showed laparoscopic surgery to be oncologically 
equivalent to open colorectal surgery.
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1.2 Principles of laparoscopic colorectal surgery
In order for the laparoscopic approach to be used to treat abdominal conditions, 
certain steps that employ specialised equipment must be followed. The steps / 
equipment required to perform this type of surgery are:
1) Creating access to the abdomen using the appropriate entry devices -  Entry into the 
ahdomen is performed using the open “Hassan” technique which can be likened to the 
now infrequently used “diagnostic peritoneal lavage” approach. In this approach, a 
small vertical incision is made through the skin, following which the abdominal fascia 
is raised with either sutures or a clip before it is incised. Generally a 10 mm trochar is 
inserted, though 5 mm ports may be used which can accept 5 mm laparoscopes. These 
trochars were initially metal re-useable ports but have been mostly replaced by 
disposable plastic trochars. Following the insertion of the first port, two to four 
additional trochars are inserted under direct vision to allow the different instruments 
to access the abdomen. These additional trochars are a variety of 5 mm or 10 mm 
ports.
2) Insufflation of carbon dioxide -  A gas is required to distend the abdomen in order 
to create a working space and hence allow the appropriate visualisation of the organs / 
pathology so that the surgery can be performed. Carbon dioxide is used due to its 
inert, non-flammable properties. In addition, it is very soluble, thereby allowing for 
easy excretion from the lungs. The carbon dioxide is inserted into the abdomen until a 
pressure of 14 millimetres of mercury (mmHg) is reached. This pneumoperitoneum is 
responsible for affecting the cardiovascular system and will be discussed in depth.
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3) Good vision — A clear sharp image is essential for safe surgery to be performed 
Light, which originates from an external light source is passed to the laparoscope by a 
fibre-optic cable. The laparoscopes used can vary in size and can be either 5 mm or 10 
mm in diameter. The image obtained is then interpreted by a camera mounted 
externally to the laparoscope, which feeds the image to a television screen.
4) Instrumentation -  Tissue graspers, scissors and needle holders are commonly used 
to undertake the surgery. New energy devices like the harmonic ultra-cision have 
become the energy devices of choice to perform major surgery in view of their 
efficiency and haemostatic properties.
5) Positioning -  Whilst the use of carbon dioxide creates a space to work, the 
abdominal organs often prevent adequate access to the tissue required. Patients are 
then placed in a head up position (reverse Trendelenburg) or the steep head down 
position (Trendelenburg position) in order to remove the small howel from the pelvis 
and allow access to the left sided colon and rectum. The extent of the head down 
position required to perform this surgery is marked, and these position changes 
consequently affect the cardiovascular system.
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1.3 Introduction to the Enhanced Recovery Programme.
During the period that the above studies were being undertaken to prove the safety 
and efficacy of laparoscopic surgery, major developments were made regarding the 
peri-operative management of patients undergoing conventional “open” colorectal 
surgery. A list of interventions regarding the peri-operative management of patients 
was compiled and titled “The Enhanced Recovery Programme” (ERP) (Hazebroek, 
2002, Fearon et al., 2005). Patients treated in accordance with this ERP had shorter 
hospital stays than patients treated with conventional post operative care. As further 
evidence has become available, the programme has undergone revision by the 
“Enhanced Recovery after Surgery” committee. The ERP currently consists of a 20- 
point plan (see figure 1).
Enhanced Recovery After Surgery (ERAS) (Fearon et al., 2005) was developed to 
optimise perioperative care in order to attempt to accelerate recovery, reduce 
morbidity and shorten hospital stay after elective colorectal surgery (Kehlet and 
Wilmore, 2008). However the evidence which illustrates the benefits of the ERP 
originated from open colo-rectal surgery (Wind et al., 2006b, King et al., 2006). The 
Enhanced Recovery criteria currently used for laparoscopic surgery have been 
adopted directly fi*om open surgery with no modification at all due to the current lack 
of evidence.
18
1) Pre-Operative education regarding ERAS
2) Avoidance of bowel preparation
3) Pre-operative carbohydrate drink
4) Avoidance of pre-operative long acting sedatives
5) Intra-operative thoracic epidural started before skin incision
6) Upper body forced -  air heating cover
7) Avoidance of abdominal drains
8) Avoidance of a nasogastric tube
9) Intra-operative intra-venous fluid administration of less than 3000 ml
10) At least 800 ml of fluid (water, tea) taken orally on day 0 following surgery
11) At least one unit of oral nutritional supplement taken on the day of surgery 
before midnight
12) At least two units of oral nutritional supplement taken on the first day after 
surgery before midnight
13) Intra-venous fluid terminated on day 1
14) Termination of urinary drainage on post-operative day 2
15) Solid food eaten on day 1
16) Aperient given
17) Mobilisation on the day of surgery
18) Mobilisation of at least 6 hours on day 1
19) Post-operative thoracic epidural
20) Termination of thoracic epidural on day 2
Figure 1 - Enhanced Recovery Protocol
Certain elements of the Enhanced Recovery Programme have been shown to be 
clearly beneficial, some make good common sense whilst others remain contentious. 
An example of a simple beneficial element would include the administration of 100 g 
of carbohydrate drink (Pre-Load®, Vitaflo Limited, Liverpool, UK) in 800 ml of 
water the night before surgery and 50 g of carbohydrate in 400 ml of water 2-3 hours 
prior to surgery. This has been shown to be safe (Nygren et al., 1995), to reduce the
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systemic response to surgery (Soop et al., 2001, Ljungqvist et al., 2000, Nygren et al., 
1999) and to shorten the hospital stay (Nohlett et al., 2006b). In addition the pre­
operative oral fluid helps prevent pre-operative dehydration, a factor that can he 
further reduced by avoiding the routine use of pre-operative bowel preparation was 
stopped (Jung et al., 2007, Bucher et al., 2005).
With regards to laparoscopic colorectal surgery, two of the contentious ERP elements 
relate to:
1) The use of thoracic epidural, which is a key point in the ERP and constitutes 3 
points (5, 19, 20; epidural commencing before the skin incision, running 
throughout surgery and continuing post-operatively) of the 20 point plan, and
2) The volume of intra-operative fluid administered (point 9 - suggested to be 
less than 3 litres intra-operatively).
Analgesia is a key area for ERAS, with the use of epidurals and avoidance of systemic 
morphine encouraged (Kehlet and Wihnore, 2008, Wind et al., 2006a). The most 
appropriate post-operative analgesia to use for patients undergoing laparoscopic 
colectomy remains uncertain. The main analgesic methods used for laparoscopic 
colorectal surgery so far have heen continuous thoracic epidural and patient controlled 
analgesia (PCA), which have been adopted from open colorectal surgery. Whilst post­
operative analgesia has been investigated significantly in open surgery (Rimaitis et 
al., 2003, Jayr et al., 1993, Liu et al., 1995, Zutshi et al., 2005, Steinberg et al., 2002, 
Carli et al., 2001), with a meta-analysis showing better pain control and a shorter 
post-operative period of ileus with epidural analgesia, there are relatively few studies 
addressing this issue in laparoscopic surgery (Marret et al., 2007).
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spinal anaesthesia is limited to providing analgesia when the post-operative 
requirements are moderate. Consequently its use in open colorectal surgery has been 
very limited but interest in the use of spinal analgesia for laparoscopic colorectal 
surgery is increasing. There has only been one study investigating the use of spinal 
anaesthesia which found that the use of intra-thecal morphine and local anaesthetic 
provided better pain relief than intra-thecal local anaesthestic alone (Kong et al.,
2002). Single dose spinal analgesia may provide a logical alternative, providing 
intense analgesia for the immediate post-operative period, and then permitting rapid 
mobilization on the first post-operative day.
The creation of the pneumoperitoneum in laparoscopic surgery together with use of 
the Trendelenburg position, places a significant demand on the cardio-vascular 
system. The pneumoperitoneum results in an increase of the systemic vascular 
resistance (SVR), consequently decreasing the cardiac output and hence the oxygen 
delivery (D02) (Haxby et al., 1997, Joshi et al., 2005, Koliopanos et al., 2005), 
although the SVR slowly decreases as the procedure continues (Meininger et al., 
2008). Given the increase of SVR peri-operatively, patients who undergo sympathetic 
blockade (from spinal or epidural anaesthesia) might be expected to have some of the 
effects of the pneumoperitoneum and Trendelenburg position reduced. However, the 
effects of the different analgesic modalities on the cardiovascular physiological 
changes and the related intra-operative fluid requirements with each analgesic 
modality are unknown.
Specifically related to the ERP, part of the purpose of this research therefore was to:
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1) Ascertain the most appropriate analgesic regime for patients undergoing 
laparoscopic colorectal surgery
2) Ascertain the impact of the analgesic regime on cardiovascular physiology and 
the volume of intra-venous fluid required to achieve fluid optimisation in 
patients undergoing this type of surgery.
Prior to assessing these issues with a formal study, the literature was reviewed in 
order to obtain a comprehensive understanding of the evidence published with regards 
to the questions being addressed.
22
1.4 The current evidence for post-operative analgesia
Several studies have investigated the use of epidural analgesia in open surgery 
(Rimaitis et al., 2003, Jayr et al., 1993, Liu et al., 1995, Zutshi et al., 2005, Steinberg 
et al., 2002, Carli et al., 2001), and their results have been summarised in a recent 
meta-analysis which showed no significant difference in the length of hospital stay 
but did show better post operative pain control and a decrease in ileus in the patients 
managed with epidural anaesthesia (Marret et al., 2007). As the optimal post­
operative analgesic method for patients undergoing laparoscopic colorectal surgery is 
unknown, various alternative analgesic methods are currently being employed. These 
have included epidural analgesia, patient controlled analgesia, intra-venous agents and 
spinal anaesthesia.
In order to obtain a comprehensive understanding of the current evidence regarding 
the effects of post-operative analgesia, a systematic review was performed. This 
examined the current published evidence concerning the impact of differing peri­
operative analgesic regimens on the short-term outcomes following laparoscopic 
colorectal surgery.
The systematic review was performed by identifying comparative studies that 
reported on the outcomes of different analgesic regimens following laparoscopic 
colorectal resections. These studies were identified from electronic databases 
(Pubmed, Medline, the Cochrane Controlled Trials register published by the Cochrane 
Library, Embase and the Institute of Health and Life Sciences). The search was 
performed using the following MeSH search terms: “analgesia laparoscopy/
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laparoscopic”, “epidural laparoscopy / laparoscopic”, “PCA laparoscopy / 
laparoscopic”, “analgesia laparoscopic colectomy”, “patient controlled anaesthesia”, 
“spinal anaesthesia”, “analgesia colon”, and “analgesia randomized controlled trial 
laparoscopic”. These terms were applied in various combinations, together with use of 
the related articles function in order to maximise the search. No restriction of 
language of publication was made and additional articles were retrieved by manually 
searching reference lists in the identified articles.
Studies were included if they reported randomised controlled trials, observational or 
cohort studies comparing outcomes following the use of different analgesic regimes in 
patients who had undergone elective laparoscopic colorectal resections for benign or 
malignant conditions. Studies were excluded from further analysis if the procedure 
was laparoscopically assisted with a hand port or if a laparotomy incision (including 
Pfannenstiel) was routinely used to complete the colonic mobilisation, but not if 
incisions were made for specimen extraction and/or anastomosis. These studies were 
excluded as open surgery and laparoscopically assisted surgery have been shown to 
consequently have considerably higher markers of stress response (interleukin 6; IL 6) 
to surgery than pure laparoscopic surgery, which would otherwise confound the issue 
(Evans et al., 2008).
The primary outcome of interest was length of hospital stay (LOS). This was chosen 
as the primary outcome as most of the studies comparing analgesic regimes had used 
this as their primary end point. Secondary outcomes were time until return of bowel 
function, time to tolerate a normal diet, incidence of vomiting, pain, post-operative 
complications and re-admissions. The secondary outcomes were used as the surgical
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community are interested in the interaction between the analgesic regime employed 
and bowel recovery following the surgical insult, in addition to the effectiveness of 
the analgesic regime.
The methodological quality of included RCTs was assessed using the Jadad score 
(Jadad et al., 1996), giving an overall assessment based on adequate sequence 
generation, allocation concealment, blinding, addressing incomplete outcome data, 
selective reporting and other biases (see table 1). The Jadad score was introduced so 
that methodological errors such as poor randomisation or poor allocation concealment 
would not allow factors such as selection bias to adversely affect the results of a trial. 
Three initial points are addressed in obtaining a Jadad score:
1. Was the study described as randomised?
2. Was the study described as double blind?
3. Was there a description of withdrawals and dropouts?
Each yes scores a single point, each no scores zero points.
Additional points were given if:
• The method of randomisation was described in the paper, and that method 
was appropriate.
• The method of blinding was described, and it was appropriate.
Points were deducted if:
• The method of randomisation was described, but was inappropriate.
• The method of blinding was described, but was inappropriate.
The scores range from the lowest (zero) to the highest (five).
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For studies comparing epidural versus PCA, heterogeneity in reporting between the 
studies precluded formal meta-analysis of the main outcome of interest (LOS). 
However, using data from randomised controlled studies only, a crude mean of the 
length of stay and the secondary outcomes for each analgesic regimen, weighted for 
the size of individual study populations, was calculated to allow overall comparisons 
to be made. Where quantitative dichotomous data was available that compared similar 
analgesia groups, meta-analysis of the randomised controlled trials was performed 
according to the recommendations from the Cochrane Collaboration and the Quality 
of Reporting of Meta-analyses (QUORUM) guidelines (Clarke and Horton, 2001, 
Stroup et al., 2000). The analyses were performed using Revman 5.0 (Cochrane 
Collaboration, Nordic Cochrane Centre, Copenhagen, Denmark). Dichotomous data 
was assessed using the Mantel-Haenszel statistical method, using a random-effects 
technique. The random effects model is preferable due to the fact that patients were 
operated on in different centres using variations in the surgical technique.
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The search criteria identified 189 abstracts that related to post-operative analgesia. Of 
these, 160 were excluded because they assessed other specialities, open or 
laparoscopically assisted cases, only one analgesic modality or they were letters (see 
figure 2). Twenty-five articles were reviewed in full text of which 17 (Beaussier et al.,
2006, Chen et al., 2005, Gatt et al., 2005, Teng et al., 2004, Kuo et al., 2006, Kaba et 
al., 2005, Kraft et al., 2006, Herroeder et al., 2007, Hong et al., 2006, Nightingale et 
al., 2007, Kucukemre et al., 2005, Beaussier et al., 2007, Joels et al., 2003, De Cosmo 
et al., 2005, Carli et al., 2001, Mann et al., 2000, Rigg et al., 2002) were excluded 
(open surgery n=15, laparoscopic versus open n=l, case series describing a single 
modality n=l) leaving 8 (Neudecker et al., 1999, Senagore et al., 2003, Taqi et al.,
2007, Kong et al., 2002, Schlachta et al., 2007, Zingg et al., 2008, Kaba et al., 2007, 
Senagore et al., 2001) relevant studies for further analysis.
The demographics and outcomes for each study are illustrated in tables 2 and 3. Three 
RCTs (Senagore et al., 2003, Taqi et al., 2007, Neudecker et al., 1999), one 
observational (laparoscopic sub-group analysis of a RCT) (Zingg et al., 2008) and one 
consecutive matched cohort study (Senagore et al., 2001) compared epidural versus 
PCA / iv morphine. The other three studies compared i) different forms of spinal 
anaesthesia, ii) the effects of ketorolac versus placebo and iii) iv lidocaine versus 
placebo.
Assessment of the factors that were related to the ERP revealed that six of the studies 
reported the routine use of ftill bowel preparation (Neudecker et al., 1999, Senagore et 
al., 2001, Senagore et al., 2003, Taqi et al., 2007, Schlachta et al., 2007, Zingg et al., 
2008), two specifically reported that naso-gastric tubes were not routinely used
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(Schlachta et al., 2007, Kaba et al., 2007) and only one study routinely used 
abdominal drains (Kaba et al., 2007). The length of time that the epidural was left in- 
situ varied considerably from 18 hours (Senagore et al., 2003) after the end of surgery 
to five days (Zingg et al., 2008) (see tables 2 & 3). Senagore et al (Senagore et al.,
2003) in their 2003 study employed early feeding and were the first to report the use 
of elements of the ERP to laparoscopic surgery. Taqi et al (Taqi et al., 2007) removed 
the catheter on day 2 in the PCA group and encouraged active mobilisation whilst 
Schlata at al (Schlachta et al., 2007) removed the catheter on day 1 and avoided 
abdominal drains and naso-gastric tubes. Kaba et al avoided naso-gastric tube use, 
encouraged early feeding and active mobilisation but they routinely left an abdominal 
drain in situ (Kaba et al., 2007). The other studies (Senagore et al., 2001, Zingg et al., 
2008, Kong et al., 2002, Neudecker et al., 2002) did not mention the use of any fast 
track elements.
With regards to the primary outcome, length of stay, seven (Neudecker et al., 1999, 
Senagore et al., 2003, Senagore et al., 2001, Taqi et al., 2007, Zingg et al., 2008, 
Schlachta et al., 2007, Kaba et al., 2007) out of the eight studies measured the length 
of hospital stay. Of the three RCTs comparing epidural versus iv opioid, all three 
(Neudecker et al., 1999, Senagore et al., 2003, Taqi et al., 2007) found no significant 
difference in LOS between these two methods. The calculated overall average length 
of hospital stay with regards to epidural or iv opioid usage in the RCTs was 5.1 versus
5.4 days respectively, comparing 53 versus 55 patients. Similarly in Zingg's (Zingg 
et al., 2008) RCT, the sub-group analysis of the laparoscopic resections showed no 
significant difference in the median LOS which was 9 versus 11 days for epidural 
versus PCA. Only Senagore et aTs (Senagore et al., 2001) cohort study two years
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prior to their RCT (Senagore et al, 2003) showed a shorter stay with the use of 
epidural.
The use of intravenous ketorolac versus placebo significantly reduced the length of 
hospital stay, as did the use of intra-venous lidocaine versus intravenous saline (see 
table 2). Kong at al’s study comparing various spinal anaesthesia formulae did not 
report the length of hospital stay and only measured the pain scores (Kong et al., 
2002).
The first of the secondary outcomes assessed was the time to tolerating diet. Three 
(Zingg et al., 2008, Taqi et al., 2007, Neudecker et al., 1999) of the studies comparing 
epidural versus opioid and one (Schlachta et al., 2007) investigating the effect of 
ketorolac reported the time to tolerating diet. Of the two epidural RCTs, one 
(Neudecker et al., 1999) found no significant difference in the time to tolerance of diet 
compared with intravenous opioid while the other (Taqi et al., 2007) study found this 
time to be significantly shorter with epidural. Comparison of the overall average time 
until diet was tolerated for epidural versus intravenous opioid was 2.8 versus 3.9 days 
respectively with 35 patients in the epidural group and 35 in the intravenous opioid 
group. Zingg’s study showed no difference in the median time until tolerating diet 
with a median time of four days in both the epidural and PCA groups. One (Schlachta 
et al., 2007) RCT showed that the use of ketorolac versus placebo significantly 
reduced the time until diet was tolerated fi*om a median of 3.0 days to 2.5 days.
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With regards to the time to passing flatus, one RCT (Taqi et al., 2007) and one 
observational study (Zingg et al., 2008) compared epidural versus PCA, whilst 2 
(Schlachta et al., 2007, Kaba et al., 2007) other RCTs compared the time until flatus was 
passed. The one RCT (Taqi et al., 2007) comparing the epidural versus opioid group 
found the epidural group to have a significantly shorter time to passing flatus with a 
median of two versus three days respectively, whilst the one observational study (Zingg 
et al., 2008) found no significant difference between these analgesic regimes. The 
independent use of ketorolac and iv lidocaine both significantly shortened the time until 
flatus was passed (Schlachta et al., 2007). The use of intravenous lidocaine resulted in 
the shortest overall average time until flatus was passed in this review which was 0.71 
days (Kaba et al., 2007) (see table 2).
Four studies reported on the time to bowels opening. Of the two RCTs (Taqi et al., 2007, 
Neudecker et al., 1999) that compared epidural versus PCA, both of these studies 
reported a reduced time until bowels opened in the epidural group, though this was only 
significant in one (Taqi et al., 2007) of the studies. The overall average time was 2.0 
days versus 2.8 days in the epidural versus intravenous opioid groups respectively. 
Zingg's study (Zingg et al., 2008) also showed a significantly shorter time until bowels 
opened with the use of epidural compared with PCA. The use of intravenous lidocaine 
versus placebo was shown to significantly lower the dose of PCA morphine required and 
was associated with a significantly shorter time to bowels opening (1.2 versus 2.1 days) 
(Kaba et al., 2007).
Six (Senagore et al., 2003, Taqi et al., 2007, Senagore et al., 2001, Zingg et al., 2008, 
Kaba et al., 2007, Schlachta et al., 2007) of the eight studies reported on pain, with two
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(Senagore et al., 2003, Taqi et al., 2007) RCTs comparing epidural versus intravenous 
opioid. In both of these RCTs, the pain scores (visual analgue scale of 0-10) were 
significantly lower in the thoracic epidural group. The calculated overall averages were
2.5 versus 5.4 in the epidural versus intravenous opioid groups respectively. Pain scores 
were also lower in the epidural group of Zingg’s study though they were not statistically 
significant. The use of intrathecal morphine in addition to 0.5% bupivacaine resulted in 
significantly better pain control than 0.5% bupivacaine alone (Kong et al., 2002). 
Similarly, the use of ketorolac or intravenous lidocaine versus placebo both resulted in 
significantly lower pain scores (Schlachta et al., 2007, Kaba et al., 2007).
Two (Senagore et al., 2003, Taqi et al., 2007) RCTs comparing epidural versus PCA 
reported on the incidence of nausea and two (Taqi et al., 2007, Neudecker et al., 1999) 
RCTs reported on vomiting although in none of the studies was nausea and vomiting 
precisely defined. There was no statistically significant difference between the PCA 
versus epidural studies in terms of nausea or vomiting (see figures 3 and 4).
The overall complications were reported in two (Senagore et al., 2003, Taqi et al., 2007) 
RCTs comparing epidural versus PCA and in two other studies (Senagore et al., 2001, 
Schlachta et al., 2007). One (Senagore et al., 2003) of the RCTs reported no 
complications in both groups and consequently the odds ratio was not estimable. The 
other by Taqi et al (Taqi et al., 2007) reported five compHcations in each group that 
included a pleural effusion, gastric ulcer, wound infection, paralytic ileus and abdominal 
wall haemorrhage, but no reported anastomotic leaks (Taqi et al., 2007). In the study 
comparing ketorolac versus placebo, the incidence of anastomotic leaks was higher in
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the ketorolac group (4 leaks) versus the placebo group (1 leak) (p value not reported) 
(Schlachta et al., 2007).
Four studies (Senagore et al., 2003, Senagore et al., 2001, Taqi et al., 2007, Schlachta et 
al., 2007) compared the re-admission rates. Of the two (Senagore et al., 2003, Taqi et al.,
2007) incorporated in the meta-analysis comparing PCA versus epidural, there was no 
significant difference in the re-admission rate with an odds ratio (OR) of 0.56 (95% 
confidence interval (c.i.) of 0.12 to 2.65) (see figure 5). There was also no significant 
re-admission rate in the ketorolac study (Schlachta et al., 2007). The odds ratio is a 
measure describing the strength of association between two data values. It is the ratio of 
the odds of an event occurring in one group to the odds of it occurring in another group. 
These results may be displayed graphically in the form of a Forest plot, which was 
developed for use in medical research as a means of graphically representing a meta­
analysis of the results of randomised controlled trials. The Forest plot shows the strength 
of the evidence in the different quantitative scientific studies in addition to the overall 
effect. The size of each square is proportional to the study's weight in the meta-analysis. 
This meta-analysed measure of effect is commonly plotted as a diamond extending to 
two lateral points which indicate the confidence intervals for this estimate.
Two (Senagore et al., 2003, Neudecker et al., 1999) PCA versus epidural RCTs reported 
on urinary retention and whilst no significant difference was demonstrated between 
these two methods, there was a non-significant trend towards higher levels of urinary 
retention in the epidural group with an OR of 0.29 (95% c.i. of 0.03 to 3.00) (see figure 
6). Hypotension was reported in two (Senagore et al., 2003, Zingg et al., 2008) studies, 
one of which was a RCT that showed no significant difference between the epidural
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versus PCA groups. In the second study which was Zingg’s sub-group analysis (Zingg et 
al., 2008), hypotension was more frequent in the epidural group though this was not 
statistically significant.
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This systematic review has highlighted the relative lack of evidence comparing 
outcomes between differing analgesic regimes. At present, there is no convincing 
evidence to suggest the superiority of either PCA or epidural in terms of LOS for 
laparoscopic colorectal surgery. In the short term, no significant difference has been 
identified in terms of adverse events, although post-operative pain appears better 
controlled in the epidural group.
The major limitation of this review is the inability to provide a quantitative meta­
analysis comparing LOS between the groups, due to an overall lack of comparative 
studies together with the heterogeneity in reporting that exists between these studies. 
Hence, for the primary outcome a crude average from the mean / median, weighted for 
the size of the population, was calculated. Although this incorporated randomised 
studies, the results of this analysis, which used means and medians, should be 
interpreted with caution as the potential exists for bias to have been introduced. While 
the dichotomous data was reported in the RCTs in a form permitting meta-analysis, 
similar quantitative pooling of data was not possible in relation to the primary outcome 
data due to differences in the manner in which the results of individual studies was 
presented. Attempts to contact the authors of the RCTs who had reported their data as 
medians were unsuccessful. The clinical heterogeneity in the conduct of the individual 
trials, and the statistical heterogeneity in reporting have therefore limited the extent to 
which quantitative meta-analysis is possible and appropriate, although such pooling of 
data may be possible in the future as further similar studies are published.
Furthermore, the overall results should be interpreted in relation to the fact that 
adherence to the ERP between studies was variable and it is possible that well designed
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studies in which both populations are subjected to strict ERP protocols may generate 
different results. In addition the position of the individual surgeon on their laparoscopic 
learning curve is not clearly stated and the experience of the operating surgeon in the 
colorectal unit may impact on the degree to which accelerated post operative care may 
be undertaken in the context of laparoscopic colonic resection.
There is considerable variation in the length of hospital stay documented in existing 
studies. A study published in 2003 reported a mean length of hospital stay of 2.4 and 2.3 
days respectively for epidural versus PCA (Senagore et al., 2003) whilst a recent study 
published in 2008 reported stays of 9 versus 11 days respectively (Zingg et al., 2008). 
Whilst the prolonged use of epidural anaesthesia (5 days) may have lengthened the 
hospital stay in the epidural group, it is unclear why the non-thoracic epidural group 
remained in hospital for so long. Such variations are a recurring theme in the current 
literature and could potentially be minimised by the use of standardised post-operative 
protocols.
The findings of several large trials comparing epidural analgesia versus PCA in patients 
undergoing major open surgery have shown that pain is better controlled with thoracic 
epidural but with no difference in mortality or morbidity. Despite the benefits in terms 
of pain control, the length of time that an epidural should remain in-situ remains a 
contentious issue. Within the studies reviewed the length of time that an epidural was 
left in-situ varied from 18 hours (Senagore et al., 2003) to 5 days (Zingg et al., 2008). 
For open surgery, the recommendation is that the epidural should be left in-situ for 48 
hours. In our unit and others (Delaney, 2008), many patients undergoing laparoscopic 
colonic resections are discharged home on day two and consequently leaving an epidural
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in for 48 hours would hinder their progress. If patients are well enough to go home at 
one to two days, then the epidural should be removed some time before this, raising the 
issue of whether a spinal may be more appropriate. The use of epidural anaesthesia is 
labour intensive, and despite the presence of a dedicated nursing team, its use may delay 
mobilisation due to motor block. Furthermore, epidural failure rates of up to 40% have 
been reported (Ready, 1999). The use of spinal anaesthesia post-operatively may offer 
many advantages with its lower complication rate, higher insertion rate, lack of 
unilateral blocks and lack of prolonged motor block.
Whilst most of the studies initially compared epidural versus PCA, there have been trials 
published that have investigated alternative methods. Only one study, published in 2002, 
assessed the use of spinal anaesthesia in laparoscopic colorectal surgery (Kong et al., 
2002). In this study, intrathecal 0.5% hyperbaric bupivacaine was compared with 
intrathecal 0.5% hyperbaric bupivacaine with 0.2 mg of intrathecal morphine and found 
the later to be more effective for pain control. None of the RCTs, though, have 
compared the use of epidural or PCA against spinal anaesthesia.
More recently, Kaba et al reported the use of intravenous lidocaine for post-operative 
pain control (Kaba et al., 2007). They found a significantly shorter length of hospital 
stay, time to passing flatus, bowels opening and better pain scores in patients who 
received intravenous lidocaine. The doses that were used were equivalent to cardiac 
doses previously used for arrhythmias. Whilst they used these doses post-operatively on 
the ward with no complications, some may raise concern regarding the use of this dose, 
unsupervised on a ward.
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Schlata et al found that the use of NSAIDs was significantly beneficial in controlling 
post operative pain (Schlachta et al., 2007). They did however report five anastomotic 
leaks in 44 patients, four of which were in the NSAID group. This leak rate was higher 
than their previous leak rate of 2.5% in the last 750 cases. The precise reason for this 
discrepancy is not clear, but the authors felt it not to be related to the use of NSAIDs.
Due to the limited literature available, this systematic review illustrates the point that 
further trials are required to assess the most appropriate analgesia for patients 
undergoing laparoscopic colorectal surgery. It is essential that these trials are performed 
within an ERP.
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1.5 Justification for the study.
The findings of the literature review did not appear to correlate with what was being 
observed in clinical practice. The anecdotal evidence was that patients who received an 
epidural for postoperative pain were staying in hospital longer than patients receiving a 
spinal anaesthetic or a PCA. As this was only an impression, it was necessary to perform 
a review of the patients who had undergone laparoscopic colorectal resections in the 
RSCH within the last five years.
From August 2003 until October 2007, 424 laparoscopic colorectal cases were 
performed at The Royal Surrey County Hospital (RSCH). In order to examine the 
impact of different types of analgesia on patients undergoing laparoscopic colorectal 
surgery, a review was performed using the patients’ hospital length of stay as the 
principal endpoint. The length of hospital stay was used as the primary end-point in 
order to allow comparison with previous studies, most of which have used this as the 
primary end point. The secondary outcomes of interest were the amount of analgesia 
used, the amount of break-through analgesia required with the use of PCA and spinal 
anaesthesia, and the intra-operative volumes of fluid administered.
The prospectively collected database contained the mformation regarding the 424 
laparoscopic resections that had all been performed by one surgeon in a single centre. 
The details of the operations performed, length of hospital stay, post-operative analgesia 
used and analgesic and post-operative and complications were reviewed and in the event 
of missing data, the clinical notes were retrieved to obtain the information. In addition, 
the notes and drug charts of all patients who had received a spinal anaesthetic and PCA
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since Aug 2003 were reviewed to obtain the doses of break-through analgesics used. The 
review included patients operated on until October 2007 which was when we 
commenced our randomised controlled trial comparing the use of epidural, spinal and 
PCA in fluid-optimized patients following laparoscopic colectomy.
The anaesthetic technique used for 2003 until 2007 had essentially remained unchanged 
since the anaesthetic department had developed guidelines when laparoscopic colorectal 
surgery was started in 2003, and the same four consultants covered this list during this 
time period. All patients were assessed at a pre-operative clinic and if there were any 
concerns regarding their health status, they were reviewed by a consultant anaesthetist. 
Patients were admitted on the evening prior to surgery. Those patients undergoing a left­
sided resection received a phosphate enema whilst no bowel preparation was given to 
those undergoing a right hemicolectomy. Picolax® (sodium picosulfate 10 mg, 
magnesium citrate 12.5 mg), two sachets orally was only used if a patient was definitely 
going to have a defunctionmg loop ileostomy. The method of post-operative analgesia 
was determined after discussion between the anaesthetist and the patient, depending on 
patient wishes and contra-indications. Anaesthesia was induced using propofol (2-3 
mg/kg), alfentanil 10 mcg/kg and rocuronium 0.6 mg/kg or vecuronium 0.1 mg/kg 
depending on the anaesthetists’ choice. The trachea was intubated and the patient’s 
lungs were mechanically ventilated. The use of nasogastric tubes was routinely avoided. 
Anaesthesia was maintained using sevoflurane at mean alveolar concentration (MAC) of 
1.0-1.4, oxygen-enriched air and a remefentanil infusion (40 p-g/ml) titrated to effect. All 
patients had a 16g peripheral line, bear-hugger® and a urinary catheter. The 
anaesthetists’ clinical judgement was used to determine the need for a 20g radial arterial 
line and a 4 lumen right internal jugular central venous line.
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The department of anaesthesia had agreed that patients undergoing laparoscopic 
colorectal surgery would receive one of the three methods of analgesia.
1) Spinal anaesthesia -  The usual method involved insertion prior to induction of 
anaesthesia. This was performed at the L2-3 or L3-4 interspace using 2.5 ml of 
0.5% bupivacaine with 0.25 mg of diamorphine, with the patient in the sitting 
position.
2) Thoracic epidural -  An epidural catheter was inserted between T9-T12. The 
patient received 10 ml of 0.20% bupivacaine, with 100 pig of fentanyl given as a 
bolus. An infusion of 0.15% bupivacaine with fentanyl 0.0002% was then 
commenced running at 4-8 ml/hr if tolerated.
3) PCA -  Patients were given 10 mg of morphine intra-operatively and then 
attached to pump in the post-operative anaesthetic unit with a maximum dose of 
20 m g/4 hours.
At the end of surgery, anaesthesia was reversed with neostigmine 2.5 mg and 
glycopyrolate 0.5 mg, and all patients received 4 mg of ondansetron or 25 mg of 
cyclizine. All patients received cefiiroxime 1.5 g and metronidazole 500 mg at induction 
followed by further doses of 750 mg and 500 mg respectively at 8 hours and 16 hours 
post-operatively as antibiotic prophylaxis.
Post operatively 1 litre of normal saline or Hartmann’s solution over 6-8 hours was 
administered. The following fluid regime was not fixed and depended on the fluid status, 
blood pressure and urinary output. Patients were prescribed a variety of oral medications 
that included paracetomol, voltarol, codydromol and tramadol. Breakthrough analgesia 
was tramadol (50-100 mg po/iv qds) if not already given, or morphine (2.5-10 mg qds) if
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tramadol had already been given. Nausea and vomiting were treated with cyclizine (25 
mg im/iv) or metaclopromide (10 mg im/iv) as first line, or if this failed ondansetron (4 
mg iv).
Patients were actively encouraged to sit out of bed on the evening of surgery (day 0) and 
to mobilize on day 1. Free fluids and feeding was started on the day of surgery with 
whatever the patient felt like eating. Patients with an epidural in-situ had it removed at 
36-48 hours. The urinary catheter was removed 3-4 hours after the epidural was 
removed.
The surgical technique had not changed over this time period. Right-sided colectomies 
were performed by early ligation of the vessels using a laparoscopic stapler or the 
Harmonic Scalpel, followed by a medial to lateral dissection. The resection and 
anastomosis were performed extra-corporeaUy through a short midline incision. Anterior 
resections, left and sigmoid colectomies involved early division of the inferior 
mesenteric artery followed by a medial to lateral dissection. The splenic flexure was 
mobilized as required for sigmoid colectomies and anterior resections. The specimen 
was removed through a small Pfannenstiel incision, before being re-anastomosed using a 
rectal stapler. Drains were not used routinely.
The outcomes of interest in this review were:
1) Length of hospital stay was the primary outcome
2) Complication rates (anastomotic leaks, chest infections, deep vein thromboses, 
pulmonary emboli, epidural/spinal complications)
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3) Amount of breakthrough analgesia required by patients receiving PCA and spinal 
anaesthesia
4) Volume of fluid administered intra-operatively
The data were assessed using SPSS version 15.0.1 Categorical variables were analysed 
using Fisher’s exact test, whilst continuous variable were analysed with one-way 
ANOVA, using Bonferroni post-hoc test.
During the time period being investigated, a total of 424 patients underwent 
laparoscopic bowel resections. Seventy of these were for complex invasive 
endometriosis and have been excluded from analysis due to the gynaecological nature of 
the disease. Nineteen (5.3%) of the cases were converted to open surgery and have been 
excluded from the laparoscopic analysis. Nineteen further patients were also excluded as 
they had perineal surgery in the form of pan-proctocolectomies (PPCs) or abdomino­
perineal resections (APRs). Consequently 316 patients underwent laparoscopic bowel 
resections / anastomoses during this period for colorectal pathology, though 48 patients 
did not receive either spinal, epidural or PCA. Due to the heterogeneous nature of the 
group who received pro rae nata (pm) analgesia only, these patients were excluded from 
further analysis, leaving 268 patients for further analysis. The operations performed 
were ileocaecal resections / right hemicolectomies (n=94), left hemicolectomies / 
sigmoid colectomies (n=54), anterior resections (n=89) and others e.g. resectional 
rectopexy (n=31). The patient details of the different groups are shown in table 4.
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Table 4: Patient details by mode of analgesia. ASA=American Society of 
Anaesthesiologists, p-values calculated using ANOVA test.
Epidural Spinal PCA p values
Number of patients n=87 n=36 n=145
Mean(+/- sd) age (years) 69 (16) 65(17) 65 (18) 0.20
Mean (+/- sd) weight (kg) 69 (17) 71 (9) 70 (14) 0.94
Number of ASA 1 patients 9 (10%) 7 (19%) 21 (15%) 0.39
Number of ASA 2 patients 63 (72%) 24 (67%) 102 (70%) 0.82
Number of ASA 3 patients 15 (17%) 5 (14%) 22 (15%) 0.87
Number of ASA 4 patients 0(0%) 0 (0%) 0 (0%)
Ileocaecal resection / right 
hemi colectomy
27 (31%) 12 (33%) 55 (38%) 0.55
Left hemicolectomy / 
sigmoid colectomy
15 (17%) 7 (19%) 32 (22%) 0.67
Anterior resection 35 (40%) 15 (42) 39 (26%) 0.58
Other procedures 10(11%) 2(6%) 19 (13%) 0.45
Median (IQR) length of stay 4(3-9) 3(3-4) 3 (3-5) 0.009
The median length of stay was significantly longer after epidural anaesthesia compared 
with spinal (p=0.007) and PCA (p<0.001) (see figure 7). There was no difference 
between the lengths of stay in patients who received PCA compared with spinal 
anaesthesia (p=1.0).
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Figure 7: Length of hospital stay related to analgesic regime employed. Data = median 
(IQR).
There were 3 anastomotic leaks, one from each group (epidural, spinal and PCA p=1.0). 
The frequency of complications related to the type of analgesia used was similar 
(p=0.845) (see table 5). There were no complications relating to the use of regional 
anaesthesia in the epidural or spinal group.
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Table 5: Complications related to analgesic regime used.
Epidural Spinal PCA p value
Anastomotic
leak
1 1 1
0.85
Post-operative
haemorrhage
0 0 2
Chest
Infection
2 0 0
Deep vein 
thrombosis
0 0 0
Pulmonary
embolus
1 0 3
The p-value relates to the sum of complications per analgesic modality, and has been 
calculated using the chi squared test, DVT -  deep vein thrombosis, PE -  pulmonary 
embolus.
The post-operative morphine requirements of the 36 patients who received spinal 
anaesthesia for pain control compared to the PCA patients are shown in table 6. The 
mean dose of morphine administered after spinal anaesthesia was approximately a tenth 
of that in the PCA group. Twenty two (61%) of the patients who received spinal 
anaesthesia for post-operative pain did not require any morphine. Of the 14 (39%) that 
required morphine the median dose required was only lOmg.
Table 6: Morphine consumption in spinal and PCA groups.
Amount of morphine (mg) Amount of morphine (mg) p value
for spinal patients for PCA patients
(n=14) (n=145)
Median (IQR)
7.5
(0-13.8)
55
(28.1-76.1)
0.001
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The mean (+/-sd) volume of fluid administered intra-operatively in the 268 patients was 
1814+/-637 ml.
In this review, the commonest analgesic regimes were epidural and PCA with spinal 
anaesthesia slowly increasing in popularity. The results of this review show that patients 
receiving an epidural anaesthetic remained in hospital for significantly longer than 
patients receiving PCA or a spinal anaesthetic.
The use of spinal anaesthesia in this review has shown this method to be an effective 
form of post-operative analgesia. More than half the patients’ post-operative pain was 
controlled with oral analgesia alone. Of those that required morphine, the median dose 
was only 7.5 mg. When this is compared to the median doses of morphine used post- 
operatively with a PCA, it is noted that spinal anesthesia has significant opioid-sparing 
qualities.
One of the strengths of this review is that a large proportion of the elements of the 
“Enhanced Recovery Programme” (ERP) had been implemented from the beginning of 
this series. The points where the ERP had not been fiilly adhered to were the lack of a 
pre-operative glucose drink and the use of epidural analgesia, which was the issue in 
question. Had the ERP not been implemented, the results of this review would have been 
significantly weakened by the unknown possible benefits of the ERP with the various 
analgesic regimes.
One of the major limitations of this review was that patients were not treated in a 
standardised manner, with a wide variety of fluid therapy regimes used both intra- and
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post-operatively in addition to a variety of post-operative oral analgesic regimes. As an 
oesophageal Doppler was not routinely used, there was no way of ensuring that patients 
were fluid optimized.
Although epidural anaesthesia is listed as one of the Enhanced Recovery criteria, several 
forms of analgesia are currently being used for laparoscopic colorectal surgery and it is 
not clear at present to what extent the analgesic modality (epidural, spinal or PCA) will 
influence the patient outcome. The ERP continues to change as new evidence becomes 
available. At present there are no studies that have compared all three types of analgesia 
in terms of length of stay and gastro-intestinal fimction.
52
1.6 Minimally invasive surgery, maximally invasive cardiopulmonary stress.
The major benefit of laparoscopic surgery is the fact that it is minimally invasive, 
thereby reducing the analgesic requirements and placing less of a metabolic demand on 
the subject (Evans et ah, 2008). As laparoscopic surgery became more popular, there 
was hope that the incidence of post-operative anaesthetic complications would decrease. 
However, it was found that the post-operative incidence of myocardial infarctions was 
no different from that of open surgery (Devereaux et ah, 2008). Whilst the surgery is 
minimally invasive, the physiological demands placed on the cardio-vascular system 
during laparoscopic surgery are significant.
The physiological changes that occur in patients undergoing laparoscopic surgery were 
first investigated in patients undergoing laparoscopic cholecystectomy. These 
physiological changes, that occur with the pneumoperitoneum and the head-up position 
have been documented and will be discussed below. However the cardiovascular 
changes occurring with patients in the Trendelenburg position are far less clear, though 
there have been some publications addressing this issue in patients undergoing 
laparoscopic gynaecological and urological surgery (Hirvonen et al., 1995).
There have been several studies that have assessed the cardiovascular changes that occur 
with the creation of the pneumoperitoneum and placement in the reverse Trendelendurg 
(head up) position required to perform a laparoscopic cholecystectomy or a Nissen 
fundoplication. Dickson et al used an oesophageal Doppler probe to ascertain the 
cardiovascular changes in patients undergoing a laparoscopic anterior fundoplication 
(Dickson et al., 2000). They obtained cardiovascular readings from 10 patients. Baseline
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readings were obtained in theatre, followed by readings 1 minute after creation of the 
pneumoperitoneum, and then at 2, 5 and 10 minutes after adopting the reverse 
Trendelenburg position. Overall they found an increase in mean arterial pressure (MAP) 
and the indexed systemic vascular resistance (SVRI) together with a decrease in cardiac 
output, both of which were statistically significant. Although they noted an overall 
increase in the MAP, three out of the ten patients became hypotensive and required 
vasoconstrictor support with ephedrine. However, they did not continue the 
measurements beyond 10 minutes. Koliopanos et al, using an oesophageal Doppler 
probe also found an increase in MAP and decrease in cardiac output with abdominal 
insufflation and the reverse Trendelenburg position required for a variety of 
laparoscopic operations (Koliopanos et al., 2005).
There have been a few publications related to gynaecological and urological procedures 
that have investigated the cardiovascular changes that occur with laparoscopy in the 
Trendelenberg (head down) position. In Meininger et aTs study (Meininger et al., 2008), 
ten ASA I-III patients undergoing totally endoscopic robot-assisted radical 
prostatectomy had their cardiovascular parameters measured by transpulmonary arterial 
thermodilution, using a femoral artery catheter connected to a pulse contour computer 
(PICCO). The analgesic regime used for these procedures was not stated. They found 
that the head-down position with a pneumoperitoneum resulted in an increase in the 
MAP and SVRI. Over the period of the operation, SVRI slowly decreased and cardiac 
output slowly increased. The findings of a decrease in cardiac output and stroke volume 
with an increase in SVRI have also been documented in several laparoscopic 
gynaecological studies, though these tended to be young patients undergoing short 
operations (Stone et al., 1998, Hirvonen et al., 1995).
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The minimally-invasive approach has led to the misconception that laparoscopic surgery 
is far safer than open surgery in patients with cardiovascular disease (Devereaux et ah,
2008). There is considerable cardiovascular stress placed on subjects undergoing this 
surgery, and the extent of this risk needs to be weighed up against the surgical benefits 
of laparoscopic. Whilst the physiological changes that occur in the Trendelenburg 
position have been assessed in a simple form, the changes in fluid optimized patients 
with varying analgesic regimes have not been investigated. It is not known whether the 
use of regional blockade (epidural or spinal anaesthesia) will influence the marked 
increase in SVRI when the pneumoperitoneum and reverse Trendelenburg position is 
adopted. Given the increase in SVRI, patients who undergo sympathetic blockade (from 
epidural or spinal anaesthesia) might be expected to have some of the effects of the 
pneumoperitoneum and Trendelenburg position reduced.
Closely interlinked with this is fluid therapy. Fluid optimisation is now recognised as an 
extremely important factor affecting patient outcome (Abbas and Hill, 2008). Whilst all 
of the studies above measured cardiovascular parameters, none of the studies ensured 
that the patients were fluid optimized. It is important to remove the major confounding 
factor of hypovolaemia, thereby allowing the true physiological changes to be 
documented in fluid-optimized patients. In addition, it is unclear what effect sympathetic 
blockade has on fluid requirements in these patients. These various analgesic regimes 
may have different effects on the patients’ cardiovascular physiology and possibly the 
incidence of hypotension and vasoconstrictor use as the SVRI decreases during their 
surgery.
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The numbers of subjects included in previous studies has been small. Thirty percent of 
the patients in Dickson et aTs study (Dickson et al., 2000) required vasoconstrictor 
support, but due to the small cohort (n=10), the significance of this is difficult to 
ascertain (Dickson et al., 2000). This study proposed that the observed hypotension was 
due to a decrease in intravascular volume: this may be a contributor as these patients 
were not fiuid-optimized using a target-driven protocol. Furthermore, the analgesic 
method used in these studies was not documented.
The aim of fluid optimization is to maximize the cardiac output and hence the oxygen 
delivery, without placing the patients at risk of fluid overload. The importance of 
increased oxygen delivery (DO2) and the concomitant increase in survival benefit was 
first documented by Shoemaker et al 25 years ago (Bland et al., 1985). In their study, 
patients with an indexed oxygen dehvery (DO2I) greater than 600 ml/min/m  ^ had a 
significantly better outcome than those with a lower DOI2 . In many cases, increasing the 
DO2 can be achieved by intravenous fluids alone; in other cases inotropes such as 
dopexamine may be required although recent meta-analysis revealed no added benefit 
with the use of inotropes (Pearse et al., 2008).
The increase in SVRI associated with the pneumoperitoneum and the Trendelenburg 
position is associated with a decrease in DO2I (Haxby et al., 1997, Joshi et al., 2005, 
Koliopanos et al., 2005) due to the decrease in CO, although the SVRI slowly decreases 
as the procedure continues (Meininger et al., 2008). At present, it is unclear: what levels 
of DO2 are achievable in these patients even when fluid-optimized; whether the mode of 
analgesia affects this; and whether the lower levels of DO2 in minimally invasive surgery 
result in ischemia-related complications. More importantly, there is little data on
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whether this reduction results in or correlates with more ischaemia-related complications 
such as anastomotic leaks.
There are several different ways of monitoring the cardiovascular changes and oxygen 
delivery occurring during laparoscopic procedures. Very invasive cardiovascular 
measuring devices are no longer feasible in view of the associated risks. The safe viable 
options available include the oesophageal Doppler probe and the LIDCO (Lithium 
Dilution Cardiac Output). The studies that used the oesophageal Doppler probe all 
reported on its ease of use and the ability to quickly adjust the probe after the patient 
was moved into the various positions required for surgery (Abbas and Hill, 2008). The 
LIDCO system is relatively new and its reliability is being ascertained.
Further work, with a larger number of patients who are fluid-optimised and receiving 
various analgesic regimes, needs to be undertaken to measure further cardiovascular 
variables in order to allow protocols to be developed that reduce the cardiovascular 
stress placed on the patient.
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1.7 Fluid therapy -  A key confounder.
There have been few areas in medicine as controversial as fluid management. The 
debates and publications regarding whether to have liberal or restrictive fluid 
administration protocols have been major points of discussion as has the issue of 
whether to use crystalloids or colloids. These issues are further complicated by the type 
of surgery performed, with evidence that a more restrictive fluid regime is required in 
thoracic surgery than in abdominal surgery due to the very strong association between 
the amount of administered fluid and the development of post-pneumonectomy 
pulmonary oedema (Moller et al., 2002, Zeldin et al., 1984).
One of the key factors in the aetiology of postoperative morbidity is covert compensated 
hypovolaemia. This may not be detected by routine heart rate and arterial pressure 
measurements. The belief is that splanchnic and cutaneous vasoconstriction (Jonsson et 
al., 1987) maintains the blood pressure prior to surgery despite the presence of 
hypovolaemia. Hypoperfusion, as a consequence of hypotension, is thought to occur 
during anaesthesia once the sympathetic vasoconstriction is lost (Kleinman, 2002) on the 
background of dehydration from fasting, bowel preparation and evaporative losses from 
the abdomen during surgery.
Shires was the first to promote liberal fluid regimes in the early 1960s (Shires et al., 
1961), a few years after Francis Moore first advocated fluid restriction. Moore’s 
argument was that the stress of surgery caused sodium and fluid retention and proposed 
that fluids should be restricted. Shires however believed that major surgery was 
associated with a loss of intravascular fluid into the interstitial fluid, which became
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known as the “third space” and hence Shires believed that patients needed liberal fluid 
therapy to replenish and maintain the intravascular volume. Many people supported this 
belief and as a consequence it was common practice to see large volumes of fluid given 
to peri-operative patients. There was such a marked increase in the amount of fluid that 
was given to patients, with a concerning increase in pulmonary oedema, that it provoked 
Moore and Shires to publish a joint paper entitled “Moderation” (Moore and Shires, 
1967). However, liberal fluid regimes continued as standard practice, a consequence that 
was in part propagated by overestimation of pre and intra-operative fluid losses and by 
the fact that supra-normal oxygen delivery (Shoemaker et al., 1988) as a consequence of 
cardiac output optimisation using fluid and inotropes showed improved outcome
It has become evident that caution regarding fluid volumes administered needs to be 
exercised, as the administration of excessive fluid in the peri-operative period can cause 
multi-organ dysfunction. The accumulation of fluid in the lungs can initially cause 
pulmonary oedema with respiratory failure that can be fatal (Arieff, 1999). Failure to 
clear this fluid can later predispose to pneumonia. Increasing fluid volumes can cause 
excessive demand to be placed on the heart as increasing volumes of fluid push 
Starling’s curve to the right and hence increase stroke work. The increased demand 
placed on the heart may create a disparity between the myocardial oxygen delivery and 
oxygen consumption, a situation that results in serious cardiological complications 
(Holte et al., 2002).
Liberal fluid therapy causes gastrointestinal motility to be inhibited with the 
prolongation of the post-operative ileus (Holte et al., 2002, Lobo et al., 2002) in addition
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to the belief that excess fluid may cause oedema at the anastomosis causing poor 
anastomotic healing.
Whilst fluid therapy has been aggressively debated, its evolution has brought us to a 
position of better understanding regarding fluid management. The initial studies 
compared fixed volume fluid regimes with fixed volume regimes in patients undergoing 
open colorectal surgery. With time this has changed to flexible fluid regimes guided by 
an oesophageal Doppler, allowing variable volumes of fluid to be administered 
according to the response to the fluid challenge.
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1.8.1 Fixed fluid regimes leading to the development of Doppler guided regimes
There have been four prospective randomised trials (Brandstrup et ah, 2003, Kabon et 
ah, 2005, Nisanevich et ah, 2005, Holte et ah, 2007) that have investigated intra­
operative fluid restriction, standard therapy, or liberal fluid therapy respectively in 
general surgery. These studies are presented in Table 7. Three of the studies focused on 
patients undergoing open colo-rectal surgery and one on general surgical patients 
undergoing open upper and lower gastro-intestinal (GI) surgery.
Although the number of studies is small, several end-points are comparable. One of the 
problems with analysing these studies is the wide variety of fluids that have been used 
(and not recorded in others) both pre-operatively and intra-operatively as shown in table 
7. Additionally, in some studies different fluid regimes were used for different limbs of 
the trial (Kabon et al., 2005).
Table 7: Type of fluid used pre and intra-operatively
Brandstrup 
(Brandstrup 
et al., 2003)
Kabon 
(Kabon et al., 
2005)
Nisanevich 
(Nisanevich 
et al., 2005)
Holte 
(Holte et al., 
2007)
Type of 
Surgery
Colorectal Colorectal Colorectal
Upper and 
lower GI
Pre­
operation
5% glucose 
or
0.9%NaCl
? fluid 
given
Dextrose/
saline
Ringer’s
Lactate
Intra­
operation
HAES or 
HAES + 
NaCl
Ringer’s
lactate
Ringer’s
lactate
Ringer’s 
lactate + 
voluven®
HAES - hydroxyethyl starch, NaCl — sodium chloride.
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Another problem is that the definitions of the fluid regimes used by the different authors 
are extremely varied for the three categories (restricted, standard and liberal). In the 
^restricted’ fluid regime defined by Nisanevich et al (Nisanevich et al., 2005), they 
found that an average of 1.4 +/-0.9 litres was given whilst the ^restricted’ fluid regime 
described by Kabon et al (Kabon et al., 2005) administered more than twice this volume 
with an average of 3.1+/-1.5 litres. Brandstrup et al (Brandstrup et al., 2003) defined a 
’standard’ regime of fluid management which resulted in an average of 5.4 (2.7-11.1) 
litres per patient, whilst Nisanevich et aTs (Nisanevich et al., 2005) definition of 
‘liberal’ fluid therapy gave 3.8 +/-1.2 litres per patient. Similarly Kabon et aTs (Kabon 
et al., 2005) ’liberal’ fluid regime resulted in 5.7+/-2.0 litres, 50% more than that of 
Nisanevich et al (Nisanevich et al., 2005) ‘liberal’ protocol. Within these studies, there 
was no difference in the length of surgery between the two groups of each trial, although 
the mean length of surgery between the studies ranged from two hours to four hours. As 
the fluid regime definitions resulted in such a broad spectrum of fluid given, it was 
necessary to re-classify the regimes in terms of the volume of fluid given in order to 
analyze them as shown below (see table 8).
Table 8: Re-classification of the studies according to average fluid volumes given
Restricted 
(<2 litres)
Standard 
(2-4 litres)
Liberal 
(>4 litres)
Brandstrup (Brandstrup et al., 2003) 2.7 5.4
Kabon (Kabon et al., 2005) 3.1 5.7
Holte (Holte et al., 2007) 1.64 5.05
Nisanevich (Nisanevich et al., 2005) 1.4 3.8
Reclassification revealed that the most striking observation is the complication rates. 
Table 9 presents various aspects of the different studies for comparison.
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Table 9: Complications in the three groups.
Restricted 
group (R)
Standard 
group (S)
Liberal 
Group (L)
Significant P-values 
(Fishers Exact Test)
Total number of 
patients
93 268 217
Pulmonary
oedema
1 0 5* S:L= 0.017
Intra-operative
hypotension
27/93
(29%)
1/75
(1.3%)
9/16
(56%)
R:S<0.001
R:L=0.04
S:L<0.001
Postoperative
hypotension
20/69=
(28%)
16/72=
(22%)
Pneumonia 5 8 10*
MI 1 1 1*
Arrhythmia 3 3 1*
Deaths 0 0 5 S:L=0.017
Patients with 
complications
29/93
(31%)
48/268
(17%)
58/217
(27%)
R:S= 0.012 
S:L=0.021
Total number of 
complications
50/93
(54%)
58/268
(22%)
113/217
(52%)
R:S<0.001
S:L<0.001
Numbers marked with an asterix indicate that the actual number from the studies may be 
greater.
Deaths were clearly reported in all the studies. The deaths, which were five in total, were 
all in the liberal fiuid regime group. Four of the deaths were from Brandstrup et aTs 
study where two of the cases died from pulmonary oedema, one from pulmonary 
embolus and one from pneumonia. The fifth patient died from another study (Nisanevich 
et al., 2005) due to pulmonary oedema. The liberal therapy group had at least 5 patients 
with pulmonary oedema.
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In Kabon et al’s (Kabon et al., 2005) paper there is no formal list documenting the exact 
number of patients with specific complications. In their discussion, they mention that 
several patients from the liberal volume group, were admitted to intensive care. Three of 
these had surgical site infection, one had a myocardial infarction and one had an 
arrhythmia. Despite this limitation, there were at least five patients that were admitted to 
intensive care, all from the liberal fiuid group with pulmonary oedema and none from 
the standard therapy group (p=0.017).
Only Nisanevich et al (Nisanevich et al., 2005) clearly reported intra-operative 
hypotension that responded to fiuid therapy. In this study, patients in the restricted group 
had significantly more intra-operative hypotensive episodes that required fiuid therapy 
to correct them. Holte et al (Holte et al., 2007) gave 10 mg of intravenous ephedrine and 
40 mg of intramuscular ephedrine at induction. They treated all hypotension with 10 mg 
of ephedrine intravenously. The presence of hypotension in their ‘restrictive group” 
implies that there will be some degree of compensatory splanchnic vasoconstriction. 
Hypotension threatens an increased morbidity in terms of anastomotic healing (Foster et 
al., 1985) and further vasoconstriction with ephedrine may worsen the problem. This 
may in part explain why their fiuid restricted group had 3/16 anastomotic leaks whilst 
the liberal fiuid group had 0/16 anastomotic leaks. In Nisanevich et al’s (Nisanevich et 
al., 2005) study the restricted (according to the re-classification above) fiuid therapy 
regime did seem advantageous in terms of significantly shorter time to pass flatus and 
time in hospital (3 vs 4 and 8 vs 9 days respectively). This suggests that hypotension due 
to hypovolaemia has far fewer serious consequences if treated with fiuid than with
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inotropes. There was no significant difference in post-operative hypotension or hospital 
stay between the standard therapy and liberal therapy regimes.
Nisanevich et al (Nisanevich et al., 2005) found that a restricted fiuid regime resulted in 
a shorter hospital stay and fewer complications. However when Holte et al (Holte et al.,
2007) compared their restricted fiuid regime with the liberal regime they found no 
difference in the length of hospital stay or the length of post-operative ileus. The only 
difference was slightly better respiratory function in the restricted group, but this was 
associated with significantly more complications in the restricted fiuid therapy group. 
Holte et aTs (Holte et al., 2007) study was small in comparison with Nisanevich et aTs 
(Nisanevich et al., 2005) which was five times larger.
Analysis in table 9 showed that the standard fiuid therapy group had the lowest number 
of patients with complications and the lowest total number of complications. This was 
significantly different from the restricted and liberal therapy groups. The lack of 
reported complication data from Kabon et al (Kabon et al., 2005) means that this 
analysis may assist with understanding the trends, though the figures documented may 
be under-reporting, (i.e. there may be additional complications that are not reported).
In summary, fiuid therapy on its own plays a major role in the patients’ outcome and it 
must be optimized to ensure that it does not become a confounding factor. Liberal intra- 
operative fiuid therapy appears to be associated with severe complications (death and 
pulmonary oedema) whilst restricted fiuid therapy is associated with numerous 
hypotensive episodes and an increased complication rate, though this regime may have 
slightly shorter hospital stays. For open abdominal surgery, the evidence favours the
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standard fluid therapy regime due to its lower complication rate. With fixed volume 
regimes, the problem remains the fact that unless a device is used to guide fluid volume 
replacement, there is no way of clinically ascertaining the volume of fluid that needs to 
be administered to each patient.
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1.8.2 Flexible regimes with Doppler-directed fluid replacement.
The key issue with all the studies above is that fixed-volume fluid regimes (ml/kg) have 
been used whilst failing to measure oxygen delivery. Excess fluid in addition to a 
volume required for maximal oxygen delivery will predispose the patient to 
complications, whilst restrictive regimes wül prevent maximal oxygen delivery from 
being achieved. The slowly evolving opinion is that a generic formula that covers all 
patients is not appropriate and that the correct amount of fluid needs be determined for 
each individual patient at the correct time. The risks associated with pulmonary catheter 
use (Connors et al., 1996) to attain this have given way to alternative methods to assess 
the cardiac output such as the oesophageal Doppler probe. Trials using target-driven 
oesophageal Doppler-directed fluid replacement have all shown a reduction in hospital 
stay (Mythen and Webb, 1995, McKendiy et al., 2004, Sinclair et al., 1997, Verm et al., 
2002, Gan et al., 2002, Conway et al., 2002, Wakeling et al., 2005, Noblett et al., 2006a) 
or a reduction in critical care admissions (Conway et al., 2002) in all fields of surgery 
(see Table 10).
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Table 10: Benefits of oesophageal Doppler use related to the type of surgery
Number of 
patients
Type of 
surgery
Outcome
Mythen (Mythen and 
Webb, 1994)
60 Cardiac
37% reduction 
in stay
McKendry (McKendry 
et al., 2004)
174 Cardiac
39% reduction 
in stay
Sinclair
(Sinclair et al., 1997)
40 Orthopaedic
39% reduction 
in stay
Venn
(Venn et al., 2002)
90 Orthopaedic
44% reduction in 
stay (medically fit)
Gan
(Gan et al., 2002)
100
General/gynae/
urology
29% reduction 
in stay
Conway
(Conway et al., 2002)
55 Colorectal
Reduction in 
critical admissions
Wakeling
(Wakeling et al., 2005)
128 Colorectal
13% reduction 
in stay
Noblett
(Noblett et al., 2006a)
103 Colorectal
22% reduction 
in stay
Studies examining fluid administration in abdominal surgery have primarily recorded 
the total volumes of fluid infused, with only a few studies measuring oxygen delivery 
and the timing of fluid administration in open surgery. Studies by Wakeling (Wakeling 
et al., 2005) and Conway (Conway et al., 2002) have shown that oxygen delivery 
targeted by manipulating cardiac output is the most significant factor in determining 
morbidity and length of stay. By giving enough fiuid to achieve good oxygen delivery 
and normal oxygen extraction, but restricting fluids beyond this point we would expect 
to see
a) Benefits of the restrictive fiuid regimes
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b) Avoidance of pulmonary oedema /bowel oedema that occurs with liberal fluid 
regimes.
More recently it has also been demonstrated that fluid replacement is not only dependant 
on the volume of fluid given but also on the timing with relation to surgery that it is 
given (Noblett et al., 2006a). Fluid therapy needs to be optimized to ensure that the best 
physiologically possible cardiac output, and hence oxygen delivery, is obtained 
removing the risks of excess or restricted fluid.
Cardiac output has traditionally been measured using a pulmonary artery catheter. 
However concerns have been raised over the benefit of pulmonary artery catheters 
(Connors et al., 1996, Bernard et al., 2000, Harvey et al., 2005), the time taken to insert 
them (Lefrant et al., 2000) and the procedural complications (McArthur, 2006, Slung 
and Scher, 1984) associated with their use. This has been accompanied by the 
increasing use of less invasive techniques like oesophageal Doppler ultrasonography to 
measure cardiac output. Consequently, in view of the evidence, the oesophageal Doppler 
probe will be used for all participants of this trial to remove the bias component that 
would arise from using fixed-fluid regimes.
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1.9.1 The oesophageal Doppler.
Aortic Doppler measurements started in the late 1960s. Initial attempts directed the 
ultrasound beam towards the aortic arch. Later suprasternal trans-thoracic Doppler 
probes (Barreto et al., 1970) were developed that obtained good quality signal from the 
ascending aorta. These probes were not widely accepted because probe instability 
limited their use for repeated measurements over extended periods of time.
The oesophageal Doppler was developed in the early 1970s (Side and Gosling, 1971). 
The oesophageal probes were recognised to have two significant advantages over supra­
sternal probes. The first was that the muscle tone of the oesophagus provided a natural 
means of maintaining the probe in position for repeated measurements. The second was 
the close anatomical proximity of the oesophagus to the aorta, which minimised signal 
interference.
The current oesophageal Doppler probe is composed of 2 main parts - the Doppler probe 
itself and the monitor that computes the data and projects the results. The oesophageal 
Doppler probe (see figure 8) is flexible and measures 90 cm in length and 5.6 mm in 
diameter. It is latex-free and is licensed for use with adults 16 years and above. The 
probe has depth markers at 35 cm, 40 cm and 45 cm to facilitate correct probe placement 
within the oesophagus. The probe may be inserted orally or nasally and may be left in 
situ for days to weeks (Singer et al., 1989). A strong Doppler signal is normally 
acquired between 35 -  40 cm in oral insertion or 40 -  45 cm in nasal insertion. The 
ideal probe tip location is at the point where the aorta is adjacent and parallel to the
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oesophagus which is located between the fifth and sixth thoracic vertebra (Histand et al., 
1979).
The tip contains two piezo-electric crystals, one transmitting ultrasound waves (4 MHz 
continuous) towards the blood flowing in the descending aorta, and one receiving 
ultrasound waves reflected back from the red blood cells. The information is translated 
by the monitor into a real time display of the velocity of blood against time. The older 
oesophageal Dopplers used a 5 MHz pulsed wave, but there is a theoretical risk that this 
could bum a hole in the oesophageus and consequently only continuous ultrasound 
waves are now used.
The probe connector on the Doppler probe facilitates connection to the Patient Interface 
Cable, and contains a memory device that stores the patient’s nomogram and details of 
where and when the probe has been used. If necessary, the probe can be withdrawn and 
stored for re-use on the same patient, providing that the re-use occurs within the defined 
probe life. There are various Doppler probes with different life spans, though most 
range from 6 hours to 240 hours of monitoring.
The oesophageal Doppler is not licensed for use in patients less than 16 years of age. Its 
use is contra-indicated in patients with conditions that carry the risk of causing injury or 
perforations, with carcinoma of the pharynx, larynx or oesophagus, and with tissue 
necrosis. The turbulent aortic blood flow associated with aneurysms of the thoracic 
aorta and proximal coarctation of the aorta cause the oesophageal Doppler to be 
unreliable in these settings.
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yFigure 8: Oesophageal Doppler probe
The monitor (see figure 9) is initially set up on the opening screen with the insertion of 
patient age, height and weight. From the nomograms, these factors are used to estimate 
the cross-sectional area of the aorta. Once the Doppler probe has been inserted and the 
aortic velocity signal has been optimized, the changes in signal frequency are calculated 
by the monitor that then displays numerous variables including cardiac output, stroke 
volume and heart rate.
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Figure 9: The oesophageal Doppler monitor
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1.9.2 Theory and theoretical considerations.
Many of the equations below use the term “aortic velocity’ to calculate different 
variables. The oesophageal Doppler probe measures blood velocity by emitting an 
ultrasound beam that is directed at the column of flowing blood. The ultrasound 
beam is reflected back at a different frequency. The degree of frequency change is 
known as the Doppler shift. This is directly proportional to the velocity of red blood 
cell flow and the relationship is shown in the following equation (Huntsman et al., 
1983)
Doppler shift frequeney=(2vfcos0)/c
Where v=velocity of a red blood cell, f=transmitted frequency, c=velocity of the 
sound wave and 0 is the angle between the ultrasound beam and the blood flow. 
Rearranging the equation allows calculation of the aortic velocity.
As the velocity changes are calculated, they are recorded in a waveform as shown in 
figure 10. From this trace the heart rate and peak velocity are obtained as direct 
readings whilst the stroke distance, cardiac output, cardiac index, oxygen delivery 
index and systemic vascular resistance index are calculated.
The area under the accelerating and decelerating velocity curve is the stroke distance 
and when multiplied by the CSA gives the descending aortic output. When 
multiplied by a correction factor of 1.42 that accounts for blood loss to the 
brachiocephalic and coronary vessels, the cardiac output is obtained.
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Figure 10: Descending aortic waveform.
The cardiac output is directly related to the heart rate (HR) and the stroke volume (SV) 
CO=HRXSV.
The SV is calculated once the cardiac output is the derived from aortic velocity 
measurements.
Whilst there are many other readings from the oesophageal Doppler monitor, the key 
value of note for fluid optimization, is the cardiac output. This is the factor that will 
influence the oxygen delivery (DO2) as the formula for this is:
D02=Haemoglobin (hb)x 1.34 x cardiac output x oxygen saturation.
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This is calculated from the monitor by inputing the hb level, CO and oxygen saturation, 
and the indexed figure will also be calculated, corrected for body surface area.
The oesophageal Doppler monitor also calculates the systematic vascular resistance 
(SVR), for which the formula is:
SVR= (mean arterial pressure-central venous pressure) / cardiac output.
This again is calculated by inputting the required figures, and the SVRI is also 
calculated. In view of the very steep head down position with an extremely raised CVP 
in this position, it is important that this value is subtracted from the MAP to give an 
accurate SVR.
Figure 11 (Berton and Cholley, 2002) shows the velocity of blood in the descending 
aorta against time. The area under the maximum aortic velocity envelope (VTI) 
represents the stroke distance. The stroke distance is the distance a volume of blood is 
pushed forward by one left ventricular compression and is measured in centimetres. 
When the stroke distance (cm) is multiplied by the cross sectional area (cnf), the result 
is the stroke volume (cm^).
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Figure 11: Calculations of the stroke volume
The SV=VTIXCSA
And the C0= HRX SV
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Therefore CO=HRX VTI X CSA
There are several theoretical assumptions.
1) There are no changes in CSA with time, and blood in the descending aorta 
has negligible flow in diastole. The equations above ascertained that
SV=Velocity time integral (VTI) X CSA
The cardiac cycle however does cause dynamic changes in both velocity and 
CSA related to time. Consequently if this is taken into account it requires 
continuous integral computation of the signals.
SV=VTI X a(“ CSA / (ti-t2)-dt
where VTI is the velocity time integral, bis the start time of a cardiac cycle 
and t2 is the finishing time of the cardiac cycle, and tzf^  CSA the changing 
cross sectional area during that time period.
Studies have shown that the CSA of the descending aorta changes between 
3%-12% (Greenfield and Patel, 1962) during a cardiac cycle. Mean arterial 
pressure and age are the predominant factors that affect the CSA (Merillon et 
al., 1978). However a constant CSA is used for Doppler computation of the 
stroke volume based on age, weight and height nomogram.
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2) The second assumption is that all the red blood cells are moving at a uniform 
velocity and that the velocity is constant at all points across the aorta. The 
point of concern is the thickness of the boundary layer in contact with the 
aorta wall. This is important as the Doppler probe will record the fastest 
signal. If the boundary layer is thin then the effect is negligible and vice 
versa if it is thick. A study (Bellhouse et al., 1969) in humans has shown a 
thin boundary layer with negligible effect on the cardiac output.
3) The estimated numerical value obtained for the stroke volume is the increase 
of volume of blood in the descending aorta. This volume of blood passing 
down the descending aorta is only approximately 70% of the actual stroke 
volume from the left ventricle as some of the stroke volume leaves via the 
large vessels that come off the aortic arch. Therefore a correction factor is 
built into the monitor to correct for this with the assumption that there is a 
constant (70:30) division of blood flow between the descending aorta and the 
brachiocephalic and coronary arteries.
4) Lastly there is the assumption that the size of the aorta is equal to the 
effective size of the vessel through which there is flow. This is not true in 
severe aortic stenosis or coarctation of the aorta. Consequently the Doppler 
probe is unreliable in these clinical situations and should be avoided
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1.9.3 Practical considerations
To aid with insertion and signal acquisition, a water-based lubricant is liberally applied 
to the tip of the probe. The beveled edge of the tip is the source of the ultrasound wave. 
This should therefore face the back of the throat during insertion so that when it is in 
position in the oesophagus, (see figure 12) the beveled face is oriented posteriorly 
towards the descending aorta.
i t .
Figure 12: Intra-thoracic position of the Doppler probe
Once the probe is inserted to the required depth marker, the signal is optimized by slow 
rotation in the long axis and alteration of the depth of insertion until the characteristic 
descending aortic waveform can be seen and heard.
The ideal aortic waveform should have a sharp, well-defined outline with a 
predominantly black centre, yellow and red colouring in the outline and a small amount 
of white in the trailing edge of the wave-form (Figure 13). The signal is also transmitted
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via an audio speaker to assist the user in optimising the position. The optimum signal 
has the sharpest, clearest sound typically described as a “whip crack sound”. The depth 
and orientation of the probe is crucial, as signals from other vessels will produce 
incorrect results. The manufacturers recommend altering the depth and the orientation 
individually to allow the quickest time to obtaining a good signal.
Figure 13: Ideal aortic waveform
The probe should be adjusted before every reading to ensure that the best signal possible 
is obtained. The use of the oesophageal Doppler probe has increased substantially due to 
its many advantages. These include the fact that only a short period of training is 
required (Lefrant et al., 1998) and the Doppler probe can be inserted within minutes 
(Rodriguez and Berumen, 2000), in contrast to pulmonary artery catheters where the 
median time of insertion ranges from 52.9 minutes (Wilkinson et al., 2000) to 120 
minutes (Lefrant et al., 2000) in different centres. In addition the oesophageal Doppler 
probe is minimally invasive and gives real-time measurements.
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There is good correlation between measures of cardiac output made simultaneously with 
the oesophageal Doppler monitor and conventional thermodilution (Singer et ah, 1989). 
Fluid optimization programmes using intra-operative oesophageal Doppler monitoring 
lead to shorter hospital stays and decreased morbidity in patients undergoing colorectal 
surgery (Noblett et al., 2006a, Wakeling et al., 2005).
The main disadvantage is dislodgement of the Doppler probe, which results in a sub- 
optimal velocity wave being obtained and consequently produces inaccurate 
physiological readings. It is therefore essential to ensure that signal quality is optimal 
before every reading in order to prevent invalid physiological values. In addition the 
presence of naso-gastic tubes produces interference and consequently inaccurate 
readings.
The oesophageal Doppler has been shown to have many advantages. With basic training, 
it can easily be used to ensure fluid optimisation which has been shown to be beneficial 
for patient outcome (Abbas and Hill, 2008).
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1.10 The influence of analgesia on lung function
Numerous studies have reported that in open surgery, epidural analgesia offers many 
benefits (Popping et ah, 2008). One of the aspects where the use of epidural analgesia 
has been shown to be useful is in preserving pulmonary function and reducing 
pulmonary complications (Gendall et al., 2007).
There are now several meta-analyses that have looked at these factors in open surgery 
and these meta-analyses have shown that the use of epidural analgesia reduced the 
incidence of pneumonia (Urwin et al., 2000, Guay, 2006, Liu et al., 2004, Popping et al., 
2008, Block et al., 2003, Ballantyne et al., 1998, Rodgers et al., 2000). One of the 
problems with the earlier meta-analyses was that they grouped the respiratory 
complications together with the result that atelectasis and respiratory failure requiring 
intubation were both simply classified as a single respiratory complication (Guay, 2006, 
Liu et al., 2004) although this was corrected in later meta-analyses that had clearer 
definitions.
More importantly and in keeping with changes in peri-operative patient management, 
the meta-analysis by Popping et al clearly showed over the past 35 years, the respiratory 
benefits of epidural compared to PC A have decreased significantly (Popping et al.,
2008). Meta-analysis of trials fi*om the 1980s showed that the number needed to be 
treated to prevent a pneumonia by using an epidural was 9. In the 1990s, this increased 
to 23 and between 2000 and 2006, this had further increased to 25 (Popping et al., 2008). 
This is interesting because over this time, the definitions of pneumonia have not changed 
significantly and neither have the techniques of epidural analgesia, although there has
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been some degree of variation regarding the placement lumbar and thoracic epidurals. 
What has changed over this period has been the progressive encouragement to mobilize 
patients and the use of chest physiotherapy.
In terms of quantifying the respiratory benefit of these analgesic regimes, different 
aspects have been investigated. Carli et al’s primary outcome was fiinctional exercise 
capacity as measured by the 6-minute walking test and their secondary outcome was 
quality of life assessed by using the SF 36 health related quality of life score (Carli et al., 
2002). They did their tests at 3 weeks and at 6 weeks and they found that patients in the 
epidural group were able to mobilize significantly fiirther than patients in the PCA group 
at 3 and 6 weeks.
In terms of formal respiratory measurements, the recent comprehensive metaranalysis by 
Popping et al reported that the use of epidural analgesia significantly improved forced 
vital capacity (FVC) at 24 hours, forced expiratory volume in 1 second (FEVl) at 24 
hours and peak expiratory flow rate (PEFR) at 24 hours (Popping et al., 2008).
The marked change regarding “early active mobilization” that is now used within the 
ERP may further narrow the benefits of epidural analgesia over PCA in terms of 
maintaining lung function. In addition to this, laparoscopic colorectal surgery analysed 
independently of analgesic technique might be expected to preserve pulmonary function 
better than open surgery due to the smaller incisions. However, at present the effect of 
the epidural, spinal and PCA on post-operative lung function measured with PEFR, FVC 
and FEVl / FVC has not been studied yet within this laparoscopic context.
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1.11 Quality of life related to analgesic modality used.
Health-related quality of life is increasingly being used as a primary outcome in clinical 
trials (Bottomley, 2002). This has been recently demonstrated in the EnROL (Enhanced 
Recovery, Open versus Laparoscopic) trial where the primary end point is not length of 
stay but rather post-operative physical fatigue. Following open abdominal surgery, the 
quality of life is reported to be enhanced by the use of epidural analgesia (Carli et al., 
2002). A meta-analysis from 2007 that assessed epidural analgesia versus parenteral 
opioid analgesia showed that epidural analgesia was associated with improved analgesia 
and a decrease in the length of post-operative ileus (Marret et al., 2007). In nearly all of 
the studies that were included, the cases were performed as open procedures. As a 
consequence of lower pain scores and post-operative ileus, it would seem predictable 
that the quality of life in the early post-operative period would be improved.
A systematic review of the quality of life following laparoscopic surgery compared to 
open colorectal surgery revealed that there was no difference between these 2 
approaches (Dowson et al., 2008). There were however a number of issues that 
accounted for the finding of no difference between the 2 approaches such as many of the 
surgeons being on their laparoscopic learning curve. Recent work performed in this 
department (Henry Dowson, personal communication) demonstrated that there was a 
significant difference in favour of laparoscopie surgery in quality of life scores between 
patients recovering from laparoscopic and open colorectal surgery
Hence, if the use of epidural analgesia improves the quality of life following open 
surgery and the use of the laparoscopic approach as an independent factor also improves
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the quality of life, the question to be answered is whether the use of epidural analgesia 
used as the analgesic modality offers any advantage in post-operative quality of Hfe 
compared to other analgesic modalities in patients undergoing laparoscopic colorectal 
surgery.
This study used the SF-36 questionnaire (Ware and Sherboume, 1992). This is a generic 
questionnaire that is designed to measure specific aspects of quality of life and it is one 
of the most widely used health status questionnaires in the world (Bowling and Ebrahim, 
2005). It has been used extensively following laparoscopic and open colorectal surgery 
(Roblick et al., 2002) and it is now the quality of life questionnaire that is currently 
recommended for the evaluation of these procedures by the European Association for 
Endoscopic Surgery (Veldkamp et al., 2004). As a result of its wide and fi*equent use, it 
allows comparison with other patient groups and has the advantage of being single, 
relatively quick to use (each questionnaire taking 10 minutes to complete), and is 
suitable for self-administration.
Patients were required to complete SF-36 questionnaires at 0, 1,2,3 and 4 weeks post- 
operatively. This acute version, which has been validated, was used weekly for the first 
4 weeks following surgery (Bowling, 1997). The standard SF-36 questionnaire is 
completed at 0, 1 , 2 , 4  and 6 weeks. The acute version was chosen in view of the fact 
that many patients treated with a laparoscopic procedure within an ERP have very short 
hospital stays and as a consequence of the quick recovery, the period to detect a 
difference is early in the post-operative period. The SF-36 questionnaire is composed of 
36 items that measure 8 main variables, each of which consists of a different number of 
items.
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The 8 main variables are:
Physical functioning (10 items),
Social functioning (2 items).
Role limitations due to physical problems (4 items)
Role limitations due to emotional problems (3 items)
Mental health (5 items)
Energy and vitality (4 items)
Pain (2 items)
General perception of health (5 items)
For each variable item scores are coded, summed, and transformed on to a scale from 0 
(worst possible health state) to 100 (best possible). The eight variables can be combined 
into physical and mental health summaries, as well as an overall score.
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1.12 The systemic response in colorectal surgery
The systemic response to major surgery may be sub-divided into the stress, 
inflammatory and immune response. It continues to be a contentious subject with many 
unanswered questions. One issue is that the terms “stress response”, “inflammatory 
response” and “immune response” are often used vaguely and even interchangeably as if 
they have similar meanings whilst they in fact have very distinct definitions. Another 
area is that various analgesic interventions modify aspects of this response. The overall 
effects / benefits of this have yet to be proven.
The trauma caused by surgery results in marked systemic changes resulting in:
1) Activation of the classical systemic stress response, mediated by neuroendocrine 
pathways and a consequent catabolic response
2) Activation of the acute phase response via IL-6
3) Suppression of the cell mediated host immune function (Immune Response).
Clarification of what the terms mean together with the influence exerted by the use of 
epidural analgesia and laparoscopy are discussed below.
1) Systemic stress response - The stress response arises as a consequence of the 
surgical insult and is similar to the normal physiological response to stress. One 
of the main hormones released as part of the stress response is 
adrenocorticotropic hormone (ACTH), which is released fi*om the anterior 
pituitary and consequently results in the secretion of cortisol from the adrenal 
cortex. In addition, there is secretion of catecholamines, glucagon and growth
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hormone with a decrease in insulin secretion. This results in hyperglycaemia and 
relative insulin resistance and a catabolic state.
Of the many markers of the stress response, insulin levels have been used. There 
is increasing evidence that suggests that insulin resistance in surgical stress is 
associated with poorer outcomes (Ljungqvist et al., 2002). Nygren et al found 
that the administration of pre-operative carbohydrate drinks caused a reduction in 
the post-operative insulin resistance (Nygren et al., 2007). This was one of the 
main reasons why carbohydrate pre-loading was incorporated into the ERP. The 
lower the stress response, with lower levels of counter-regulatory hormones, 
leads to lower levels of insulin being secreted. Therefore, the measurement of 
insulin in the post-operative period is useful to help evaluate the degree to which 
the stress response has been activated (Thorell et al., 1999).
The secretion of these stress hormones is driven by the afferent stimuli (from the 
site of the surgical trauma) that are consequently conducted centrally via the 
spinal cord. The use of epidural analgesia to block these afferent stimuli has been 
shown to result in a decrease of the stress response (Holte and Kehlet, 2002). 
This blockade is dependant on:
• The level that the epidural is placed
• The time that the epidural is started relative to the commencement of 
surgery
• The length of time that the epidural is running.
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It is for this reason that the ERP states that a thoracic epidural rather than a 
lumbar epidural be used in order to ensure that there is sufficient coverage of the 
surgical field so as to block the stimuli. The ERP also recommends that the 
epidural be started prior to the first incision and that it continues for two days. In 
order to avoid a temporary afferent stimulus block, Holte and Kehlet state that 
“single dose neural blockade, applied as either intra-operative epidural or spinal 
anaesthesia has only a transient stress reducing effect without prolonged 
endocrine or metabolic effects” (Holte and Kehlet, 2002).
There is evidence that if epidural analgesia is used according to the ERP 
guidelines, its use results in decreased levels of catabolic hormones, plasma 
glucose, gluconeogenesis and lipolysis (Holte and Kehlet, 2002).
With regards to protein metabolism, several studies comparing single dose 
epidural with local anaesthetic versus general anaesthetic alone showed no 
difference in protein metabolism (Lattermann et al., 2001). There are however 
additional factors to consider which influence protein metabolism as shown by 
Tsuji et al (Tsuji et al., 1987) who compared nitrogen excretion following 
surgery in 3 groups of patients undergoing gastrectomy -
• Group 1 -  Received general anaesthetic alone + IM analgesia post- 
operatively
• Group 2 -  Received prolonged epidural analgesia with local anaesthetic 
throughout surgery and post-operatively for 72 hours
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• Group 3 -  Received epidural analgesia with local anaesthetic intra- 
operatively only and then epidural analgesia using opioids rather than 
local anaesthetic post-operatively. >
They found nitrogen excretion to be significantly less in groups 2 and 3 than 
group 1. However, nitrogen excretion in group 2 was only slightly lower than 
group 3 with a similar pattern noticed for cortisol and catecholamine levels post- 
operatively. Similar results by Schricker et al (Schricker et al., 2000) were found 
in patients undergoing colonic surgery with thoracic epidural, although Licker et 
al (Licker et al., 1994) found no reduction in nitrogen excretion when a lumbar 
epidural was used. Therefore short-term regional blockade with local anaesthetic 
followed up with adequate post-operative analgesia appears to provide 
comparative results to prolonged epidural analgesia with local anaesthetic in 
terms of nitrogen excretion.
The studies above were initially performed in patients undergoing open surgery 
and a further dimension has now been added by performing the surgery using a 
laparoscopic approach. A review by Kehlet in 1999 assessing whether the 
endoscopic approach reduced the stress response generally showed no significant 
difference in the endocrine (cortisol, adrenalin, insulin) or metabolic (protein, 
lipid and glucose) response (Kehlet, 1999). The main problem was that many of 
the earlier studies included in the analysis did not look at major bowel resections 
but rather at smaller procedures like open cholecystectomy versus laparoscopic 
cholecystectomy. Furthermore, these studies were not carried out within an ERP, 
which incorporates factors that are known to decrease the stress response to
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surgery like carbohydrate pre-loading. However, since this review by Kehlet 
(Kehlet, 1999), later studies have clearly shown that the laparoscopic approach 
does reduce the stress response when compared to open surgery in patients 
undergoing laparoscopic cholecystectomy (Crema et al., 2005, Haque et al., 
2004).
2) Activation of the acute phase response via Interleukin 6 (IH6) -
IL-6 - is a cytokine that is secreted by T cells and macrophages to stimulate an 
inflammatory response to trauma. IL-6 represents an early marker of 
inflammatory activation that is secreted as a consequence of direct trauma, 
surgery or bums. Once secreted, IL-6 then binds to cell-surface type I cytokine 
receptors, which are transmembrane receptors expressed on the surface of cells 
that recognize and respond to cytokines that have 4 a-helical strands. The 
binding of IL-6 then stimulates hepatocytes to produce acute phase reactants and 
B lymphocytes to produce immunoglobulins (Dasgupta et al., 1992).
In terms of analgesic regimes, the use of epidural analgesia has not been shown 
to cause any reduction in the cytokines or acute phase proteins that arise as a 
consequence of surgery (Holte and Kehlet, 2002).
Early reviews assessing the effect of laparoscopy on the inflammatory response 
induced via the interleukins found no benefit from employing laparoscopic 
surgery (Kehlet, 1999). Again, this may have been due to the magnitude of the 
operations being assessed and the absence of ERPs. Newer studies have 
demonstrated that levels of serum IL-6 are significantly lower following
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laparoscopic surgery than open surgery (Wu et al., 2003, Ordemann et al., 2001, 
Evans et al., 2009). In one of these studies (Ordemann et al., 2001), the analgesia 
used was PCA but the analgesic regime used was unclear in the others.
3) Suppression of the cell mediated host immune function -
Cell-mediated immunity involves the activation of macrophages, natural killer 
cells and antigen-specific cytotoxic T-lymphocytes. Cellular immunity protects 
the body by activating cytotoxic T-lymphocytes that are able to induce apoptosis 
in body cells displaying fi*agments of foreign antigen on their surface, such as 
virus-infected cells and cancer cells displaying tumor antigens. Cellular 
immunity also involves the activation of macrophages and natural killer cells 
which allows them to destroy the intracellular pathogens.
As a consequence of surgery, there is a decrease in cell-mediated immunity. The 
use of epidural analgesia does not appear to offer any preservation to this 
function (Holte and Kehlet, 2002).
With regards to the use of laparoscopic surgery, the results of the early studies 
and reviews appeared to show no benefit from the use of laparoscopic surgery 
(Holte and Kehlet, 2002). There is now increasing evidence that post-operative 
cell mediated immunity is better preserved with immune homeostasis restored 
earlier following laparoscopic surgery than open surgery (Evans et al., 2009, 
Ordemann et al., 2001)
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The current understanding is summarized in the table 11.
Table 11: Table summarizing the effects of epidural analgesia and laparoscopy on 
metabolic, immune and cell mediated response.
Endocrine/Metabolic
response
Immune
response
Cell mediated 
response
Use of epidural analgesia 
in open surgery 4/
Use of laparoscopy 4/ 4/ 4/
Use of epidural, spinal or 
PCA with laparoscopy ?
? ?
It is logical to suggest that blocking the stress response is beneficial for patients 
undergoing major abdominal surgery, although there is no firm evidence correlating the 
stress response (eg. cortisol secretion) with a higher incidence of complications or a 
longer length of hospital stay. Furthermore, if they are associated with a higher 
incidence of complications or a longer length of stay, it is not known above what level 
of stress response that it becomes detrimental. Whilst the stress response has developed 
as part of evolution, its benefit within die hospital setting where all the factors that 
support survival are readily present, is questioned.
The individual effects of epidural analgesia and laparoscopy on the stress, inflammatory 
and immune response following surgery have been assessed but the combined effects of 
laparoscopy with various analgesic regimes in fluid optimized patients undergoing 
colorectal surgery within an ERP are not known. Furthermore, it is not known whether 
the analgesic modality with the most effective blockade of the stress response will result 
in the shortest hospital stay.
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1.13 Hypotheses
The hypotheses for this study were:
HO: The type of analgesia used has no effect on the defined patient outcomes, both 
primary and secondary. (Primary=time until medically fit for discharge and length of 
hospital stay, secondary^ return of bowel function, post-operative nausea, vomiting and 
distension, pain scores, additional analgesia, fluid therapy, mobility, complications, 
quality of life, effects on intra-operative cardiovascular changes and post-operative 
respiratory fimction)
HI : The use of epidural analgesia is inferior in terms of the defined patient outcomes 
when compared to PCA or spinal anaesthesia both primary and secondary.
HO: The volume of intra-operative fluid required to fluid optimise patients is equivalent 
to the 3 litres suggested by the ERP.
HI: The volume of intra-operative fluid required to fluid optimise patients is 
significantly less than the 3 litres suggested by the ERP.
HO: The type of analgesia used has no effect on the volume of intra-operative fluid 
required.
HI: Regional anaesthesia results in a greater intra-operative fluid volume requirement 
than PCA.
HO: The type of analgesia used has no impact on the cardiovascular physiology and 
oxygen delivery.
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HI: Regional anaesthesia has a greater impact on the cardiovascular physiology and 
oxygen delivery than PCA.
HO: The level of oxygen delivery (D02) achieved has no effect on the anastomotic leak 
rate.
HI: The level of oxygen delivery (D02) achieved has an effect on the anastomotic leak 
rate.
HO: The type of analgesia used has no impact on the preservation of respiratory 
function.
HI: Regional anaesthesia has a greater impact on the preservation of respiratory 
function.
HO: The type of analgesia used has no impact on the quality of life following surgery.
HI: Epidural analgesia reduces the quality of life following laparoscopic surgery 
compared to PCA or spinal analgesia.
HO: The type of analgesia used has no impact on the stress response following 
laparoscopic surgery.
HI: Regional analgesia reduces the stress response following laparoscopic surgery 
significantly more than PCA.
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2 Methods
2.1. Patient selection and preparation
2.1.1 Patient identification
All patients with colorectal disease (cancer, diverticular disease and inflammatory bowel 
disease) were seen in the outpatient clinic. The patients were investigated with routine 
blood tests and a variety of imaging modalities that included colonoscopy, barium 
enema and computerized topography (CT) colonography.
In patients with suspected neoplastic disease, tissue was required to obtain a definitive 
diagnosis. This was achieved by taking biopsies of the relevant area / tissue at the time 
of the colonoscopy. Patients with proven malignancy, together with those with suspected 
malignancy despite indeterminate histology, were investigated with a CT scan of the 
chest, abdomen and pelvis to assess the extent of disease spread and magnetic resonance 
imaging (MRI) scan for lesions in the lower and mid rectum in order to ascertain the 
extent of contiguous and nodal spread into the mesorectum.
The presence of indeterminate intra-hepatic lesions were assessed with further imaging 
modalities that included ultra-sound and MRI of the liver. In a few patients, where the 
exclusion or diagnosis of neoplastic disease was indeterminate on the CT scan, a 
positive emission tomography (PET) scan was performed.
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All cases with malignancy or suspected malignancy were discussed at the multi­
disciplinary meeting. The patients with benign disease had their cases discussed in clinic 
and were offered surgery based on the potential benefits versus the potential risks.
All patients undergoing planned laparoscopic colorectal resections were considered for 
the trial if they met the criteria below.
2.1.2 Patient selection -  Inclusion criteria
Patients with colorectal disease (benign or malignant) that required a laparoscopic large 
bowel resection that did not involve a stoma or perineal dissection were considered for 
the trial. In cases where a stoma was planned, these patients were not included as 
previous work undertaken in this department revealed that the quality of life was 
significantly affected by the presence of a stoma to the point that no difference was 
found between open and laparoscopic surgery. In view of the significance of this 
confounding factor, only patients who did not have a stoma were included in the trial.
2.1.3 Patient selection -  Exclusion criteria
Patients with rectal cancer that threatened the resection margin were treated with pre­
operative chemo-radiotherapy. A defimctioning stoma was required following rectal 
radiotherapy in order to protect the anastomosis and therefore excluded patients for 
selection. Patients were so excluded from possibly entering the trial if there was a 
contra-indication to the use of regional anaesthesia. This included abnormal clotting, 
skin infection over or near the back or the presence of neurological disorders or
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anatomical abnormalities of the vertebral column. Patients were also excluded if there 
was a contra-indication to the use of the oesophageal Doppler probe such as oesophageal 
disease, recent oesophageal or upper airway surgery, moderate to severe aortic valve 
disease and a bleeding diathesis.
2.1.4 Post diagnosis patient consultation
When the diagnosis and therapeutic options were explained to the patient in the clinic, 
the concept of enhanced recovery was introduced. This explained the proposed post­
operative length of stay, the ability to eat normally until the night before surgery, 
together with the process of active mobilization and early re-introduction of food.
During this consultation, the current post-operative analgesic methods (epidural, spinal 
and PCA) used were explained to the patient explaining that the most ^propriate 
analgesic regime was not known yet and hence introducing the reason for the trial. All 
potential participants of the trial were given the trial information leaflet that had been 
authorized by the ethics committee explaining the process of the trial (see appendix 1).
All patients were assessed at a pre-operative clinic and if there were any concerns 
regarding their health status, they were reviewed by a consultant anaesthetist.
2.1.5 Consent
Patients were admitted to hospital the night before surgery. After they had signed the 
routine consent form for their surgery, the issue of the trial was re-addressed by
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discussing each point in the information leaflet with the patient, after which they were 
asked to express any concerns or opinions. If they were satisfied with all aspects of the 
trial and agreed to enter the trial, they were asked to initial each point of the consent 
form and sign it (see appendix 2).
2.1.6 Pre-operative measurements
After the consent form was signed, the patients’ height (cm) and weight (kg) were 
measured to enable the oesophageal Doppler probe to correlate with the correct 
nomagram thereby allowing correct calculation of the cardiac parameters. The weight 
was measured using a digital scale. The same scale was used for all weight 
measurements throughout the patients’ hospital stay. The abdominal circumference was 
measured at the level of the anterior superior iliac spines.
In open abdominal surgery, the use of epidural analgesia has been shown to result in 
better preservation of respiratory fimction than PCA (Rigg et al., 2002, Gendall et al., 
2007). In view of this, the patients’ lung function tests (LFTs) were measured using a 
Micro Plus spirometer (©Micro Medical). The correct technique of ensuring a fiill 
breath, maintaining a good seal around the disposable spirometer tube and exhaling as 
fast and for as long as possible was explained and demonstrated. Three attempts were 
made by the subject with the LFTs measured each time and tiie best result was recorded 
for the forced expiratory volume in 1 second (FEVi), forced vital capacity (FVC), 
percentage of FEVi / FVC and the peak expiratory flow rate (PEFR). In the event of 
poor LFT technique, the correct method was re-explained and the LFT repeated. All the 
measurements were documented on the patients’ data collection sheet (see appendix 3).
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At this stage the pain scoring system was explained to the subject to allow an early 
understanding of the scoring system. This is because the first time they would be asked 
their pain scores would be in the immediate post-operative period whilst they were still 
very drowsy from the anaesthetic. A visual analogue score (VAS) with zero representing 
no pain and ten representing the worst pain imaginable was used. This was recorded (i) 
at rest and (ii) with both coughing and movement; the higher of the scores recorded.
The Short Form 36 (SF-36) was used to calculate the quality of life. This consists of 
questions (see appendix 4) that assess eight factors that needed to be measured pre- 
operatively and at weeks 1 , 2 , 3  and 4. The eight factors measured by the SF36 
questionnaire are physical function, role function, body pain, general health, vitality, 
social functioning, role emotion and mental health. These scores are then combined into 
two main scores -  physical health and mental health before being combined again to 
give a total score.
Once the initial physical and respiratory measurements had been taken, the format of the 
SF-36 form was explained and the patient was asked to fill this in over the course of the 
evening prior to their surgery. The pre-operative blood results were recorded to allow 
calculation of the Physiological and Operative Severity Score (POSSUM score) 
(Copeland et al., 1991). The POSSUM scoring system was developed in 1991 as a 
method to predict morbidity and mortality in patients undergoing surgical procedures. 
The initial POSSUM scoring system over-predicted death, especially in the low-risk 
group and consequently this was modified by the Portsmouth predictor equation and has 
become known as the P-POSSUM scoring system (Prytherch et al., 1998).
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2.1.7 Pre-operative patient preparation
In keeping with the enhanced recovery programme, the patients were informed that they 
could eat and drink normally during the course of the evening prior to their surgery. One 
hundred grams of carbohydrate drink (Pre-Load®, Vitaflo Limited, Liverpool, UK) in 
800 ml of water was prescribed for 21:00 hours the night before surgery and 50 g of 
carbohydrate in 400 ml of water two hours prior to the planned commencement of 
surgery.
Those patients undergoing a right hemicolectomy received no bowel preparation whilst 
those undergoing a left-sided resection received a phosphate enema, which was 
administered at 22:00 hours on the night prior to surgery and at 06:00 hours on the 
morning of surgery.
After signing the consent form and the initial measurements, the randomisation code, 
which was kept in an opaque envelope in an off-site building was opened. The 
randomisation code was created by a business company, which used a computer 
randomisation programme to generate the sequence, following which it placed the 
appropriate analgesic regime in sequential numbered opaque envelopes. The patient was 
informed of the analgesic method to be employed and a note was placed on the front of 
the notes for the anaesthetist to see when they assessed the patient on the morning of 
surgery. The theatres were notified of the planned analgesic method so that the 
appropriate printed protocol could be followed thereby minimizing the chance of 
inconsistent events occurring which would introduce bias.
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On the morning of surgery, 10 ml of venous blood was obtained from the patient and 
placed into two Vacuette® yellow top tubes (Z Serum Sep Clot Activator) and one 
Vacuette® red top (Z Serum Sep Clot Activator) blood tube. This blood was taken 
directly to the laboratory where it was then spun and frozen at -30 degrees centigrade. 
Following this, the subject was asked whether they had any further questions and to 
confirm that the carbohydrate drink and the phosphate enemas (if indicated) had been 
given to them. During that visit, the SF36 form was collected and fixed to the main data 
form (see appendix 4). The pain scoring system (scores between zero and ten) was re­
visited in order to help with the pain scoring system that would be used post-operatively 
in recovery and then back on the ward. This point was emphasized prior to surgery, as 
the first time the patients would be asked a pain score was whilst they were recovering 
from the anaesthetic in the recovery room.
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2.2 Peri-operative methodology
2.2.1 Anaesthetic methodology
In keeping with the enhanced recovery protocol, no pre-medications were administered. 
Anaesthesia was induced using propofol (2-3 mg/kg), alfentanil 10 pg/kg and 
rocuronium 0.6 mg/kg. The trachea was intubated and the patient’s lungs were 
mechanically ventilated. The use of nasogastric tubes was routinely avoided. 
Anaesthesia was maintained using sevoflurane at a mean alveolar concentration (MAC) 
of 1.0-1.4, oxygen enriched air and a remifentanil infusion (40 pg/ml) titrated to effect. 
All patients had a 16-g peripheral line, 20-g radial arterial line and a 4-lumen right 
internal jugular central venous line that was inserted under ultrasound guidance. A bear 
hugger® and a urinary catheter were used in all cases. During induction, 250 ml of 
gelofusine was administered.
Patients received one of the following methods of analgesia as determined by the 
randomisation code.
1) Spinal anaesthesia -  The method involved insertion of the spinal anaesthesic prior
to induction of general anaesthesia. This was performed at the L2-3 or L3-4
interspace using 2.5 ml of 0.5% hyperbaric bupivacaine with 0.25 mg of 
diamorphine, with the patient in the sitting position.
2) Thoracic epidural -  An epidural catheter was inserted between T9-T12. The
patient received 10 ml of 0.20% bupivacaine with 100 pg of fentanyl given as a 
bolus. An infusion of 0.15% bupivacaine with fentanyl 0.0002% was then 
commenced running at 4-8 ml/hr if tolerated.
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3) PCA -  Patients were given 10 mg of morphine intra-operatively and then attached 
to a pump in the post-operative anaesthetic unit with a maximum dose of 20 mg / 4 
hours.
The oesophageal Doppler probe (Deltex ®), which has three white marks on it, was 
marked with a pen to assist with the orientation once the probe was placed within the 
oesophagus (see figure 8). Marking the probe aided the investigator to know which way 
was posterior thereby allowing quick and easy alignment of the probe in order to obtain 
the best signal. The lower five cm of the oesophageal Doppler probe was well lubricated 
with KY jelly® (water-based lubricant jelly) prior to its insertion which was performed 
using either the trans-oral or trans-nasal method.
A Foley catheter was inserted soon after anaesthesia was induced. All patients received 
cefuroxime 1.5 g and metronidazole 500 mg iv at induction followed by two further 
doses of 750 mg each. Note was made of whether any patients required a vasoconstrictor 
(ephedrine or phenylephrine) in the anaesthetic room or prior to surgery. Hypotension 
requiring vasoconstrictor support was defined as a MAP less than 50 mmHg. Once the 
MAP decreased to less than 50 mmHg, treatment with phenylephedrine was initiated by 
the anaesthetist. The volume of vasoconstrictor given was titrated to the response.
2.2.2 Standard theatre set up for a laparoscopic bowel resection.
Once anaesthetized, the patient was brought into the theatre and transferred to the theatre 
trolley. The patient was placed in the Lloyd Davis position, before the bed sheet was 
removed so that the patient was on an adhesive gel-mat, thereby reducing the risk of the
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patient sliding off. Two shoulder supports and a lateral support (on the patient’s right 
hand for an ileo-caecal resection / right hemi-colectomy and on the left for a left 
hemicolectomy, sigmoid colectomy and anterior resection) were placed to secure the 
patient when the steep head down position with the appropriate lateral tilt was adopted. 
A thermal blanket set to 40 degrees centigrade was placed on the upper part of the body 
in order to maintain normothermia during the operation.
2.2.3 Additional theatre set up for a laparoscopic bowel resection.
The central line and arterial line were connected and calibrated. The central line 
transducer was attached to the patient’s chest wall or shoulder support using adhesive 
tape at the level of the stemo-manubrial joint, to ensure that the sensor remained at the 
correct relative height as the patient’s various positions that would be required for the 
surgery were adopted.
The oesphageal Doppler was connected to the monitor via the Doppler lead. Once this 
was connected the patient’s details height and weight were confirmed on the Doppler 
monitor, which also calculated the surface area fi*om nomograms. The waveform was 
optimized by gently advancing and retracting the Doppler probe and rotating it until the 
strongest signal was obtained.
After administration of the first 250 ml of gelofusine® in the anaesthetic room, the 
baseline readings that included cardiac output (CO), stroke volume (SV), cardiac index 
(Cl), mean arterial pressure (MAP), and heart rate (HR) were obtained. From the 
anaesthetic monitor, the central venous pressure (CVP) and oxygen saturation were
106
recorded. The oxygen delivery (DO2), indexed oxygen delivery (DO2I), systemic 
vascular resistance (SVR) and indexed systemic vascular resistance (SVRI) were 
calculated and recorded.
The DO2 is calculated by pressing the monitor button marked “calculations” and then 
“oxygen delivery”. The formula for DO2  is:
DO, (1/min/m )= (hb (g/1) X CO (1/min) X (oxygen saturation/100) X 1.34)
These values are entered when prompted which allows the Doppler monitor to calculate 
both the DO2 and DO2I (indexed for the body surface area).
The SVRI is also calculated by pressing the monitor button marked “calculations” and 
then “systemic vascular resistance index”. The formula for SVRI is:
SVR (dyn*s/cm )= (MAP (mmHg) - CVP (mmHg) / CO (1/mm)
Entering these values allows the Doppler monitor to calculate both the SVR and SVRI 
(indexed for the body surface area). Other readings recorded were the peak ventilation 
pressure, mean alveolar pressure, end tidal carbon dioxide and peak expiratory pressure 
(PEEP). All the readings were documented in the patient’s data form (see appendix 4).
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The patient was then placed in the steep Trendelenburg position. The probe was 
refocused and after 30 seconds fi*om the time that there was a change in position, the 
cardiovascular parameters were recorded. If the stroke volume increased by more than 
10%, the patient was placed flat and a further 250 ml of gelofusine was administered. 
This process was continued until the adoption of the steep head down position did not 
result in an increase of more than 10 percent of the stroke volume. At this point, the 
patient was considered euvolaemic and the final horizontal and head-down readings, 
which did not result in an increase in the stroke volume, were recorded as the 
physiological measurements that would be entered into the database.
After performing these measurements, the patient was placed flat and the 
pneumoperitoneum was created by inserting carbon dioxide into the abdomen to a 
pressure of 14 cm H2O. Measurements were taken 30 s after this physiological change, 
having ensured that the oesophageal Doppler probe had been focused. The steep head- 
down position was then adopted and the process was repeated. Once the 
pneumoperitneum had been created and the head-down position adopted, a further 250 
ml colloid fluid challenge using gelofusine® was administered according to the 
algorithm shown in figure 14. Physiological cardiac measurements were taken at 5- 
minutes intervals.
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Figure 14: Modified Wakeling protocol (Wakeling et al., 2005).
Fluid challenges of 250 ml of gelofusine were given to ensure that the patients were 
fluid optimized. It is important to note that if the fluid challenges were administered in 
the process of reaching the maximum basehne stroke volume possible for the first time, 
an increase in the stroke volume of greater than 10% indicated that a further fluid 
challenge was required. However, once the maximal attainable baseline had been 
reached but had then decreased, the algorithm above was followed using an increase in 
stroke volume of greater than 15% to signify the need for a further colloid bolus. The 
timings and volumes of fluid administered intra-operatively were recorded in the 
patient’s information booklet (see appendix 4)
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This caveat of 15% was necessary otherwise the patient would always be given an extra 
250 ml of fluid despite having reached their maximal SV. As the SVR decreased and the 
stroke volume increased spontaneously by more that 10 percent from the previous 
baseline SV, a further fluid challenge was administered to ensure that patients were fluid 
optimized.
Surgical technique — Right-sided colectomies were performed by early ligation of the 
vessels using a laparoscopic stapler or the Harmonic Scalpel, followed by a medial to 
lateral dissection. The resection and anastomosis were performed extra-corporeally 
through a short midline incision. Anterior resections, left and sigmoid colectomies 
involved early division of the inferior mesenteric artery followed by a medial to lateral 
dissection. The splenic flexure was mobilized as required for sigmoid colectomies and 
anterior resections. The specimen was removed through a small Pfannenstiel incision, 
before being re-anastomosed using a rectal stapler. Drains were not routinely used.
Twenty-five minutes after the creation of the pneumoperitoneum, a central venous blood 
sample was taken to measure the central venous oxygen saturations (SVcvc) and this 
was measured using a blood-gas analyzer. The haemoglobin was rechecked from this 
sample in view of the dilution that might have occurred from the fluid therapy 
administered thus far. Once this new haemoglobin reading was obtained, this value was 
then used for the calculation of oxygen delivery.
Intra-operative hypotension was defined as a MAP of less than 50 mmHg. If patients 
required vasoconstrictor support during the course of the surgery, the volume of
110
ephedrine or phenylephrine and the time from the creation of the pneumoperitoneum 
were documented.
The time until pneumoperitoneum release and the end of surgery were recorded as were 
the total volumes of fluid, vasoconstrictor, remifentanil and epidural bupivacaine that 
were administered intra-operatively.
Ten minutes before the end of surgery, 1 g of paracetomol was given intravenously. At 
the end of surgery, residual neuromuscular block was reversed with neostigmine 2.5 mg 
and glycopyrolate 0.5 mg, and all patients received ondansetron 4mg.
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2.3 Drug chart prescribing prior to leaving theatre.
Cefixroxime 750 mg iv and metronidazole 500 mg iv were prescribed respectively at 8 
hours and 16 hours post-operatively as antibiotic prophylaxis. Post-operatively one litre 
of Hartmann’s solution over 8 hours was administered. Patients were prescribed 
paracetomol 1 g per os (po) quarter in die (qid) and voltarol 50 mg po ter die sumendis 
(tds). Patients who had a contra-indication to voltarol were given paracetomol 1 g po qid 
and tramadol 100 mg po tds. Breakthrough pain was treated with tramadol (50-100 mg 
po/iv qid) if not already given or morphine (2.5-10 mg q.i.d) if tramadol had already 
been given. Nausea and vomiting were treated with cyclizine (25 mg im/iv pm) as first 
line, or if this failed ondansetron (4 mg intravenous (iv) pm). Patients were also 
prescribed omeprazole 20 mg po omni in die (od), lactulose 10 ml po bis die (bd) and 
one fortisip po tds.
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2.4 Post-operative management
2.4.1 Recovery
The times that patients arrived and left the post-operative recovery suite were 
documented. Initial pain scores once the patient was conscious were recorded prior to 
additional post-operative analgesia being given. Consciousness was defined as the 
ability to maintain a discussion and have knowledge of their whereabouts and the fact 
that they had undergone a procedure. Venous blood for the measurement of the stress 
response was obtained at 3 hours following the start of surgery. Due to the timing, this 
was nearly always performed in recovery following which the bloods were taken straight 
to the laboratory where they were spun and fi'ozen. Further blood for stress hormone 
analysis was taken at 6, 12 and 24 hours following the start of surgery and the timings 
for these were noted. Prior to the patient returning to the ward, a central venous oxygen 
saturation (SVcvc) analysis was performed.
2.4.2 Return to the ward.
All patients were given a drink (usually a cup of tea) on their return to the ward. Patients 
were actively encouraged to sit out of bed for one hour on the evening of surgery (day 0) 
and to sit out for 4 to 6 hours with intermittent mobilisation on day-1. Free oral fluids 
and feeding were started on the day of surgery with the patient choosing their diet. There 
were no dietary restrictions though patients were advised to eat in moderation. Patients 
with an epidural in-situ had this titrated to their pain levels. The rate was reduced 
according to the comfort of the patient with the aim to have the epidural removed by 48
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hours. Hypotension was defined as a systolic blood pressure of less than 90 mmHg. In 
patients who developed hypotension due to the epidural, this was treated by stopping the 
epidural for two hours and administering a bolus of colloid. If this corrected the 
hypotension, the epidural was recommenced at a lower rate. If the hypotension was due 
to another aetiology, this was treated appropriately.
Once the patient had returned to the ward, all the data that had been collected were 
entered into SPSS version 15.0.1. From then on all the data were in duplicate on the 
patient sheets and on the SPSS database.
2.4.3 Evening of surgery
Patients were assessed on the evening of surgery. The pain scores were recorded and 
documentation was made regarding whether breakthrough analgesia had been required. 
Breakthrough analgesia was given to any patient whose current analgesic regime was 
not controlling their pain to a level that would enable the patient to describe their clinical 
situation as relatively comfortable.
For patients who had received an epidural, the levels of the upper and lower block were 
assessed using ice, together with the presence or absence of sacral anaesthesia and an 
overall impression of the quahty of the epidural were recorded. The ice was used to 
easily and accurately determine the levels to which regional analgesia extended as the 
use of light touch does not clearly define the level of change.
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For those patients that had received a spinal anaesthetic, the extent of sensory and motor 
loss was measured as defined below.
The motor effect of the spinal anaesthesia was classified as
0. Normal movement
1. Movement but legs feel heavy
2. Slight movement only
3. No movement
The sensory effect of the spinal anaesthesia was classified as
0. No sensory loss
1. Sensation present but decreased
2. Normal sensation
For patients who had received a PCA, conJBrmation that the patients were entirely 
familiar with its function was undertaken by comparing the patients’ comfort with the 
dose of PCA morphine that had been administered.
The presence or absence of bowel sounds was noted as were Ihe presence of nausea, 
vomiting, hiccups, belching and pruritus.
Nausea was defined and scored as
0. None
1. Intermittent, with periods of relief
2. Continuous -  with no relief despite anti-emetics
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Vomiting
This was defined by the number of times that a patient vomited since the time of the last 
assessment.
Hiccups were classified as
0. None
1. Mild -  Occasional and not really noticeable with a rate of less than one per hour
2. Moderate -  Easily noticeable with a rate of two to three per hour.
3. Severe -  Persistent with a rate of four or more per hour
Belching was classified as
0. None
1. Mild -  Occasional and not really noticeable with a rate of less than one per hour
2. Moderate -  Easily noticeable with a rate of two to three per hour.
3. Severe -  Persistent with a rate of four or more per hour
Prurtis was classified as
0. None
1. Mild -  Occasional and not troublesome
2. Moderate -  Very noticeable but relieved by scratching
3. Severe -  Persistent despite scratching
It was also noted whether or not the patients had eaten a meal or not. This would help in 
the assessment of when a normal diet was tolerated. The definition of the “time until 
tolerating diet” was the first meal that the patient consumed more than 90 percent, after
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which, for the rest of the hospital stay, he / she did not feel nauseous or vomit after any 
meal and the subject did not experience moderate or severe hiccups or belching. If a 
patient ate four whole meals but then vomited after the fifth, this meant that that the 
patient had not reached the “time until tolerating diet”.
A central venous oxygen saturation (SVcvc) analysis was obtained on the evening after 
surgery. If the central venous saturation was below 60 percent, suggesting increased 
oxygen extraction due to hypovolaemia, an additional 500 ml of gelofusine® was 
administered intravenously over two hours. If the venous saturation was between 60- 
65%, they were encouraged to take more fluid orally. If patients became hypotensive or 
the urine output decreased, a fluid challenge of an additional 250 ml of gelofusine ® was 
administered intravenously over 30 minutes. The urine output was monitored and only if 
there was less than 0.5 ml/kg/hr did patients receive a fluid challenge o f250 ml.
For patients without an epidural, it was aimed to remove the catheter on the evening of 
the first day. For patients with an epidural, the urinary catheter was removed four hours 
after the epidural catheter was removed. In the few cases where it was considered that 
patients would have a short hospital stay, the urinary catheter was removed at midnight 
on the day of surgery.
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2.4.4 The morning of day 1 post-operation
The volumes of intravenous and oral fluid, urine output and fluid balance from the time 
of surgery until midnight of day 0 and from midnight until 08:00 hours of day 1 were 
calculated from the fluid charts. A further central venous oxygen saturations (SVcvc) 
analysis was performed. If the central venous oxygen saturations were below 60 percent, 
suggesting increased oxygen extraction due to hypovolaemia, an additional 500 ml of 
gelofusine® was administered intravenously over 2 hours. If the venous saturations were 
between 60-65 percent, they were encouraged to take more fluid orally. After the 
morning central venous blood gas had been taken, the central line was removed.
2.4.4.1 Variables noted every morning
For the entire length of the patients’ hospital stay, the following variables / 
measurements were recorded.
• Pain scores at rest and with movement or coughing, whichever was worse, 
scored out of 10.
• The level of sensory block and the extent of the motor block in the case of an 
epidural (or the time that the epidural was stopped and the time it was removed).
• An assessment of any residual motor or sensory block following the spinal 
anaesthetic.
• The weight in kilograms, measured on the digital scale.
• The abdominal circumference in centimeters measured at the level of the anterior 
superior iliac spine.
• The presence or absence of bowels sounds / passing flatus / bowels opening.
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• The presence or absence of nausea, vomiting, hiccups, belching, pruritus.
• Lung function tests, with the best result of the three measurements recorded.
• Pulse rate, blood pressure, arterial oxygen saturation and inspired oxygen 
concentration.
• The time when intravenous fluid infusion was stopped and if any additional 
intravenous fluids were required, and if so how much?
All times were recorded in days and hours.
2.4.4.2 Variables noted every day at 13:00 hours
• The pain scores at rest and with movement or coughing, whichever was worse, 
scored out of 10
• The level of sensory block and the extent of the motor block in the case of an 
epidural (or the time that the epidural was stopped and the time it was removed)
• The presence or absence of bowels sounds / passing flatus / bowels opening
• The presence or absence of nausea, vomiting, hiccups, belching, pruritus,
• Lung function tests with the best result of the three measurements recorded.
• Pulse rate, blood .pressure, arterial oxygen saturations and inspired oxygen 
concentration
• The time when intravenous fluid infusion was stopped and if any additional 
intravenous fluids were required, and if so how much
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2.4.4.3 Variables noted every day at 19:00 hours
• The pain scores at rest and with movement or coughing, whichever was worse, 
scored out of 10
• The level of sensory block and the extent of the motor block in the case of an 
epidural (or the time that the epidural was stopped and the time it was removed)
• The presence or absence of bowels sounds / passing flatus / bowels opening
• The presence or absence of nausea, vomiting, hiccups, belching, pruritus,
• The lung function tests with the best result of the three measurements recorded.
• The pulse, blood pressure, arterial oxygen saturations and inspired oxygen 
concentration
• The time when intravenous fluid infusion was stopped and if any additional 
intravenous fluids were required, and if so how much?
Patients who developed nausea and vomiting as a consequence of an ileus were initially 
treated with iv fluids and anti-emetics. (An ileus was defined as the presence of 
abdominal distension with the absence of bowel sounds, in patients with nausea and 
vomiting. Those with protracted vomiting or marked distension had a naso-gastric tube 
inserted.
Patients were discharged once the following criteria were met
• Their clinical observations were normal
• They were comfortable with oral analgesia only
• They were fully mobile
• They had passed urine
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• They were tolerating a normal diet.
Prior to discharge the length of time until the patients developed bowel sounds, were 
tolerating food, passed flatus and opened their bowels were recorded. Measurements of 
the time until their nausea, vomiting, hiccups, belching and pruritus had stopped were 
checked.
The type and amount of regular analgesia, breakthrough analgesia and anti-emetic that 
was consumed during the hospital stay was documented.
Patients were given SF-36 forms to fill in at 1,2,3 and 4 weeks. They were given these in 
self-addressed stamped envelopes. For patients that had not opened their bowels yet, the 
question “ what was the date and time that you first opened your bowels?” was written 
on the bottom of the first sheet and the patients were asked to record this once this had 
occurred.
The time in days, to 2 decimal points, was recorded for the patients’ length of stay, with 
both the time until medically fit and the time that the patient actually left the hospital 
being recorded. If the patient left the ward to go to the day ward, then the time of 
discharge was until the time that they left the hospital.
All patients who had undergone colorectal resections for cancer had their cases 
discussed at the multi-disciplinary meeting. All patients were seen in the clinic at two 
weeks to review their postoperative progress and to review and discuss their histology.
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2.5 Outcome measures
The primary outcome was length of hospital stay.
The secondary outcomes were
• The time until bowel sounds returned 
The time until diet was tolerated 
The time until flatus was passed 
The effect of surgery on the lung fimction tests
The quality of post-operative analgesia measured at rest and with movement or 
coughing and scored on a visual analogue score ranging from 0 to 10 
The incidence of nausea, vomiting, hiccups, belching and pruritus 
The volume of fluid given intra-operatively 
The necessity for vasoconstrictor support intra-operatively 
The incidence of hypotension post-operatively 
The incidence of post-operative complications 
The incidence of réadmissions
The quality of life measured using SF-36 measured at weeks 0,1,2,3 and 4.
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2.6 Sample size calculation
The primary outcome measure in this study is length of stay (LOS) in hospital.
Previous data on the length of post-operative stays obtained from the database at the 
Royal Surrey County Hospital exhibited a substantial clustering around 2 to 4 days, with 
a long tail thereafter that had no clear endpoint. The observed distribution did not 
display normality after applying any standard transformation. Consequently, standard 
techniques for calculating required sample numbers were inadvisable.
A pragmatic approach of looking at the proportion of stays greater than and less than 
three days and assessing whether this could be improved was chosen. Forty eight percent 
of the patients had a LOS of 3 days or less. Given that patients in the greater than 3 days 
group spent a mean of 7.28 days in hospital, and those in the 3 days or less group spent a 
mean of 2.51 days in hospital, then identifying a procedure that delivers 20% more 
patients into the 3 days or less group would deliver a saving of (7.28 - 2.51)*20 = 95.4 
days per 100 patients, i.e. on average around 1 day per patient. Using a test (with 
size=5% and power=80%) to detect a 20% difference between the procedures, 97 
patients in each procedure group would be needed. This comes down to 77 if doing a 1- 
sided test (i.e. assuming only one of the 2 procedures can deliver an improvement).
Replacing a 20% difference with a 40% difference in the above, 29 patients per 
procedure would be required (2-sided test) or 23 patients for a 1-sided test. (For the 2- 
sided test, this tests the null hypothesis of 48% under both procedures versus the 
alternative hypothesis of 28% under one procedure and 68% under the other). This
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would provide the ability to detect an average saving of almost 2 days per patient as 
outlined above.
Assessment of the surgeon’s laparoscopic database from the previous 5 years revealed a 
conversion to open surgery rate of 5%. In view of this and an 8% rate for failed epidural 
insertion, epidural displacement and unforeseen complications, the number of subjects to 
be recruited was increased by 13% from 87 to 99.
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2.7 Statistical analysis
Statistical analysis was undertaken using SPSS version 15.0.1. Many data sets were 
asymmetrically distributed. For such non-parametric data sets, a Kruskall-Wallis test 
was initially performed to determine whether there was any statistical significance when 
all three medians were compared. If the Kruskal-WaUis test identified a value of 
statistical significance in the data, a Mann-Whitney test was then used in a pair-wise 
fashion to identify the exact parameters that were statistically significant. The data was 
presented as box and whisker plots demonstrating the median, inter-quartile range and 
minimum and maximum values excluding outlying values which are defined as points 
greater than or less than one and a half times the inter-quartile range fi'om the edges of 
the box.
Normally distributed continuous data sets were analysed by ANOVA, with a Bonferroni 
post hoc test to identify the particular data points that were statically significant fi*om the 
remainder.
Categorical variables were analysed using Chi squared test.
The quality of hfe data was entered into the SF-36 quality of life calculator. From this, 
the scores of the eight individual variables, 2 sub-totals and overall total were obtained 
for weeks 0,1,2,3 and 4. The line graphs of each of these factors variables were obtained 
using SPSS version 15.0.1 and statistical significance was determined by calculating the 
difference in the area under each analgesic related quality of life graph.
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3. Results
Ninety-nine patients undergoing elective colorectal resections were enrolled in this 
randomised controlled trial (NCT 18926278). Ninety-one patients completed the trial. 
The flow chart in figure 15 demonstrates the reasons for exclusions.
Three (9%) patients were excluded from the PCA group. One of these patients, with a 
known cardiac history, had a myocardial infarction on the evening of the day of surgery 
and was transferred to another hospital for urgent angioplasty that led onto urgent 
cardiac surgery and was consequently lost to follow up.
Within the epidural group, three (9%) of the 33 patients had a problem relating to the 
unsuccessful insertion of the epidural catheter or due to the epidural catheter becoming 
disconnected or accidentally removed.
The time until medically fit for discharge and length of hospital stay data were analysed 
with the exclusions discussed above and on an intention-to-treat basis.
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Figure 15: Flow chart illustrating the patients excluded from the trial.
Open conversion was defined as any procedure that could not be completed entirely 
using the laparoscopic approach.
There were no significant differences in the demographics of the 3 patient groups except 
for patient weight, which was highest in the PCA group (see table 12).
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Table 12: Patient demographics of the three patient groups.
Epidural Spinal PCA p-value Multiple comparisons
Patients
completing trial 30 31 30
Mean (sd) age 
(years) 68(11) 70 (13) 66 (12) 0.519
Gender M:F 16:14 11:20 16:14 0.271
Mean (sd) weight 
(kg) 75 (14) 71 (13) 82 (15) 0.006
spinal:epidural=0.711 
epidural: PCA=0.134 
spinaI:FCA=0.005
Mean (sd) P- 
Possum score 26.2 (4.1) 27.7 (4.5) 26.6 (3.4) 0.323
ASA I 3 2 4
ASA II 22 25 23 0.854
ASA in 5 4 3
Diverticular
disease 6 4 9
Cancer 21 24 19 0.655
Other 3 3 2
Right
hemicolectomy 12 10 9
Left
hemicolectomy 2 5 0
Sigmoid
colectomy 7 4 11 0.266Ant resection (not 
fullTME) 5 6 7
Ant resection 
(Full TME) 3 3 2
Other 1 3 1
Median (IQR) 
time (min) in 
anaesthetic room
55
(50-60)
50
(45-55)
35
(25-45) <0.001
spinal: epidural =0.016 
epidural: PCA <0.001 
spinal:PCA <0.001
Mean (sd) length 
of surgery (min)
105
(28)
109
(3)
97
(23) 0.252
128
3.1 Primary end points.
The median (IQR) times until medically fit for discharge and the post-operative length 
of stay are shown in figures 16 and 17. Statistical analysis using the Kruskal Wallis test 
showed that there was a significant difference in both the time until medically fit for 
discharge and the length of hospital stay (p<0.001 and P<0.001 respectively). The p- 
values of less than 0.001 in the figures 16 and 17 above are the results generated from 
the Kruskall Wallis test that compares all 3 groups to ascertain if there is a statistical 
difference.
Further analysis using multiple comparisons performed in a pair-wise manner revealed 
that the use of epidural analgesia resulted in a significantly longer time until medically 
fit for discharge and a significantly longer length of hospital stay compared with patients 
who received a spinal or a PCA as shown in table 13. There was however no difference 
between the spinal group and the PCA group with regards to the time until medically fit 
and the length of stay (p=0.796 and p=0.559 respectively).
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Table 13: Multiple comparisons of time until medically fit and length of hospital stay in 
the exclusions group.
Epidural Spinal PCA Multiple comparison 
p values
Median (IQR) time 
(days) until 
medically fit
3.7
(2.9-6.5)
2.6
(2.0-3.0)
2.6
(1.9-3.1)
Spinal: epidural p=<0.001 
Spinal : PCA p=0.796 
PCA : Epidural p<0.001
Median (IQR) 
length of stay 
(days)
3.7
(3.0-7.0)
2.7
(2.2-S.7)
2.8
(2.1-3.2)
Spinal: epidural p=0.002 
Spinal : PCA p=0.559 
PCA : Epidural p<0.001
Analysis of the data on an intention to treat basis is shown in table 14. This showed a 
reduction the median times in the epidural group when compared with the exclusion 
group above in table 13, but with similar results for the spinal and PCA groups.
Table 14: Multiple comparisons of time until medically fit and length of hospital stay in 
the intention to treat group.
Epidural Spinal PCA Multiple comparison 
p values
Median (IQR) time 
(days) until 
medically fit
3.1 
(2.8-6.5)
2.6
(2.0-3.3)
2.7
(2.0-3.3)
Spinal: epidural p<0.001 
Spinal : PCA p=0.711 
PCA : Epidural p=0.001
Median (IQR) 
length of stay 
(days)
3.2
(3.0-6.5)
2.9
(2.2-3.7)
2.8
(2.1-3.4)
Spinal: epidural p=0.001 
Spinal : PCA p=0.662 
PCA : Epidural p=0.005
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3.2 Secondary end points.
3.2.1 Time in recovery.
Concerning the time in recovery, the median stay was longest in patients receiving an 
epidural although there was no statistical difference between the groups (see table 15).
Table 15: Median time in recovery
Epidural Spinal PCA p values
Median (IQR) time 
(minutes) in 
recovery
128
(85-169)
105
(75-150)
103
(58-141) p=0.216
3.2.2 Return of bowel function
The median times until the different aspects of bowel function were restored are shown 
in table 16. The time until patients were tolerating a full diet was significantly shorter in 
the spinal and PCA group than the epidural group. There was no difference in the time 
to pass flatus. The median time until the bowels opened was significantly shorter in the 
spinal group with no difference between the other two groups.
Table 16: Median time in days until return of bowel fimction
Epidural Spinal PCA Kruskal-WaUis
Multiple comparison 
p-values
Median (IQR) 
time until 
bowel sounds
1.00
(0.72-1.90)
0.70
(0.58-1.00)
0.90
(0.70-1.15) P=0.037
Spinal: epidural p=0.017
Spinal : PCA p=0.066 
PCA : Epidural p=0.370
Median time 
until tolerating 
diet
2.0
(1.29-4.6)
1.00
(0.70-2.00)
1.43
(0.80-2.30) P=0.003
Spinal: epidural p=0.001
Spinal : PCAp=0.172 
PCA : Epidural p=0.020
Median (IQR) 
time until 
flatus
1.50
(0.90-2.20)
1.33
(0.90-2.30)
1.60
(1.20-2.00) P=0.622
Median time 
until bowels 
open
3.10
(2.25-4.75)
2.70
(1.60-3.50)
4.00
(2.43-4.55) P=0.007
Spinal: epidural p=0.040 
Spinal : PCA p=0.002
PCA : Epidural p=0.346
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3.2.3 Assessment of nausea, vomiting, hiccups and belching.
The median times until nausea, vomiting, hiccups and belching stopped together with 
the median time until the anti-emetics were stopped are shown in table 17. The median 
times until nausea, vomiting, hiccups and belching stopped were longest in the epidural 
group with significant values reached in all except hiccups. In addition the median time 
until the use of anti-emetics stopped was significantly longer in the epidural group than 
both the spinal and PCA group.
Table 17: Times until nausea, vomiting, hiccups and belching stopped and the median 
time until anti-emetics were stopped.
Epidural Spinal PCA Kruskal-WaUis
Multiple comparison 
p-values
Median (IQR) 
time (days) 
until nausea 
stops
1.70
(0.95-4.45)
1.00
(0.00-1.70)
0.55
(0.00-1.55) P=0.007
Spinal: epidural p=0.007
Spinal : PCA p=0.813 
PCA : Epidural p=0.006
Median time 
(days) until 
vomiting stops
1.0
(0.00-2.15)
0.00
(0.00-1.30)
0.00
(0.00-0.25) P=0.020
Spinal: epidural p=0.075 
Spinal : PCA p=0.229 
PCA : Epidural p=0.008
Median (IQR) 
time (days) 
until hiccups 
stop
0.00
(0.00-3.25)
0.00
(0.00-1.10)
0.00
(0.00-2.15) P=0.304
Median time 
(days) until 
belching stops
2.20
(1.00-3.45)
0.00
(0.00-1.15)
1.15
(0.00-2.03) P=0.001
Spinal: epidural p<0.001 
Spinal : PCA p=0.034 
PCA : Epidural p=0.033
Median time 
(days) until 
anti-emetics 
stop
1.50
(0.50-2.20)
0.90
(0.00-1.70)
0.00
(0.00-0.96) P=0.002
Spinal: epidural p=0.019
Spinal : PCA p=0.147 
PCA : Epidural p=0.001
134
3.2.4 Assessment of abdominal distension.
The maximum percentage increase in abdominal circumference, time until maximum 
increase in abdominal circumference was reached and the percentage increase in 
abdominal circumference at discharge are shown in table 18.
Table 18: Percentage maximum increase in circumference at maximum and at discharge 
with time until maximum discharge.
Epidural Spinal PCA Kruskal-WaUis
Multiple comparison 
p-values
Median (IQR) 
maximum % 
increase in abd 
circumference
6.9
(4.6-10.7)
5.6 
(2.2-8.1)
3.9 
(1.6-6.8) p=0.005
Spinal: epidural p=0.083 
Spinal : PCA p=0.128 
PCA : Epidural p=0.001
Median time 
(days) until 
maximum 
increase in 
abdominal 
circumference
2.0 
(1.8-3.0)
2.0
(1.0-2.0)
2.0
(I.0-2.0) p=0.026
Spinal: epidural p=0.043 
Spinal : PCA p=0.693 
PCA : Epidural p=0.011
Median (IQR) % 
increase in abd 
circumference at 
discharge
3.3
(2.0-5.6)
3.0 
(1.2-6.1)
1.8
(0.8-4.7) p=0.146
The PCA group had the lowest percentage increase in abdominal circumference that was 
significantly less than the epidural group which had the greatest abdominal distension. 
Whilst the median time until the maximum increase in abdominal circumference was 
two days in all three groups, analysis of the non parametrically distributed data revealed 
that the time until the maximum increase in abdominal circumference was reached was 
significantly longer in the epidural group than to the spinal and PCA group.
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At the time of discharge, the median percentage increase in abdominal circumference 
was again smallest in the PCA group although this was not significantly shorter than the 
epidural or spinal group.
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3.2.5 The assessment of pruritus and the use of antihistamines.
The incidence of pruritus and the acceptance (by the patients) to use antihistamines are 
shown in table 19. Although the incidence of pruritus was twice as high in the PCA 
group when compared to the spinal and epidural group, this was not statistically 
significant. Furthermore, although the PCA group had the highest incidence of pruritus, 
with all of these patients being offered an antihistamine, only two patients accepted this 
offer with the reason for declining being that the pruritus was very mild. Of those that 
were treated with anti-histamines, the dose used by the PCA group was twice as high as 
the dose used the epidural group. However as only 2 patients in each of these groups 
required anti-histamine, it was felt to be inappropriate to perform statistical analysis on 
this.
Table 19: Incidence of pruritus and use of anti-histamines.
Epidural Spinal PCA p values
Number of 
Patients 30 31 30
Number of patients 
c/o pruritus 3 (10%) 3 (10%) 7 (23%) 0.224
Number of patients
accepting
antihistamines
2 (67%) 0 (0%) 2 (29%) 0.206
Mean dose (mg) of 
antihistamine used 4 8
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3.2,6 Time until epidural and PCA were stopped and the doses used.
The time that the epidural and PCA were being used together with the results of the 
mean time in-situ are shown in table 20, with the PCA being stopped and removed 
approximately 0.6 days before the epidural.
Table 20: Time that the epidural or PCA were running, time until analgesic modality 
was removed and the doses used in the epidural and PCA groups.
Epidural Spinal PCA p values
Median (IQR) time 
(days) that epidural 
or PCA was 
running
1.72
(1.42-1.94) N/A
1.10
(1.00-1.50) P<0.001
Median (IQR) time 
(days) until 
epidural or PCA 
was removed
1.97
(1.80-2.13)
1.30
(1.30-1.84) P<0.001
Although the data concerning the times that the epidural and PCA were running and the 
time to their removal were not normally distributed, the amounts used were normally 
distributed. Table 21 shows the volumes of bupivacaine / fentanyl administered via the 
epidural and the amount of morphine used in the PCA. These results do not include the 
10 ml of 0.20% bupivacaine with 100 pg of fentanyl administered prior to the first 
incision or the 10 mg of morphine administered intra-operatively prior to the end of 
surgery.
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Table 21: Volume of bupivacaine / fentanyl administered via the epidural and the dose 
of morphine administered via the PCA during the peri-operative period.
Epidural Spinal PCA
Mean (sd) epidural (ml) or PCA 
(mg) dose administered
243
(109) n/a
44
(24)
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3.2.7 Pain scores
The analysis of the pain scores that were obtained from the patients whilst they were at 
rest are shown in figure 18 below. The pain scores were significantly higher in the PCA 
group compared against the spinal and epidural group in the early post-operative stages 
as shown in table 22. After the morning of the first day, there were no statistically 
significant differences in the pain scores.
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Figure 18: Median (IQR) pain scores at rest related to the analgesic modality used
N=The number of patients still in hospital in whom the pain scores were measured, 
which decrease with time as patients are discharged.
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Table 22: Comparison of median pain scores at rest
Epidural Spinal PCA p-value Multiple comparisons
In recovery 1.5
(0-5.0)
3.0
(0-5.0)
5.5
(2.8-T.3) 0.003
Spinal : epidural p=0.521 
Spinal : PCA p=0.005 
Epidural : PCA p=0.002
Evening of 
day 0 2.0(0-4.0)
3.0 
(1.0-4.0)
5.0
(3.0-6.3) <0.001
Spinal : epidural p=0.372 
Spinal : PCA p<0.001 
Epidural : PCA p=0.001
Day 1 am 2.0
(0-3.0)
2.0 
(1.0-3.0)
4.0 
(1.0-6.0) 0.027
Spinal : epidural p=0.557 
Spinal : PCA p=0.033 
Epidural : PCA p=0.015
Day 1 pm 2.0 
(1.0-4.0)
2.0 
(1.0-3.8)
3.0 
(1.3-4.0) 0.497
Day 2 am 2.0
(0-4.0)
2.0
(0-3.0)
2.0
(0.3-3.0) 0.914
Day 2 pm 3.0 
(1.0-5.0)
2.0 
(1.0-3.0)
2.0
(0-3.3) 0.110
Day 3 am 2.0
(0.5-3.0)
2.0 
(1.0-2.0)
1.0
(0.5-3.0) 0.972
The pain scores with movement or coughing, whichever was worse, were found to be 
significantly higher in the PCA group in the early post-operative period (see figure 19). 
The PCA group had significantly higher pain scores in recovery and on the evening of 
the day of surgery when compared to spinal and epidural analgesia. Table 23 shows that 
on the morning of the first post-operative day, PCA pain scores were significantly higher 
than the spinal but not the epidural pain scores. After the morning of the first post­
operative day, there were no differences in the pain scores.
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Figure 19: Median (IQR) pain scores on movement / coughing.
N=The number of patients still in hospital in whom the pain scores were measured, 
which decrease with time as patients are discharged.
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Table 23: Comparison of median pain scores on movement / coughing.
Epidural Spinal PCA
p-value
(Kruskal-
WaUis)
Multiple comparisons 
(Mann-Whitney)
In recovery 3.5
(0-8.0)
5.0
(1.0-7.0)
7.0
(4.5-8.0) 0.027
Spinal : epidural p=0.942 
Spinal : PCA p=0.019 
Epidural : PCA p=0.021
Evening of 
day 0 4.5(2.8-6.0)
4.0
(3.0-6.0)
7.0
(6.0-8.0) <0.001
Spinal : epidural p=0.907 
Spinal : PCA p<0.001 
Epidural : PCA p<0.001
Day 1 am 4.0
(2.0-5.0)
4.0
(3.0-6.0)
6.0
(5.0-7.0) <0.001
Spinal : epidural p=0.703 
Spinal: PCA p<0.001 
Epidural : PCAp=0.310
Day 1 pm 4.0
(2.5-8.0)
4.0
(3.0-7.0)
5.5
(4.0-7.0) 0.497
Day 2 am 4.0
(2.0-6.5)
4.0
(2.0-6.0)
4.0
(3.0-6.0) 0.914
Day 2 pm 4.0
(2.0-7.0)
4.0
(2.0-4.0)
4.5
(2.8-6.0) O.IIO
Day 3 am 3.0
(2.0-5.0)
3.0
(2.0-4.0)
3.0
(1.0-5.0) 0.972
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3.2.8 Additional analgesia
Table 24 shows the frequency with which additional analgesia was administered to the 
three different groups. Although the spinal group of patients had the highest frequency 
for requiring additional analgesia, there was no significant difference in the number of 
patients requiring breakthrough analgesia with regards to the type of analgesic regime 
used. Most breakthrough analgesia was required in the early post-operative phase.
Table 24: Frequency of patients receiving breakthrough analgesia
Epidural Spinal PCA p-value
No. of patients 
requiring additional 
analgesia
16 21 14
0.237No. of patients not 
requiring additional 
analgesia
14 10 16
Median (IQR) time 
(days) until 
breakthrough 
analgesia stopped.
0.1
(0.0-2.0)
0.1
(O.O-l.O)
0.0
(O.O-l.O) 0.075
In terms of additional morphine required as breakthrough analgesia, a total of 12 patients 
from the spinal group required this. Overall, for the complete spinal group, the median 
(IQR) morphine required as breakthough analgesia was 0 (0-10) mg. For the 12 patients 
that required morphine as breakthrough analgesia, the mean (sd) morphine consumed 
was 17 (14) mg.
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3.2.9 Average intra-operative fluid.
The median volumes of fluid given during the intra-operative period in order to maintain 
fluid optimisation throughout surgery were lowest in the PCA group compared with the 
regional anaesthetic group although this difference was not significant (see table 25).
Table 25: The median (IQR) intra-operative fluid volumes administered.
Epidural Spinal PCA Kruskal-WaUis
Median (IQR) 
intra-operative 
fluid (ml) given
1100
(850-1350)
1100
(850-1250)
925
(850-1100) p=0.398
However, due to the patients in the PCA group having a significantly higher weight than 
the other 2 groups, the volume administered was corrected to the volume administered 
per kilogram body weight. The results corrected to ml/kg in table 26 below show that the 
volume administered was lowest in the PCA group and this was significant when 
compared to the spinal group.
Table 26: The mean intra-operative fluid administered per kilogram (ml/kg)
Epidural Spinal PCA ANOVAp-value
Multiple comparison 
p-values
Mean (sd) intra­
operative fluid 
(ml) given per 
kg
14.3
(3.9)
15.1
(4.5)
12.0
(3.9) 0.011
Spinal: epidural p=l.000 
Spinal : PCA p=0.012 
PCA : Epidural p=0.081
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3.2.10 Incidence of hypotension
The incidence of hypotension (defined as a systolic blood pressure of less than 90 
nunHg) in the post-operative period was significantly higher in the epidural group when 
compared to the spinal and PCA group. The frequency of hypotension is shown in Table 
27.
Table 27: Incidence of hypotension
Epidural Spinal PCA P value
Number of patients 
ingroup 30 31 30
Number of patients 
with hypotension 4 (13.3%) 1(3,2%) 1 (3.3%) 0.192
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3.2.11 Additional fluid requirements within the first 24 hours.
Thirty (33%) patients required additional fluid within the first 24 hours. The requirement 
for the additional fluid and the fi-equency for that requirement revealed that there was no 
difference between the groups as shown in table 28 below
Table 28: Aetiology for additional fluid to be administered
Epidural Spinal PCA P value (Chi squared test)
Hypotension +/- 
low urine output 4 1 1
0.405
Low urine output 2 1 1
Low Scvc 5 5 6
Low urine output 
& Scvc 2 1 1
Total 13 8 9
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3.2.12 Central venons oxygen saturations at various times
The mean central venous oxygen saturations at certain times during and after the 
operation are shown in table 29 below. The intra-operative readings were higher than the 
post-operative readings as the work of breathing had been removed, but there was a 
similar trend to the post-operative values in all three groups. The results in this table 
though are the central venous oxygen saturation results obtained fi*om the first reading 
taken at that time. Some of the patients had low venous oxygen saturations as shown in 
table 28 and consequently required additional fluid, following which a repeat central 
venous saturation reading was obtained.
Table 29: Central venous saturations at various times in patient pathway.
Epidural Spinal PCA p values
Median intra-op 
SVcvc
82.3
(75.8-87.3)
85.0
(82.2-87.7)
82.9
(79.0-86.3) p=0.395
Median SVcvc in 
recovery
72.0
(68.9-77.0)
75.0
(70.0-79.0)
73.5
(69.0-76.4) p=0.223
Median SVcvc on 
day 0 pm
69.1
(62.7-74.3)
70.0
(63.0-77.0)
68.8
(66.0-72.3) p=0.757
Median SVcvc on 
day 1 am
67.2
(60.1-71.3)
67.0
(62.0-72.4)
66.0
(60.0-70.3) p=0.679
In the 20 (22%) patients with low central venous saturations (SVcvc) who received an 
additional 500 ml of gelofiisine®, the mean increase in the SVcvc following this bolus 
are shown in table 30 below. Only two (10%) of the 20 patients required a second bolus 
of gelofiisine®, to increase the central venous saturations to above 60%.
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Table 30: The average increases in the central venous saturations (SVcvc) following 500 
ml of gelofusine®.
Epidural Spinal PCA P values
Number of patients 
requiring
additional fluid for 
low SVcvc
7
(23%)
6
(19%)
7
(23%) 0.987
Median (IQR) 
increase in SVcvc 
after 500 ml of 
gelofusine
8.0
(8.0-10.0)
7.0
(5.0-10.7)
7.0
(6.0-8.0) 0.336
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3.2.13 Additional fluid required after 24 hours
Ten (11%) patients required further intravenous fluid after the first 24 hours with the 
indication being nausea / ileus. Table 31 shows that a significantly higher number of 
patients in the epidural group required further fluid compared to the spinal or PCA 
group.
Table 31 : The frequency of patients requiring intravenous fluid further after the initial 
24-hour period.
Epidural Spinal PCA P value Multiple comparisons p -values
Number of 
Patients 30 31 30
No of patients 
requiring ftirther 
fluid for nausea 
/ ileus
7
(22.6%)
2
(6.4%)
1
(3.3%) p=0.028
Spinal: epidural = 0.063 
Epidural: PCA=0.023
PCA: spinal=0.573
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3.2.14 Weight gain following surgery.
The median weights gained at various times are shown in table 32. The weight gained 
was significantly higher in the epidural group when compared to the spinal and PCA 
group. Furthermore the median time until the maximum weight gain was one day longer 
in the epidural group compared with the spinal and PCA group, with both of these 
findings being statistically significant. At the time of discharge though, the median 
weight gain in all patients were similar and ranged between 0.8 and 1.0 kg, although it is 
important to take into account that the length of stay was longest in the epidural group.
Table 32: Table showing the maximum weight gain, the time until the maximum weight 
gain and the weight gain on discharge.
Epidural Spinal PCA Kruskal-WaUis
Multiple comparison 
p-values
Median (IQR) 
maximum 
weight gain 
(kg) of patient
2.73
(1.60-4.45)
1.80
(0.80-2.80)
1.60
(1.03-3.00) p=0.029
Spinal: epidural p=0.021 
Spinal: PCA p=0.891 
PCA : Epidural p=0.022
Median (IQR) 
days until 
maximum 
weight gain of 
patient
2.00
(2.00-3.00)
1.00
(1.00-2.00)
1.00
(1.00-2.00) p=0.007
Spinal: epidural p=0.011 
Spinal : PCA p=0.853 
PCA : Epidural p=0.004
Median (IQR) 
weight gain of 
patient on day 
of discharge
1.00
(-0.25-2.95)
0.8
(0.00-1.60)
1.00
(0.63-2.07) p=0.609
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3.2.15 Difficulty weighing patient
The weighing of patients in the post-operative period revealed that the patients who had 
received an epidural required significantly more help and support to get onto the scale to 
be weighed following surgery than was required pre-operatively (p=0.001). The number 
of patients requiring support to stand on the scale both pre-operatively and post- 
operatively is shown in table 33 and 34. On the morning of the first day following 
surgery, 80% of the patients who had an epidural required some support to stand on the 
scale, whilst one patient was unsafe to stand on the scale even with two people assisting.
Table 33: The support required to stand on the digital scale pre-operatively.
Epidural Spinal PCA
No help required 28 (93%) 30 (97%) 29 (97%)
One person required to help 2(7%) 1(3%) 1(3%)
Two people required to help 0 0 0
Not safe even with 2 people 0 0 0
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Table 34: The support required to stand on the digital scale on the morning of the first 
day following surgery.
Epidural Spinal PCA
No help required 6 (20%) 22 (71%) 22 (73%)
One person required to help 10 (33%) 9 (29%) 8 (27%)
Two people required to help 13 (44%) 0 0
Not safe even with 2 people 1(3%) 0 0
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3.2.16 Days until catheter out
The median time until the catheter was removed was significantly longer in the epidural 
group due to the fact that this was only removed after the epidural had been taken out. 
The median times until the catheter was removed are shown in table 35.
Table 35: The median time in days until urinary catheter was removed.
Epidural Spinal PCA KruskalWallis
Multiple comparison 
p-values
Median time 
(days) until 
catheter 
removed
2.20
(1.85-2.55)
1.30
(0.90-1.60)
1.38
(0.90-1.79) p<0.001
Spinal: epidural p<0.001 
Spinal : PCA p=0.868 
PCA : Epidural p<0.001
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3.2.17 In-hospital complications
Whilst the incidence of compUcations was highest in the epidural group, they were not 
significantly greater in frequency than the spinal or PCA group. There were four 
anastomotic leaks that occurred whilst the patients were still in hospital and all of these 
required surgical intervention (see table 36).
One patient from the epidural group developed pressure sores as a consequence of 
significant motor block. (Although it is recognised that this could have been prevented 
by improved nursing.)
Table 36: In-hospital complications
Epidural Spinal PCA P value (Chi squared test)
Anastomotic leak 
not leading to 
death
1 1 0
Anastomotic leak 
leading to death 1 1 0
Port site bleed 0 0 1
Chest infection 1 0 0 p=0.616
Urinary retention 1 0 1
Supra-ventricular
tachycardia 1 0 0
Pressure sore 1 0 0
TOTAL 6 2 2
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3.2.18 Complications / re-admissions following discharge
Eleven patients developed a complication following discharge with ten of these patients 
being admitted for investigation / management (see table 37). The one patient who was 
not admitted was one with a wound infection. Two patients were admitted with 
abdominal discomfort and were investigated with a CT scan with rectal contrast. Both of 
these scans showed no evidence of a leak / collection and consequently these patients 
were discharged. Two patients presented with an anastomotic leak and required further 
surgery.
Table 37: Complications arising following discharge.
Epidural Spinal PCA P value (Chi squared test)
Abdominal
discomfort 1
0 1
Anastomotic leak 
not leading to 
death
1 1 0
Small bowel 
obstruction/ileus 1 1 1
Urinary retention 0 0 1 p=0.720
Urinary tract 
infection 0 0 1
Wound infection 1 0 1
TOTAL 4 2 5
156
3.2.19 Cardiovascular system changes
The cardiovascular changes were fully documented in 75 patients and the patient 
demographics of these patients are shown in table 38 below.
Table 38: Patient demographics of patients for which cardiovascular variables were 
collected.
Epidural Spinal PCA P values
Number of patients 23 27 25
Mean age (s.d) (years) 70.4 (10.8) 64.6 (12.8) 66.8 (13.3) 0.28
Mean weight (s.d) (kg) 71.7 (13.7) 70.3 (14.6) 76.2 (16.2) 0.31
Number of ASA 1 patients 1 2 3
0.75
Number of ASA 2 patients 18 21 17
Number of ASA 3 patients 4 3 5
Number of ASA 4 patients 0 0 0
Ileocaecal resection / 
right hemicolectomy
10 13 7
0.43
Left hemicolectomy / 
sigmoid colectomy
5 5 8
Anterior resection 8 8 9
Other procedures 0 1 1
(ASA -  American society of Anaesthesiologists).
The changes in the indexed systemic vascular resistance (SVRI), the mean arterial 
pressure (MAP) and the cardiac output with respect to the analgesic regime employed 
are shown in figures 20 to 28. In all 3 analgesic methods, the overall physiological 
changes were similar. The creation of the pneumoperitoneum resulted in a marked 
increase in the SVRI and MAP and this was slightly increased by the adoption of the
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step Trendelenburg position. This increase was followed by a decline in the SVRI and 
MAP as the procedure continued. In some cases this decline leveled off, but in other 
cases vasoconstrictors were required to maintain a MAP of greater than 50 mmHg.
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Cardiovascular changes in the epidural group
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Figure 20: SVRI changes for epidural anaesthesia
Data represented as box and whisper charts with medians, IQRs and minimum and 
maximum values.
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Figure 22: Cardiac output changes for epidural anaesthesia
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Cardiovascular changes in the spinal group.
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Figure 23: SVRI changes for spinal anaesthesia.
Data represented as box and whisper charts with medians, IQRs and minimum and 
maximum values.
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Figure 25: Cardiac output changes for spinal anaesthesia
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Figure 26: SVRI changes for PCA
Data represented as box and whisper charts with medians, IQRs and minimum and 
maximum values.
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Figure 27: MAP changes for PCA
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Figure 28: Cardiac output changes for PCA
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The patients who received an epidural required significantly more vasoconstrictor 
support than those that had a spinal or PCA. The percentage of cases requiring 
vasoconstrictor support is shown in table 39.
Table 39: Percentage of patients requiring vasoconstrictors related to the analgesic 
modality used.
Total number 
of subjects
Number requiring 
vasoconstrictors
p value
Epidural 23 17 (74%) Epidural : PCA = 0.001 
Epidural : spinal = 0.019
Spinal: PCA =0.335
Spinal 27 11 (41%)
PCA 25 7 (28%)
In those subjects receiving vasoconstrictor support, the median dose of administered 
phenylephrine was highest in the epidural group at 600 [xg followed by the spinal group 
with a median dose of 350 jxg (see table 40). These doses were both significantly higher 
(p=0.006 and 0.041 respectively) than the median dose in the PCA group, which was 
200 p,g. The dose of phenylephrine was not significantly higher in the epidural group 
compared with the spinal group (p=0.371). The average time for vasoconstrictor 
requirement ranged between twenty seven minutes fi'om the creation of the 
pneumoperitoneum in the PCA group through to thirty four minutes in the spinal group 
(p=0.809).
None of the patients receiving regional anaesthesia had a high block (higher than T8) on 
assessment in recovery.
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Table 40:Table illustrating the mean times into surgery before vasoconstrictors 
required with the doses administered.
Epidural Spinal PCA p value Mann-Whitney test
Mean (s.d.) time 
into surgery (min) 
for VC
31.4
(22.5)
33.6
(16.4)
27.1
(19.8) p=0.804
Median (IQR) dose 
of phenylephrine
(M^g)
600
(250-
800)
350
(100-
525)
200
(125-
250)
P=0.018
Epidural: spinal p=0.407 
Epidural: PCA p=0,006 
Spinal: PCA p=0.041
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3.2.20 Oxygen delivery
The distribution of the mean intra-operative DO2I achieved overall for the group is 
shown in figure 29. Overall for the whole group, the mean intra-operative DO2I in this 
study was 480 ml/min/m^. Interestingly, only 16 (21%) patients in this study reached 
Shoemaker’s target DO2I of 600 ml/min/m^.
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Figure 29: Frequency of mean DO2I achieved.
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The mean DO2I levels achieved for the three analgesic regimes are shown in figure 30. 
The mean DO2I was only very slightly higher in the spinal group, and was not 
statistically different from the other groups (p=0.170).
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Figure 30: Mean DO2I achieved for the three analgesic regimes.
The relationship between DO2I and the incidence of anastomotic leaks is shown in table 
41 below. Patients in whom a DO2I of less than 400 ml/min/m^ was achieved had a 
significantly higher rate of anastomotic leak than patients in whom a DO2I of greater 
than 400 ml/min/m^ was achieved.
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Table 41: Incidence of anastomotic leaks related to oxygen delivery
Oxygen delivery 
achieved (ml/min/m^)
Number of 
patients
Number of 
anastomotic leaks
p-value
Less than 400 18 4 (22%)
0.01More than 400 57 1 (1.8%)
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3.2.21 Lung functions
There was no significant difference in the mean peak expiratory flow rate (PEFR) of the 
three groups prior to surgery (p=0.218). Figure 31 shows the mean (with 95% 
confidence intervals) PEFR achieved by the different groups in the first few days 
following surgery. The greatest decrease in PEFR for all groups was on the evening of 
the first day.
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Figure 31: Mean decrease in PEFR related to the analgesic regime.
N=The number of patients in hospital on whom the measurements were performed.
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Table 42 shows the mean (sd) PEFR achieved and illustrates that there were no 
statistically significant differences in PEFR between the three groups in the post­
operative period. After the morning of the 3^  ^day, many patients had been discharged, 
leaving only a small number in each group and therefore limiting further formal 
analysis. This point is highlighted by the fact that at six days, there were no PCA 
patients, two spinal patients who had both had an anastomotic leak and ten epidural 
patients.
Table 42: Table showing the mean (sd) PEFR (1/min) at different times.
Epidural Spinal PCA p-value
Pre-op 407 358 415 0.218(102) (123) (134)
Day 1 am 252 231 257 0.463(77) (90) (101)
Day 1 pm 238
(87)
217
(85)
244
(101) 0.361
Day 2 am 276
(77)
237
(77)
282
(91) 0.056
Day 2 pm 259
(94)
261
(90)
294
(112) 0.491
Day 3 am 267
(98)
265
(101)
305
(111) 0.466
Further analysis of the actual decrease in PEFR related to the analgesic modality showed 
the analgesic modality did not influence the post-operative decrease in PEFR (see table 
43).
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Table 43: Time related mean (sd) decrease in PEFR from pre-operation (ml/min)
Epidural Spinal PCA p-value
Day 1 am 155 (89) 128 (73) 158 (72) 0.515
Day 1 pm 169 (92) 141 (95) 170 (92) 0.513
Day 2 am 131 (83) 121(80) 132 (65) 0.898
Day 2 pm 148 (97) 97 (68) 120(65) 0.143
Day 3 am 122 (92) 93 (70) 110(72) 0.657
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Changes in functional vital capacity
There was no significant difference in the forced vital capacity (FVC) of the three 
groups prior to surgery (p=0.056). Figure 32 shows the changes in FVC in the first few 
days following surgery. The largest decrease in the FVC was also noted to be on the 
evening of day 1 for all 3 analgesic modalities with the changes in FVC shown in figure 
32.
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Figure 32: The 95% confidence intervals for FVC (litres) in the post operative period.
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There were no statistically significant differences in any of the post-operative F VC 
readings as shown in table 44.
Table 44: Table showing the mean F VC (htres) at different times.
Epidural Spinal PCA p-value
Pre-op 3.07 2.54 3.06 0.056
(0.88) (0.90) (1.07)
Day 1 am 2.04 1.83 2.06 0.582
(0.80) (0.76) (0.94)
Day 1 pm 2.05 1.82 2.17 0.222
(0.79) (0.61) (0.83)
Day 2 am 2.09 2.04 2.27 0.250
(0.72) (0.89) (0.79)
Day 2 pm 2.02 2.09 2.30 0.716
(0.83) (0.91) (0.75)
Day 3 am 2.19 2.21 2.50 0.446
(0.83) (0.98) (0.88)
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The actual decrease in the F VC measurements in the post-operative period are 
graphically shown in the figure 33.
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Figure 33: Mean decrease in FVC.
N=The number of patients in hospital on whom the measurements were performed.
On day-2 am, day-2 pm and day-3 am, the decrease in FVC was significantly greater in 
the epidural group when compared to the spinal group indicating a slower recovery of 
lung function in the epidural group compared to the spinal and PCA groups (table 45).
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Table 45: Table showing the mean (sd) decrease in FVC (1) at various times.
Epidural Spinal PCA p-value Bonferroni multiple comparisons
Day 1 am 1.04
(0.69)
0.71
(0.57)
1.00
(0.64) 0.052
Day 1 pm 1.18
(0.63)
0.82
(0.69)
1.07
(0.68) 0.065
Day 2 am 0.97
(0.67)
0.50
(0.27)
0.79
(0.62) 0.002
Spinal : epidural p=0.002 
Spinal : PCA p=250 
Epidural : PCA p=0.192
Day 2 pm 1.04
(0.78) 0.45(0.28)
0.76
(0.66) 0.011
Spinal : epidural p=0.009 
Spinal : PCA p=626 
Epidural : PCA p=0.308
Day 3 am 0.85
(0.77)
0.33
0138)
0.57
(0.57) 0.009
Spinal : epidural p=0.008 
Spinal : PCA p=845 
Epidural : PCA p=0.214
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As FVC readings can be affected by height, all the FVC readings were corrected to 
indexed values by dividing every obtained reading by the height of the individual 
patients. The indexed FVC values are shown in figure 34.
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Figure 34: Indexed FVC values for the different analgesic regimes.
N= The number of patients on whom lung function testing was performed.
There were no statistically significant differences in the mean indexed FVC values in the 
pre and post-operative period as shown in table 46.
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Table 46; Mean (sd) indexed FVC (l/m)
Epidural Spinal PCA p-value
Day 0 am 1.82
(0.44)
1.52
(0.46)
1.75
(0.68) 0.111
Day 1 am 1.21 1.09 1.19 0.714(0.43) (0.40) (0.55)
Day 1 pm 1.13
(0.41)
1.03
(0.36)
1.1
(0.50) 0.387
Day 2 am 1.26
(037)
1.21
(0.47)
1.27
0153) 0.423
Day 2 pm 1.22
(0.46)
1.25
(0.48)
1.29
(0.51) 0.932
Day 3 am 1.33 1.32 1.40 0.689(0.44) (0.53) (0.59
From the morning of the second day the decrease in the indexed FVC was significantly 
greater in the epidural group than the spinal and PCA group as shown in table 47. This 
difference arises due to the quicker recovery in the spinal and PCA groups.
Table 47: Table showing the decrease in indexed FVC (1) at various times.
Epidural Spinal PCA p-value Bonferroni multiple comparisons
Day 1 am 0.61
(0.39)
0.43
(0.32)
0.56
(0.39) 0.076
Day 1 pm 0.69
(0.35)
0.49
(0.39)
0.63
(0.38) 0.082
Day 2 am 0.56
(0.37)
0.31
(0.17)
0.48
0133) 0.003
Spinal : epidural p<0.001 
Spinal : PCA p=0.052 
Epidural : PCA p=0.131
Day 2 pm 0.60
(0.42) 0.28(0.17)
0.46
(0.36) 0.012
Spinal : epidural p=0.002 
Spinal : PCA p=0. I l l  
Epidural : PCA p=0.194
Day 3 am 0.49
(0.42)
0.20
(0.23)
0.35
(0.29) 0.009
Spinal : epidural p=0.004 
Spinal : PCA p=0.122 
Epidural : PCA p=0.140
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Effect of the analgesic regime on FEVj /^FVC
The FEVi / FVC measurements were not normally distributed and consequently 
statistical analysis using the Kruskal Wallis test was performed. The effects of the 
different analgesic regimes on FEVi/FVC are shown in figure 35.
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Figure 35: Changes in FEVi / FVC related to the type of analgesia used.
N=The number of patients in hospital on whom the measurements were performed.
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Statistical analysis showed that there was no significant difference in the median FEVi / 
FVC ratios at any of the different post-operative times (see table 48).
Table 48: Median (IQR) FEVi / FVC (%)
Epidural Spinal PCA p-value
Day 0 am 82
(71-86)
85
(80-88)
80
(74-88) 0.208
Day 1 am 85
(81-91)
88
(73-91)
86
(82-92) 0.859
Day 1 pm 83
(74-88)
84
(73-89)
86
(84-91) 0.472
Day 2 am 84
(76-88)
84
(70-90)
86
(74-90) 0.758
Day 2 pm 85
(81-88)
83
(78-88)
85
(82-91) 0.687
Day 3 am 83
(72-89)
83
(77-89)
83
(76-91) 0.770
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3.2.22 Quality of life
Eighty-one (89%) SF-36 questionnaires were returned from the 91 patients who 
completed the study. The insult of surgery resulted in a marked decrease in the quality of 
life in all analgesic groups. After the first week, there was a progressive increase in the 
patients’ quality of life that was similar in all three analgesic groups as evidenced by the 
relatively parallel gradients of the curves shown in figures 36 to 46. These figures 
represent the eight individual components of the SF-36 questionnaire that then generates 
the total mental health scores, total physical health scores and overall total SF 36 scores 
(see appendix 4, p254). There were no significant differences in any of the quality of life 
measurements with regards to the type of analgesia used.
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181
£
8
f
OI
I
Ü0
c19
1
0 2
A n a l g e s i a
 ci>autiiiPCA
W e e k
Figure 37: Mean social functioning scores
100-
£
i
fEo
u
c3
U
o
S
2 0 -
420
A n a l g e s i a
 eodumlPCA
W e e k
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Figure 44: Mean total physical health scores
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Figure 46: Mean total SF-36 scores.
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3.2.23 Stress response
The stress response was measured in 30 patients with 9 : 9 : 1 2  patients in epidural : 
spinal : PCA groups respectively.
The changes in plasma cortisol are shown in figure 47 below, with a cortisol peak being 
reached between 3 to 6 hours in the epidural and PCA group. In the spinal group the 
cortisol values were similar throughout the post-operative period.
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Figure 47: The effect of analgesia on the cortisol levels in the post-operative period. 
Cortisol level in pg/ml.
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A significant difference was noted at 3 hours where the cortisol levels were significantly 
higher in the PCA group compared to the epidural and spinal groups (see table 49). The 
analgesic modality used had no effect on the cortisol levels at any of ftie other times.
Table 49 - Median (IQR) changes in cortisol levels at various times.
Epidural 
(9 patients)
Spinal 
(9 patients)
PCA 
(12 patients)
p-value Bonferroni multiple 
comparisons
Pre-operative 
median (IQR) 
(pg/ml)
430
(212-430)
468
(289-576)
422
(350-478)
0.448
Median 
(IQR) at 3 
hours (pg/ml)
488
(220.3-756.4)
448
(296-752)
871
(789-979)
0.005 Epidural:spinal-0.965
Spinal:PCA-0.004
Epidural:PCA-0.015
Median 
(IQR) at 6
hours (pg/ml)
572
(319-877)
479
(357-638)
842
(401-1117)
0.212
Median 
(IQR) at 12 
hours (pg/ml)
391
(195-567)
499
(359-750)
572
(482-648)
0.116
Median 
(IQR) at 24 
hours (pg/ml)
318
(173-585)
485
(226-486)
545
(336-693)
0.567
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The changes in the insulin levels over time with relation to the analgesic modality 
analgesic modality are shown in figure 48.
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Figure 48: The effect of analgesia on the insulin levels in the post-operative period. 
Insulin level in pg/ml.
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The analgesic modality had no effect on the insulin levels in the post-operative period as 
shown in table 50 below.
Table 50: Median (IQR) post-operative insulin levels.
Epidural 
(9 patients)
Spinal 
(9 patients)
PCA 
(12 patients)
p-value
Pre-operative 
median (IQR) 
(pg /ml)
77.5
(25.3-332.3)
68.5
(15.5-159.3)
39.5
(17.3-174.3)
0.397
Median (IQR) 
at 3 hours 
(pg /ml)
54.0
(32.8-83.8)
32.0
(18.8-49.5)
56.5
(33.8-75.0)
0.145
Median (IQR) at 
6 hours 
(pg /ml)
37.0
(18.3-64.8)
25.5
(12.0-51.0)
38
(22.0-59.0)
0.268
Median (IQR) 
at 12 hours 
(pg /ml)
36.0
(30.5-89.3)
34.0
(26.3-56.8)
41.0
(37.3-96.5)
0.247
Median (IQR) 
at 24 hours 
(pg/ml)
108.0
(54.8-146.5)
173.0
(100.3-264.3)
86.5
(52.0-219.8)
0.597
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The ehanges in interleukin-6 are shown in figure 49 below. The interleukin-6 levels 
were highest between 6 to 12 hours after the commencement of surgery.
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Figure 49: The effect of analgesia on the interleukin-6 levels (pg/ml) in the post­
operative period. IL-6 level in pg/ml.
Although the PCA group had the lowest interleukin-6 values at 12 and 24 hours 
following the initiation of surgery, the analgesic regime used had no significant effect on 
the post-operative il-6 levels achieved as shown in table 51.
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Table 51 -  Peri-operative interleukin-6 levels (pg/ml)
Epidural 
(9 patients)
Spinal 
(9 patients)
PCA 
(12 patients)
p-value
Pre-operative 
median (IQR) 
(pg/ml)
2.3
(0.6-8.4)
3.9
(2.1-9.9)
3.6
(1.7-7.3)
0.685
Median 
(IQR) at 3 
hours (pg/ml)
48.3
(22.1-83.5)
47.8
(43.7-104.0)
57.1
(16.1-86.7)
0.553
Median 
(IQR) at 6 
hours (pg/nü)
90.2
(30.8-245.6)
121.9
(62.4-190.1)
100.0
(36.5-168.6)
0.850
Median 
(IQR) at 12 
hours (pg/ml)
90.5
(46.3-139.9)
115.0
(33.6-214.2)
68.8
(23.7-147.4)
0.470
Median 
(IQR) at 24 
hours (pg/ml)
59.9
(39.9-1091.7)
105.5
(30.5-208.9)
51.6
(17.0-107.1)
0.558
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3.3 23-hour stay 
3.3.1 Introduction
The use of PCA and spinal analgesia in the study resulted in some very short hospital 
stays. As a consequence of these very short hospital stays, a study was devised to assess 
the acceptability and safety of a 23-hour stay protocol developed for patients undergoing 
laparoscopic colectomy. Whilst the use of PCA and spinal analgesia had similar results 
in the main study, pain control and the return of bowel function were better following 
the use of spinal analgesia. As pain control and the early return of bowel fimction are 
key components that are essential for early discharge, the use of spinal analgesia was 
chosen as the analgesic modality of choice for the 23-hour stay study.
Permission for the study was granted from the local ethics committee. Patimts 
undergoing elective laparoscopic colorectal resections who met certain criteria shown in 
table 52 were invited to participate in the study.
Table 52 -  23-hour stay inclusion criteria
1. Colonic or high rectal procedure without a stoma
2. ASA lo r  2
3. Age less than 75 years
4. BMI less than 28
5. Competent adult present for 24 hours after discharge
6. Telephone line / mobile phone
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7. Home less than 25 miles from hospital
8. Incision less than 7 cm
9. Agreement with general practitioner
10. Uncomplicated operation
Patients were excluded if a stoma was created, the operation was converted to an open 
procedure, or if there was a strong history of previous postoperative nausea and 
vomiting following surgery.
Patients were initially approached in clinic to explain the possibility of the 23-hour stay 
protocol. All patients were assessed at a preoperative clinic and if there were any 
concerns they were reviewed by a consultant anesthetist. Patients were admitted on the 
evening prior to surgery, or on the day of surgery depending on patient choice and on 
bed availability. It was usually intended for 23-hour stay patients to be scheduled second 
on the operating hst as it prevented a very early morning discharge the next day. The 
protocol used is shown in table 53.
Table 53 -  23-hour stay protocol
1. Preoperative education
2. Eat and drink normally the day before surgery
3. Avoidance of bowel preparation
4. Preoperative carbohydrate drink. lOOg of PreLoad in 800 ml of water the night
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before surgery and 50g of PreLoad in 400 ml of water 2 to 3 hours before 
surgery
5. Avoidance of preoperative sedatives
6. Spinal anesthesia before skin incision
7.Target driven, osesophageal Doppler directed fluid therapy
8. Upper body air heating cover
9. Avoidance of abdominal drains
10. Avoidance of NGT
11. Oral fluid in recovery or on arrival back to the ward
12. Sit out on aftemoon/evening of surgery
13. Normal diet from the evening of surgery
14. Mobilization on evening of surgery, with walking on the spot for 3 to 5 minutes
15. Central venous oxygen saturation measurement on evening of day-0 and the 
morning of day-1
16. Termination of urinary drainage at midnight on day-0
17. Termination of iv fluids at 18 to 20 hours postoperatively
18. Aperient given
19. Discharged home if tolerating breakfast, passing urine, and comfortable
20. Phone on evening of discharge with follow-up in clinic at end of that week
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Bowel preparation, the use of pre-load®, the method of insertion of spinal anaesthetic, 
and the general anaesthetic were all similar to the methods used in the main study. All 
patients had a 16g peripheral line, 20g radial arterial Hne, a urinary catheter, and a 4 
lumen right internal jugular central venous line inserted aseptically under ultrasound 
guidance. The surgery was performed in a routine fashion and goal -directed fluid 
optimisation using an esophageal Doppler and following the modified Wakeling 
protocol (Wakeling et al., 2005) was undertaken.
Postoperatively patients received 1 litre of Hartmann’s over eight hours followed by 1 
litre of Hartmann’s over 12 hours. Post operative and breakthrough analgesia was the 
same as that used in the main study.
Patients received a cup of tea in recovery before being taken back to the ward. Later in 
the afternoon, patients were sat out in the chair before being offered dinner. They were 
also asked to walk on the spot for 3 to 5 minutes. A central venous blood gas was 
obtained on the evening and morning after surgery. If the central venous saturations 
were below 60%, suggesting increased oxygen extraction, an additional 500 ml of 
gelofusine® was administered intravenously over two hours. If the venous saturations 
were between 60-65%, they were encouraged to take more fluid orally. The urinary 
catheter was removed at midnight.
The following morning the patients were assessed and discharged provided their clinical 
observations were normal, they were comfortable, had passed urine, and were tolerating 
a normal diet. On the evening of discharge the research registrar called the patient to
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ensure that there were no problems. Patients were also given a contact number that they 
could call at any time 24-hours a day if there was a problem. An appointment was made 
for them to be seen in clinic three days after the surgery.
If at any point the patient developed severe pain or become unwell, they were advised to 
present themselves to Accident and Emergency where the surgeons on call would see 
them. The patients were asked not to present themselves to another hospital or to the 
general practitioner if there was a problem. The surgeons on call were notified about the 
study and were advised that patients may present to hospital.
33.2 Results of the 23-hour stay study
During the study period, a total of 40 patients underwent laparoscopic colorectal 
resections under the care of one consultant. Of these patients, 10 (25%) met the 
admission criteria and agreed to follow the 23-hour pathway. The demographics of the 
two groups are shown in Table 54. Nine of the resections were for cancer and one for 
diverticular disease. The operations performed were three right hemicolectomies, one 
left hemicolectomy, two sigmoid colectomies, two high anterior resections, and two total 
mesorectal excisions with no ileostomies.
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Table 54 -  Demographics of short stay and normal pathway patients.
23 hour stay 
patients
Normal pathway 
patients p values
Male: female 4:6 17:13 p=0.468
Average (range) age 60 (43-72) 69 (33-91) p=0.041
ASA I 1 1 p=0.442
II 9 24 p=0.663
in 0 5 p=0.316
Mean (range) Possum 
score 24.4 (20-31) 27.3 (18-38) p=0.182
Mean (range) 
operating time 
(minutes)
73 (50-110) 88 (50-160) p=0.177
Median (IQR) 
postoperative stay 
(days)
0.95 (0.95-0.96) 3.2 (2.4-3.9)
p=0.015
Mean (range) 
Intraoperative fluid 
administered (ml)
875 (600-1350) 972 (600-1600) p=0.287
On the evening of surgery, seven patients had central venous oxygen saturations of more 
than 65% whilst three had central venous oxygen saturations of less than 60%. Those 
three patients were each given 500 ml of gelofusine ® over two hours. All cases were 
discharged successfully according to the 23-hour protocol. The mean (range) visual 
analogue pain scores (range, 0-10) at rest and with movement on the morning of 
discharge were 1.5 (0-4) and 3.3 (1-6) respectively. Five patients required only 
paracetamol and diclofenac postoperatively with two patients being given paracetamol 
and tramadol due to a contraindication to diclofenac. Two patients required tramadol (50 
mg and 100 mg) and 1 patient required morphine (10 mg) as breakthrough analgesia. 
There were no complications and no réadmissions. All patients were successfully
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contacted on the night of discharge. Three patients called for advice. The first phoned to 
confirm his clinic appointment time, the second to report some diarrhoea, and the third 
to question why the right lower port site was more painful than the others and to clarify 
the analgesic regime. All patients were satisfied with the service and all ten would 
request to follow the same pathway again if required and all would recommend it to 
other patients.
3 3 3  Discussion of the 23-hour stay study
In order to safely discharge patients home within 23 hours from the commencement of 
surgery, it is essential to ensure that patients are optimized at every point of their care 
pathway and all members of the surgical, anesthetic and nursing team are familiar and 
agree to the points in the treatment program. Although patient motivation was a key 
factor in patient selection, one of the factors contributing to the safe discharge of 
patients within the 23 hours has been the modification of the ERP. The most significant 
modification to the ERP was the use of spinal analgesia using local anaesthetic (2.5ml 
heavy bupivacaine 0.5%) and 0.25mg diamorphine rather than epidural analgesia.
This study, similar to the main study showed that despite targeting intravascular volume 
using oesophageal Doppler during surgery, three of the 10 patients required further 
colloid boluses to restore / normalize oxygen delivery on the evening of surgery. Paying 
particular attention to fluid and oxygen delivery / extraction may be a key factor in the 
success of this group of patients.
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We accept that there were a small number of patients discharged along this pathway. 
However, the aim of the study was to assess, for the first time, the safety and feasibility 
of a 23-hour postoperative stay. Hence, in order to avoid any uncertainty with bed 
availability, patients were admitted on the night prior to surgery. During the time that 
this study was running, 25% of the total number of patients undergoing laparoscopic 
colorectal resections in our unit were discharged according to the 23 hour pathway. 
Patients not in the protocol stayed for an average of 3.2 days. The mean (range) Possum 
score for the 23-hour stay patients was 24.4 (20-31), which was slightly lower than the 
mean (range) Possum score of 27.3 (18-38) for the remaining patients that followed the 
normal care pathway. Consequently there appears to be potential for developing the 23- 
hour pathway to incorporate more than 25% of all patients presenting for colorectal 
resections. This has important implications for the development and delivery of the 
laparoscopic colorectal service.
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4. Discussion.
4.1 Primary and secondary outcomes
The rapidly increasing uptake and use of Enhanced Recovery Programmes (ERPs) 
(Zargar-Shoshtari and Hill, 2008, Schwenk et al., 2008, Jottard et al., 2008) is an 
indication that there is a greater appreciation of the fact that there are a multitude of peri­
operative factors, each of varying magnitude that influence a patients recovery. Whilst 
there is no substitute for good surgery, the peri-operative care that a patient receives 
plays a major role in determining their outcome.
The primary objective of this study was to determine what the most appropriate 
analgesic regime was for patients undergoing laparoscopic surgery within an ERP. 
Statistical analysis of the two primary end-points revealed that for both of these end­
points, the use of epidural analgesia resulted in a significantly longer time until 
medically fit and length of hospital stay than spinal analgesia or PCA. In terms of the 
primary end-points, there was no difference between the spinal and the epidural group.
Previous studies that have suggested that alternative analgesic regimes are superior to or 
at least equivalent to epidural analgesia, have resulted in controversy mainly because 
they have not been conducted within complete ERPs and because they have not 
accounted for the major confounding factor of fluid therapy (Senagore et al., 2003, 
Neudecker et al., 1999). This study has attempted to accurately answer the question 
concerning the most appropriate analgesic regime for patients undergoing laparoscopic
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colorectal surgery by ensuring that the patients were treated within a full ERP and that 
they were fluid-optimized using an oesophageal Doppler.
Over the last few years, there has been increased concern regarding the usage of epidural 
analgesia because of the risks, the debatable benefit and the high incidence of 
unsatisfactory analgesic block / failure associated with the use of epidurals in patients 
undergoing this type of surgery (Low et al., 2008). In terms of the benefits, the results of 
this study support the concerns of using epidural analgesia for patients undergoing 
laparoscopic colorectal surgery. The results of this study (and the results of the review of 
previous resections, chapter 1.5) showed that the patients who received epidural 
analgesia stayed in hospital significantly longer than the PCA / spinal patients. The 
question that then needs to be addressed is “why did the use of epidural analgesia result 
in a significantly longer hospital stay?” The answer to this appears to be multifactorial.
1) One of the reported advantages in open surgery is that the use of epidural analgesia 
results in a quicker return of bowel function with a reduced incidence of ileus 
(Marret et al., 2007). In 2008, Kehlet wrote in an article entitled “Post-operative 
ileus -  an update on preventative techniques” that thoracic epidural analgesia with 
local anesthetics and peripheral opioid antagonists were two factors that were 
strongly beneficial (Kehlet, 2008).
In this study, the median time until the bowels sounds returned was longest in the 
epidural group. More importantly though was the fact that the time until patients 
were able to tolerate a full diet was significantly longer in the epidural group than 
both the spinal and PCA groups, with the spinal group tolerating a full diet in half
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the time that the epidural group were. Concern has previously been raised about the 
side effects of morphine on bowel function. Not only does morphine cause nausea 
as a side effect, it also acts on the p receptors in the myenteric plexus thereby 
reducing gut motility. Despite these theoretical concerns, in this study the time until 
tolerating a full diet was still significantly shorter in the PCA group than the 
epidural group. To add to this, the PCA group had the shortest time until anti­
emetics were stopped. The only evidence of where bowel function was slowed 
down in the PCA group was that they had the longest time until their bowels opened 
but this does not appear to have affected their outcome.
A total of 12 patients from the spinal group received morphine as breakthrough 
analgesia. Overall in the spinal group, the median (IQR) morphine required as 
break-though analgesia was 0 (0-10) mg. Of the 12 patients that required morphine, 
the mean (sd) morphine required was 17 (14) mg. Although we did not find the use 
of morphine detrimental to patient outcome, it does highlight the opioid-sparing 
properties of spinal analgesia when compared to the mean (sd) dose of morphine 
used post-operatively in the PCA group was considerably more at 44 (24) mg.
Concerning gut function and in keeping with the results above, the epidural group 
had a significantly longer time until the resolution of the nausea, belching and the 
time until the anti-emetics were stopped compared to both the spinal and PCA 
groups. The epidural group also had the longest time until the resolution of vomiting 
although this was only significant when compared to the PCA group. Post-operative 
vomiting can be classified into early and late. The early vomiting soon after 
anaesthesia tends to be short-lived and does not affect the outcome. The vomiting
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that commences on day 2 or 3 is far more significant, usually indicative of an ileus 
and the probability of a protracted hospital stay until bowel function has recovered.
Abdominal distension following surgery was greater in those patients that received 
regional analgesia although statistical significance was only reached in the PCA vs 
epidural groups. However the abdominal distension persisted for significantly 
longer in the epidural group than the spinal and PCA group before the abdominal 
distension started to decrease. The term “ileus” is defined as the disruption of the 
normal propulsive gastro-intestinal motor activity from non-mechanical 
mechanisms. Clinically though, it is difficult to accurately grade with certainty the 
severity of an ileus. Symptoms and signs such as abdominal distension, together 
with ongoing nausea with or without vomiting, are common to both mechanical and 
non- mechanical mechanisms, with the magnitude of the distension often reflecting 
the severity of the pathology.
The increased abdominal distension together with the significantly higher rate of 
ongoing nausea / ileus in the epidural group indicate a delayed return of gut function 
and this appears to be strong evidence that goes against the theory that the use of 
epidural analgesia reduces the incidence of ileus following colorectal surgery. The 
aetiology for this and whether this is unique to laparoscopic surgery is unclear.
2) The intra-operative fluid volumes required to maintain fluid optimization were 
higher in those patients receiving regional analgesia although statistical significance 
was reached in the spinal versus PCA group but not the epidural versus PCA group. 
It might be postulated that this may be due to the vaso-dilatory effects of the spinal
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analgesia although as will be discussed later in the cardiovascular section, the use of 
epidural was found to cause significantly more cardiovascular instability than spinal 
analgesia. Although statistical significance has been reached, over-analysis of the 
differences in intra-operative fluid administered should be avoided as the difference 
in volume administered for a 70 kg patient was only 220 ml.
The ERP recommends that less than 3000 ml of fluid be administered intra- 
operatively. We found the median fluid administered for all three groups ranged 
from 925 ml to 1100 ml. The maximum intra-operative fluid volume administered 
was 1650 ml, which is considerably less than the 3000 ml stated with the ERP.
There is now overwhelming evidence that the use of the oesophageal Doppler 
reduces the length of hospital stay in nearly all fields of surgery (Abbas and Hill, 
2008). The terminology of “running patients wet or dry” is in our view outdated and 
all patients should be given the correct volume of fluid at the appropriate time. This 
can be simply achieved by using the oesophageal Doppler that provides a user- 
friendly method of achieving the maximum stroke volume. The only caveat to this 
is that the oesopahgeal Doppler probe needs to be focused before every reading to 
ensure the maximum stroke volume is measured. The use of the oesophageal 
Doppler to guide fluid replacement seems to be the most significant reason for 
lower intra-operative fluid volumes being administered. Additional reasons include 
the avoidance of bowel preparation, consumption of a full diet the day before 
surgery and the drinking of pre-load® mixed with water the night before and 2-3 
hours before surgery. This pre-load® drink not only serves to provide a glucose 
load but keeps the patients hydrated prior to surgery. The only slight disadvantage is
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that the oesophageal Doppler probes cost £60 each. In terms of the benefits obtained 
from using this technology, this is a small price to pay. Alternatives like the Lidco 
rapid® do exist and have the benefit of being able to be used post-operatively but 
they are not any cheaper and there have been concerns regarding the accuracy of the 
initial calibration which consequently affects all the readings.
Once patients have been fluid-optimized, there does not appear to be any difference 
with regards to the patients’ central venous oxygen saturations in the first 24 hours. 
Thirty patients (33%) required further fluid boluses of colloid. Twenty (22%) of 
these required fluid boluses of colloid to increase their central venous saturations 
and these patients were equally distributed throughout the three study groups. In 
addition to this, once patients had been fluid optimized, there was no difference 
between the groups with regards to the increase of the central venous oxygen 
saturations following the administration of the fluid bolus.
Intra-operatively, the central venous line offers no advantage. With the patient in the 
steep Trendelenburg position and a pneumoperitoneum, central venous pressure 
(CVP) readings are routinely between 30 and 40 cmHzO and it is not possible to 
derive any clinically useful information fi*om these. However, post-operatively, it 
did distinguish a group of patients (22%) who had low central venous saturations 
and required further fluid in terms of fluid boluses. This group of patients requiring 
further fluid boluses was equally distributed between all three groups and there was 
no way of predicting those likely to require further fluid. It could be argued that 
the CVP line could be avoided and all patients could be given a fluid bolus of 500 
ml at 12 hours following surgery. However as the incidence of ultra-sound guided
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CVP insertion-related complications was zero in this study and as 67% of patients 
would be given fluid that they did not require, the use of a CVP at present seems 
beneficial, especially as fluid balance seems to play a crucial role.
The only significant difference between the groups in the first 24 hours was the 
significantly higher rate of hypotension within the epidural group, which 
necessitated turning down the epidural and administering colloid in an attempt to 
increase the blood pressure.
Other than the early post-operative hypotension, the main difference in fluid 
management arose after the first 24 hours. Significantly more patients in the 
epidural group (23%) required further intra-venous fluid due to nausea / ileus than 
did patients in the spinal (6%) or PCA group (3%). The additional fluid that was 
administered resulted in a median increase in weight of 2.73 kg, which was 
significantly greater than the weight gain in the spinal and PCA groups. In addition, 
and similar to the returning of bowel function and abdominal distension, the time 
until the maximum weight gain was reached was significantly longer in the epidural 
group. All three groups retained fluid despite patients only being routinely 
prescribed 2-litres of intravenous fluid in the first 24 hours (although some required 
fluid boluses for additional reasons like low central venous oxygen saturations). All 
three groups then had a diuretic phase with a consequential decrease in weight. The 
spinal and PCA group reached their maximum weight and consequential period of 
weight loss significantly earlier than the epidural group.
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Previous studies have postulated that excess fluid administration leads to an 
oedematous bowel, which consequently causes an ileus (Holte et al., 2002). This 
additional weight gain due to fluid administration and retention may have partially 
contributed to the delayed return of bowel function within the epidural group. The 
question that follows relates to whether we are able to quantify the volume of 
additional fluid that consequently might be harmful. Determining this fluid balance 
is preferably done by weighing patients as this is far more accurate than relying on 
the fluid charts which after a day or two become very unreliable. The epidural group 
gained 2.73 kg of fluid compared to 1.8 kg in the spinal group and 1.6 kg in the 
PCA group, and this additional fluid may have partially contributed to the delayed 
outcome.
3) One of the key issues of the ERP is early mobilization. Surgeons and anaesthetists 
who support the use of epidural analgesia feel that mobility is not limited by the use 
of an epidural (Kehlet, 2005). The evidence from this study is that the use of 
epidural analgesia resulted in significantly more assistance being required to 
mobilize patients. Eighty percent of patients who had an epidural required some 
form of additional support to get them on the scale, whilst 44 % of the patients 
needed two people to support them whilst standing up onto and off the scale. This 
highlights the fact that whilst patients receiving a spinal or PCA were mobilizing 
well around the ward and going to the toilet to pass urine, epidural patients tended 
to be confined more to the chair. In addition, the urinary catheter was in situ for one 
day longer in the epidural group and this will have further limited mobility.
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Patients in the PCA limb voluntarily stopped using their PCA pump at 1.1 days. The 
ERP advises that the epidural should be running for two days. As the epidurals are 
running for 50% longer than the PC As, this does raise the issue regarding whether 
they could be stopped much earlier. However, if this trend is adopted, it soon 
becomes more beneficial to simply use spinal analgesia and avoid the problems of 
the mobility problems and the risks associated with epidural analgesia.
The main analgesic regimes in laparoscopic surgery have been epidural analgesia and 
PCA (Senagore et al., 2003, Senagore et al., 2001, Taqi et al., 2007, Zingg et al., 2009). 
The use of spinal analgesia has been limited despite the fact that the study done by Kong 
(Kong et al., 2002), which was undertaken in 2002, showed that the use of spinal 
analgesia was safe and effective. Spinal analgesia has many advantages over epidural 
analgesia. Firstly it has a higher insertion rate and does not suffer from unilateral blocks. 
In addition spinal analgesia has a lower complication rate than epidurals (Ready, 1999). 
One of the major benefits of spinal analgesia is that over the six to eight hours following 
its insertion, it allows the early return of mobility with completely normal motor tone by 
the morning following surgery.
Addition of an opioid to the spinal anesthesia provides up to 24 hours of analgesia which 
is adequate for the 4 to 6 cm pfannensteil or peri-umbilical incision used to remove the 
resected bowel in laparoscopic surgery. Our choice of the diamorphine dose was 0.25 
mg, which was selected to ensure there was no risk of late respiratory depression in 
patients at home, improved duration of analgesia, and to keep the risk of perioperative 
nausea and vomiting to a minimum. Optimal dosing of diamorphine has been done in 
obstetrics for lower segment caesarean section and larger pfannensteil incisions. This
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demonstrated a longer duration of analgesia (446 min to 668 min) increasing the dose 
from 0.2 mg to 0.4 mg. Nausea and vomiting increased in a dose dependent manner. We 
therefore choose the lower end of this scale to reduce the risk of perioperative nausea 
and vomiting (Saravanan et al., 2003).
The patients who had a PCA did very well in this study. The longest hospital stay in this 
group was 4.95 days together with a very narrow IQR indicating its consistency. The use 
of the PCA is a very attractive option to many patients who have concerns about needles 
being inserted into their backs thereby eliminating the risk of a complication arising 
from the insertion of regional analgesia. The use of a PCA shortens the anaesthetic time 
considerably and as discussed above, its use results in favourable secondary outcomes.
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4.2 Pain and quality of life
One of the advantages of undertaking clinical research is that it necessitates the 
researcher to be involved in the patients’ care and thereby allows detailed observation of 
the patients through their journey. Having been closely involved with the care of these 
patients, it transpired that one of the major areas of patient concern prior to surgery was 
how much pain they would have and how it would be controlled? Although many 
patients liked the idea of being in control of their analgesic regime with a PCA, this 
group had statistically higher pain scores at rest and with movement than the epidural or 
spinal group up to and including the morning of the first day. Thereafter though, there 
was no significant difference in the pain scores. One of the reasons for the pain scores 
being higher initially in the PCA group appears to be due to the fact that patients were 
drowsy and tired on the evening following surgery and consequently fell asleep, which 
then left long periods where they did not press their PCA button until they were awoken 
in pain. Breakthrough analgesia was used the least in this group and this may have been 
because when the nurses found out that the patients were uncomfortable, they then 
noticed that they have not been using their PCA and their advice was to use the pump.
The pain scores were on average two pain score points greater in the PCA group than the 
spinal and epidural group until the morning of the first post-operative day. However, 
after that the pain scores were comparable and interestingly the median time until 
patients voluntarily stopped pressing their PCA button was only 1.1 days.
The results of this study demonstrate that better pain scores did not solely lead to better 
outcomes, as illustrated by the fact that the epidural group had better post-operative
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analgesia scores than the PCA group yet had a significantly longer hospital stay. Pain is 
believed to be one of the factors that increases the body’s stress response following 
surgery and this is also believed to be a factor affecting outcome, but this is discussed in 
more detail below.
A further factor to consider is that this study showed that the quality of life following 
laparoscopic colorectal surgery was unaffected by the analgesic modality used. Studies 
have previously shown that the use of epidural analgesia following open abdominal 
surgery resulted in a better quality of life (Carli et al., 2002). Similarly, there is evidence 
that the quality of life following laparoscopic surgery is significantly better than 
following open surgery. Until now, there have been no studies comparing the effects of 
the analgesic regime on the quality of life following laparoscopic surgery.
The results of this study showed that despite the higher pain scores in the PCA group, 
the analgesic modality used did not affect the quality of life. Pain is just one element that 
affects the quality of life, but in view of the fact that this study also showed that there 
were numerous statistically significant differences in the primary and secondary 
outcomes related to the different analgesic regimes used, it seems peculiar then that the 
quality of life study showed no differences between the analgesic regimes. As the first 
reading after surgery was at one week, it does raise the question regarding whether there 
might possibly have been a significant difference if the quality of life had been measured 
at an additional time point at three to four days following surgery. The acute version of 
the SF-36 questionnaire was used rather than the standard SF-36 questionnaire in an 
attempt to analyse the early post-operative period, although it may have missed an early 
point where there may have been a difference.
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spinal analgesia offered pain scores similar to epidural analgesia with the advantage of 
shorter hospital stays. The use of PCA also had numerous benefits over epidural 
analgesia although it did have higher pain scores until the morning following surgery. 
Therefore, it could be argued that if there was no difference in the quality of life related 
to the analgesic regime used, and the primary outcome was better in the PCA group, is a 
pain score that is greater by two units on the visual analogue score for a short period 
significant? This study is not able to answer this question.
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4.3 Complications
The assessment of complications as a whole revealed that the analgesic regime did not 
affect the incidence of complications. The only difference noted when the complications 
were analysed separately was the incidence of hypotension which was higher in the 
epidural group, although this was not statistically significant.
There were six anastomotic leaks in this study, all of which required surgical 
intervention. This leak rate of 6.5% is higher than our previous leak rate of 1.5% in the 
previous 440 resections. The cause for these leaks though is uncertain and we have no 
explanation for this. Unfortunately, two of the six patients who developed an 
anastomotic leak died following their surgery. There were 10 (11%) re-admissions in 
this study. Two of the patients with anastomotic leaks discussed above were discharged 
but were re-admitted several days later with anastomotic leaks and consequently 
underwent surgery.
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4.4 Cardiovascular changes
The creation of the pneumoperitoneum causes an acute rise in the SVRI and the MAP 
and a resultant fall in cardiac output in fluid-optimized patients. The maximum SVRI 
was achieved soon after insufflation and placing the patient in the Trendelenburg 
position. Thereafter there was a steady decrease in the SVRI and the MAP. This 
decrease in the SVRI and the MAP was most marked in the epidural group who required 
the highest dose of phenylephrine. The spinal group did not show as high a requirement 
for phenylephrine as the spinal group despite the fact that the block height in recovery 
was T6-T8 that was similar to the epidural group.
This study demonstrated that as the procedure continued, the use of epidural analgesia 
resulted in significant cardiovascular instability, with 74% of patients requiring 
vasoconstrictor support. This is a large proportion considering that these patients were 
not fluid depleted because bowel preparation was avoided and patients were given oral 
PreLoad® in 400 ml of water 2 hours prior to surgery. In addition these patients were 
intra-operatively fluid-optimized using an oesophageal Doppler.
There was no significant difference between the groups with regards to the average time 
from the creation of the pneumoperitoneum to the point where the vasoconstrictor was 
required.
We had anticipated that spinal anaesthesia would cause the greatest cardiovascular 
instability. However, patients receiving spinal anaesthesia required significantly less 
vasoconstrictor support than those receiving epidural analgesia. The cephalad spread of
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local anaesthetic in spinal anaesthesia seems to be very limited if managed appropriately 
due to the fact that local anaesthetic “fixes” over a period of 5 to 10 minutes. It is 
therefore important that patients are not placed in a steep head-down position before this 
“fixation” has occurred. The patients that received a PCA post-operatively, and who 
were the intra-operative control group, required vasoconstrictor in only 33% of the 
cases.
This study has benefited firom gathering information on goal-directed, fluid-optimized 
patients within a randomised controlled trial where nearly all the variables have been 
standardized within an ERP.
Colorectal surgery is increasingly embracing the enhanced recovery programme (ERP) 
(Kehlet and Wilmore, 2008). However, one of the key points of the ERP is the use of 
epidural analgesia that should be started before the first incision and should run 
throughout the length of surgery. From a cardiovascular point of view, our data 
questions this, as it was associated with the greatest cardiovascular changes. The large 
fluctuations in MAP and SVRI, with the need for vasoconstrictor support, may add to 
this physiological stress rather than help reduce it. Conversely, in terms of 
cardiovascular stability, this data supports the use of spinal and PCA.
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4.5 Oxygen delivery
This study has revealed that the overall mean intra-operative DO2I in this study was 480 
ml/min/m^. Considering that these are elective patients, who have been fluid optimized, 
this appears to be a rather low average. This point is exemplified by the fact that the 
lowest DO2I was 228 ml/min/m^, with 18 (24%) patients having a DO2I of less than 400 
ml/min/m^.
The initial cause for this appears to be the creation of the pneuoperitoneum, which 
results in a significant increase the SVRI and consequently decreases the cardiac output 
and hence the DO2 . However, this increase in SVRI slowly decreases resulting in a slow 
increase in the DO2I until this levels out. In some patients, the cardiac output returned to 
pre-pneumoperitoneum levels relatively soon into surgery and these patients maintained 
a satisfactory DO2I. However, in some patients the pneumoperitoneum affected the DO2 
and hence the important factor becomes the length of the procedure, though in this group 
of patients, the operating time was relatively short. The most important factor though 
appears to be a poor cardiovascular response to pneumoperitoneum.
Despite the relative frequency of patients having a DO2I of less than 480 ml/min/m^, 
many of these patients had an uncomplicated stay. However, the incidence of ischemia- 
related complications was higher if the DO2I was less than 400, and this decreased as the 
DO2I increased (5.4% for DO2I between 400 and 550 ml/mim/m^ and 0% for patients 
that had a DO2I of greater than 550 ml/mim/m^).
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The DO2I was not affected by the type of analgesic regime used. The mean value for the 
DO2 was highest in the spinal group, although this was not significantly greater than the 
other two groups. Whilst it may be postulated that spinal anaesthesia may have a more 
profound block of the vasomotor tone thereby lowering the SVRI and hence increasing 
the cardiac output, this was not observed, with similar findings in the epidural group.
The management of patients with a low DO2I remains uncertain at present. The benefits 
of intra-operative inotropic support versus post-operative monitoring in the high 
dependency setting are yet to be evaluated.
One of the weaknesses of this part of the study is that the fluid optimization and the DO2 
calculations were only performed intra-operatively due to the difficulties of performing 
these calculations on the ward in a conscious patient. However, the advantage of fluid- 
optimizing patients intra-operatively to the end of surgery is that they return to the 
recovery unit in an optimized state. Over the next six to eight hours, the situation can 
change, hence our approach for measuring the central venous oxygen saturation (SVcvc) 
on the evening of surgery and the following morning, and administering 500 ml colloid 
over two hours in those patients with SVcvc of less than 60 percent as a surrogate 
marker for hypovolaemia.
The results obtained from this study have shown that a large proportion of patients 
undergoing laparoscopic colorectal surgery have a moderately low DO2I despite fluid 
optimisation, with a higher proportion of complications in the low DO2 I group. Further 
work is required to assess this further and to assess whether outcomes can be further 
improved with either the use of inotropes to increase DO2 in susceptible patients or with
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closer observation post-operatively with appropriate measurement and manipulation of 
DO2 .
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4.6 Respiratory function
The statistical analysis of the lung function tests was performed until the morning of the 
3"^  day. The analysis was undertaken in this manner for two reasons:
1) Firstly, by defining the time period until the morning of the 3^  ^ day, we were 
including the time period where each analgesic modality could be compared 
against the others. The median time until the PCAs were removed was 1.3 days 
whilst the median time for the epidurals to be removed was 2.0 days. Therefore 
by the morning of the 3^  ^day all patients were now on oral analgesia and hence 
the time period whilst the patients were receiving specific analgesic modalities 
was covered.
2) Secondly, there were similar numbers of patients in each group until the morning 
of the 3"^  day. After this time, there were more epidural patients in hospital than 
PCA or spinal patients. Continuing to analyse this group of patients who now 
had a higher incidence of problems delaying discharge, like an ileus would 
introduce bias and invalidate the results. Furthermore, the factors keeping that 
group of patients in hospital have already been taken into account by analysis of 
the other specific secondary end points.
The use of epidural analgesia has been shown to preserve lung function in open surgery 
(Popping et al., 2008). The findings of this study though showed that with regards to 
PEFR, there were no significant differences in the decreases on the days following 
surgery where the analysis was continued until the morning of the 3^  ^day.
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Of the three functional respiratory components measured, the F VC had the most 
significant differences. There were no differences in the decrease of F VC on day-1 
between the groups, but on day-2 and the on the morning of day-3, the decrease in the 
FVC of the spinal group was significantly less than the epidural group. These statistical 
differences resulted from the slower recovery in the epidural group than the spinal and 
PCA groups. There was however no statistically significant difference between the 
spinal group and the PCA group.
In terms of PEFR and FVC, the largest median decrease in respiratory function occurred 
on the evening of the first day. Thereafter, there was a progressive return of median lung 
function back towards the baseline.
Many of the early meta-analyses that assessed the preservation of lung function in open 
surgery looked at the incidence of pneumonia. In this series, there was only one patient 
who developed a lower respiratory chest infection and that patient was in the epidural 
group.
One of the weaknesses of the respiratory part of this study is that the measurements have 
been undertaken only in the patients during their hospital stay. In retrospect, it would 
have worthwhile visiting the patients at home on the first few days to check the lung 
function to see if it was significantly different between the different groups at home and 
if it was different from those patients recovering on the ward. What we do know is that 
up until and including the morning of the second day, there are still the same number of 
patients having their lung function measured with the similar numbers being 27: 28: 28 
for spinal: epidural: PCA respectively.
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In the meta-analysis by Popping et al, they noted a progressive decrease over the last 
few decades in the difference between epidural analgesia and PCA with regards to the 
preservation of lung function (Popping et al., 2008). They attributed this to earlier 
mobilisation and the increased use of physiotherapy. Within this stucfy, only a handful of 
patients needed to see, and consequently saw, a physiotherapist. This is a direct 
consequence of the ward nurses who have embraced the ERP and have been very good 
at getting the patients out of bed and getting them to mobilize themselves.
Whereas epidural analgesia added some respiratory benefit to the patient undergoing 
open surgery, this is not the case with laparoscopic surgery. The greatest decrease in 
lung function appears to be on the evening of day-1 and for PEFR and FEVi/FVC but 
there are no major benefits of one analgesic modahty over another. The use of spinal 
analgesia does significantly reduce the decrease in FVC on day-2 and the morning of 
day-3 when compared to epidural analgesia but it is not significant when compared to 
PCA. In addition, the analgesic modahty had no influence on the incidence of 
pneumonia / chest infections.
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4.7 Stress response
The use of epidural analgesia has been shown to reduce the stress response in open 
surgery. In this study, the analgesic regime did not effect the stress response to surgery 
except for one reading which was the cortisol level at 3 hours which was significantly 
lower in the epidural group compared to the spinal and PCA groups.
This lack of any difference in the stress response may be due to the numerous additional 
factors that are reducing the stress response, which consequently reduces the influence 
exerted by the analgesic regime. The factors include:
1. The use of the laparoscopic approach, which reduces the stress rehouse 
significantly when compared to open surgery.
2. The ERP with glucose pre-loading, maintenance of a normal diet prior to surgery 
and the avoidance of bowel preparation are believed to all reduce the stress 
response.
3. Fluid optimization which helps to reduce the stress response.
As these additional factors serially reduce the stress response, the effect of the analgesic 
regime may have a much smaller impact on the outcome.
The pain scores in this study were higher in the PCA group than the epidural and spinal 
group, yet there was no difference in the stress response. Furthermore, despite pain 
scores being higher in the PCA than the epidural group, the length of hospital stay was 
significantly shorter in the PCA group. Therefore, pain scores alone do not significantly
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influence the stress response or the outcome in fluid optimized patients treated within an 
ERP.
The limitation of this part of the study was the small number of patients. This was due to 
the fact that although ethics approval was obtained prior to the commencement of the 
study, there were logistical and financial issues that needed to be resolved before this 
part of the study could be commenced. This explains the difference in the number of 
patients within the different groups.
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4.8 Final Conclusion
The ERP has increasingly been used for laparoscopic surgery in its un-modified form 
with thoracic epidural use being a key feature. Many of the outcomes in the epidural 
analgesia group were significantly worse than the spinal and PCA groups suggesting that 
either of these two modalities could replace epidural analgesia.
In order to achieve short post-operative hospital stays, it is essential to ensure that 
patients are optimized at every point of their care pathway and fluid therapy appears to 
play a major factor in patient outcome. The ERP suggests that up to 3 litres of intra­
operative fluid should be administered. The results from this study suggest that this 
volume is excessive. However, the only way to be certain that the correct volume of 
fluid is given at the correct time is to use an oesophageal Doppler. This prevents 
overloading the patient with fluid whilst maximizing the cardiac output and hence the 
oxygen dehvery, which appears to play a major role in healing of the anastomosis.
By addressing the key issues -  analgesia, fluid therapy and treating patients within a 
modified enhanced recovery programme, extremely short post-operative hospital stays 
are possible following laparoscopic colorectal surgery.
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Appendix 1
PATIENT INFORMATION SHEET
Study Title: Peri-operative optimisation of patients
undergoing laparoscopic colectomy
Thank you for reading this information sheet.
You are being invited to take part in a research study. Before you decide it is important for you 
to understand why the research is being done and what it will involve. Please take time to read 
the following information carefully. Talk to others about the study if you wish.
• Part 1 tells you the purpose of this study and what will happen to you if you take part.
• Part 2 gives you more detailed information about the conduct of the study.
If there is anything that is not clear or if you would like more information please do not hesitate to 
ask. Take time to decide whether or not you wish to take part.
Part 1 
What is the purpose of the study?
Until relatively recently bowel operations were performed by making a cut down 
the front of your tummy. The practice of laparoscopic (keyhole) surgery has 
become very advanced at the Royal Surrey County Hospital with results that are 
very promising.
Until keyhole surgery started, the operations required a long cut down the front 
of your tummy and as a result strong pain killers were required after the surgery. 
The pain is much less in keyhole surgery but it is not known yet which is the 
best painkiller to have after this surgery.
Why have I been chosen?
All patients who are suitable for keyhole surgery are being invited to participate. 
128 patients will be entered into the trial.
Do I have to take part?
No. It is up to you to decide whether or not to take part. If you do, you will be 
given this information sheet to keep and be asked to sign a consent form. You 
are suntil free to withdraw at any time and without giving a reason. A decision to 
withdraw at any time, or a decision not to take part, will not affect the standard of 
care you receive.
What will happen to me if I take part?
In order to find out which method is best we need to make comparisons 
between the different treatments. You will be are put into one of the different 
groups that will receive a variation of one of the treatments. The results will be 
compared to see if one method is better than the others. To try to make sure the
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groups are the same to start with, each participant is put into a group by chance 
(randomly). The results are then compared.
If you agree to take part in the study you will be asked to sign a consent form. A 
narrow tube will be placed just past the back of the throat once you are under 
asleep. Measurements from the tube will help us to give us to give you the best 
operation.
You will be assigned to either have a pain killer given via pump called a PCA or 
by an epidural (a very thin tube in the back similar to what many mothers have 
at childbirth) or via a spinal anaesthetic (similar to the epidural) to see which 
method is best. All of these methods are currently used but it is not yet known 
which is the best method.
You will be discharged from hospital when you and the doctors are satisfied you 
are well enough, and then you will be seen in clinic within a few weeks. You will 
be seen regularly in clinic after this first appointment (every few months).
Throughout the trial, you will have contact details of the investigators and 
doctors involved, and you may ask for advice or help at any time.
Your GP should be contacted regarding the trial, but we will ask your permission 
before doing so.
What do I have to do?
Once you have agreed to enter the trial you will be randomly allocated into one 
group. You will have the thin tube (called a Doppler) placed just past the back of 
the mouth only for the duration of the operation. You will not need to do anything 
else.
What happens when the research study stops?
Your follow up after your procedure will be unaffected. You will be seen by your 
doctors as you would if you were not in the study.
What if there is a problem?
Any complaints that you have will be addressed. The detailed information about 
this is given in Part 2.
Will my taking part in the study be kept confidential?
Yes. All the information about your participation in this study will be kept 
confidential. The details are included in Part 2.
If you are interested in participating, or you wish to get more information, please 
contact me.
Mr. Bruce Levy 
Royal Surrey County Hospital
This completes Part 1 of the Information Sheet.
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If the information in Part 1 has interested you and you are considering 
participation, please continue to read the additional information in Part 2 before 
making any decision.
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Part 2
What will happen if I don’t want to carry on with the study?
You can withdraw from the trial at any time.
What if there is a problem?
If you have a concern about any aspect of this study, you should ask to speak 
with the researchers who will do their best to answer your questions. If for any 
reason you remain concerned you can have the issue addressed through the 
NHS Complaints Procedure.
Involvement of the General Practitioner/Family doctor (GP)
Your GP should be Informed of your participation in the study. However, we will ask your 
permission before we do so.
What will happen to the results of the research study?
The information from this trial may lead to publications within medical journals, 
but this will be anonymous. Your personal information will never be used.
Who is organising and funding the research?
The study is fully funded by the Minimal Access Therapy Training Unit.
Who has reviewed the study?
Full ethical approval has been obtained from the West Kent Research Ethics 
Committee, South East Coast Strategic Health Authority, Preston Hall, 
Aylesford, Kent, ME20 7NJ.
If you are interested in participating, or you wish to get more information, please 
contact me.
Mr. Bruce Levy
Royal Surrey County Hospital
Egerton Road
Guildford
GU27XX
Version 8.3 17/12/2007
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Appendix 2
CONSENT FORM
Title of Project: Peri-operative optimisation of patients undergoing laparoscopic 
colectomy
Name of Researcher: Bruce Levy
Please initial box
1. I confirm that I have read and understand the patient information sheet
for the above study. I have had the opportunity to consider the information, 
ask questions and have had these answered satisfactorily.
2. I understand that I am free to withdraw at any time, and that my medical care will not 
be affected in any way.
□
□
3. I agree to my GP being informed of my participation in the study. □
4. I agree to take part in the above study. □
Name of Patient Date Signature
Name of Person taking consent 
(if different from researcher)
Date Signature
Researcher Date Signature
Version 4.2 16/08/2007
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Appendix 3
Fluid Optimisation in Colorectai Surgery
Patient name/Date of Birth
Or affix label
Risk scoring:
a) Cardio-pulmonary risk factors:
b) Immnuo-nutritional risk factors:
Weight:
Height:
BSA:
Time
Surgery:
Antibiotics:
Possum score: 
SF36:
Abd circ:
Version 6.1 16/08/2007
Date of surgery 
Start/stop surgery 
Discharge date
Anaigesia:
Levei:
Biood ioss:
Pre-op BP:
ASA:
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POSSUM
(Physiologic and Operative Severity Score for the  enum eration  of 
Mortality and Morbidity)
Age
Glasgow
Respiratory
Urea
Pulse (beats/m in)
Cardiac signs 
Hb (g/dL)
W.B.C.
EGG
Potassium (mEqI/L)
Sodium (mEqI/L)
Systolic Blood Pressure 
Physiologic Score 
Operative Severity (help)
Multiple procedures 
Total Blood Loss 
Peritoneal soiling 
Cancer
Mode o f surgery 
Operative Score
Predicted Morbidity Rate
Predicted Mortality Rate
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Time (hrs)
CO (l/min)
SV (ml)
FTc (MS)
Peak vel
Cardiac
Index
MAP (mmHg)
Heart rate
ECG
CVP
0 2  Sat (%)
D 02
D02 index
SVR
SVR index
SV cvc02
Ongoing 
blood loss
Vol fluid 
given
Vasoconstric
Hb (g/dl)
Abd pressure
Tidal volume
Resp rate
Minute vol
Peak
pressure
Fi02
ET C 02
PEEP
MAP
l:E ration
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Time (hrs)
CO (l/min)
SV (ml)
FTc (MS)
Peak vel
Cardiac
Index
MAP (mmHg)
Heart rate
ECG
CVP
0 2  Sat (%)
D 02
D02 index
SVR
SVR index
SV cvc02
Ongoing 
blood loss
Vol fluid 
given
Vasoconstric
Hb (g/dl)
Abd pressure
Tidal volume
Resp rate
Minute vol
Peak
pressure
Fi02
ET C 02
PEEP
MAP
l:E ration
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Theatre
Central venous blood gas 35 min into surgery 
Volume of colloid given in theatre
Ensure pt has IL of N saline over 8 hours followed by 1 litre N saline over 16 hours
Pt to have paracetomol and voltarol or paracetomol and tramadol, lactulose and PPI + 
fortisips + lactulose.
Recovery
Give form to recovery to fill in table below 
Central venous gas before going to the ward
RECOVERY
Time in:
Time out:
Time
Pain score at rest
Pain score with mmt
Epidural / spinal Right Left
Upper level
Lower level
SVcvc 02 collection
Time
Measurement
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Sedation: 0= Awake and alert 
1=Easily reusable 
2= Difficult to rouse 
3= Unresponsive 
S=Asleep
Nausea: O=none
1=intermittent
2=Continuous
3=Vomiting
Pruritus: O=none 
1=mild 
2=moderate 
3=severe
Motor block: O=normal movement
1=heavy but movement 
2=slight movement only 
3=no movement
Sensory block: 1=no numbness 
2=slightly numb 
3=totally numb 
4=numb to xiphisternum
Sensory level: upper level T4=nipple
T10=umbilicus 
L1 =groin 
Sacral
Evening of surgery
Central venous ABG 
Pain at rest
Pain on movement BS
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Day 1 Am
IV fluid given until midnight 
Oral fluid given until midnight 
Total fluid until midnight 
Urine output until midnight 
Balance fluid until midnight
IV fluid given from midnight to 8 am 
Oral fluid given from midnight to 8 am 
Total fluid until from midnight to 8 am 
Urine output until from midnight to 8 am 
Balance fluid until from midnight to 8 am
Central venous ABG
Pain at rest 
Pain on movement
Nausea
Vomiting BS
Hiccups
Pruritus
Circumference
Weight
FEVl
FVC
PEER
%
Pulse
BP
Sats
Fi02
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Day 1 pm
Pain at rest 
Pain on movement
Nausea
Vomiting
Hiccups BS
Pruritus
FEVl
FVC
PEFR
%
Pulse
BP
Sats
Fi02
Day 2 Am
IV fluid given over past 24 hours 
Oral fluid given over past 24 hours 
Total fluid over past 24 hours 
Urine output over past 24 hours 
Balance fluid over past 24 hours
Pain at rest
Pain on movement
Nausea
Vomiting
Hiccups
Pruritus BS
Circumference
Weight
FEVl
FVC
PEFR
%
Pulse BP Sats Fi02
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Day 2 pm
Pain at rest
Pain on movement
Nausea
Vomiting
Hiccups
Pruritus
FEVl
FVC
PEFR
%
Pulse BP Sats Fi02
Day 3 Am
IV fluid given over past 24 hours 
Oral fluid given over past 24 hours 
Total fluid over past 24 hours 
Urine output over past 24 hours 
Balance fluid over past 24 hours
Pain at rest
Pain on movement
Nausea
Vomiting BS
Hiccups
Pruritus
Circumference
Weight
FEVl
FVC
PEFR
%
Pulse BP Sats Fi02
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Day 3 pm
IV fluid given over past 24 hours 
Oral fluid given over past 24 hours 
Total fluid over past 24 hours 
Urine output over past 24 hours 
Balance fluid over past 24 hours
Pain at rest
Pain on movement
Nausea
Vomiting BS
Hiccups
Pruritus
FEVl
FVC
PEFR
%
Pulse BP Sats Fi02
Day 4 Am
IV fluid given over past 24 hours 
Oral fluid given over past 24 hours 
Total fluid over past 24 hours 
Urine output over past 24 hours 
Balance fluid over past 24 hours
Pain at rest 
Pain on movement 
Nausea 
Vomiting
Hiccups BS
Pruritus
Circumference
Weight
FEVl
FVC
PEFR
%
Pulse BP Sats Fi02
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4 pm
IV fluid given over past 24 hours 
Oral fluid given over past 24 hours 
Total fluid over past 24 hours 
Urine output over past 24 hours 
Balance fluid over past 24 hours
Pain at rest
Pain on movement
Nausea
Vomiting BS
Hiccups
Pruritus
FEVl
FVC
PEFR
%
Pulse BP Sats Fi02
Day 5 Am
IV fluid given over past 24 hours 
Oral fluid given over past 24 hours 
Total fluid over past 24 hours 
Urine output over past 24 hours 
Balance fluid over past 24 hours
Pain at rest 
Pain on movement 
Nausea 
Vomiting
Hiccups BS
Pruritus
Circumference
Weight
FEVl
FVC
PEFR
%
Pulse BP Sats Fi02
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Day 5 pm
IV fluid given over past 24 hours 
Oral fluid given over past 24 hours 
Total fluid over past 24 hours 
Urine output over past 24 hours 
Balance fluid over past 24 hours
Pain at rest
Pain on movement
Nausea
Vomiting BS
Hiccups
Pruritus
FEVl
FVC
PEFR
%
Pulse BP Sats Fi02
Discharge
Total amount of voltarol 
Total amount of tramadol
If this was in addition to voltarol, on what days was it used 
Total amount of morphine, on what days was it used
Date and time of discharge
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Appendix 4: SF-36
Your Health and Well-Being
This survey asks for your views about your health. This information will 
help keep track of how you feel and how well you are able to do your 
usual activities.
1. In general, would you say yonr health is:
Excellent Very Good Good Fair Poor
2. Compared to one week ago, how would you rate your health in general now?
Much better now than one week ago
Somewhat better now than one week ago
About the same as one week ago
Somewhat worse now than one week ago
Much worse now than one week ago
3. The following items are about activities you might do during a typical day. 
Does your health now limit you in these activities? If so, how much?
Yes, limited a 
lot
Yes limited a 
little
No, not limited at 
all
Vigorous activities, such as running, lifting heaw 
objects, participating in strenuous sports
Moderate activities, such as moving a table, pushing 
a vacuum cleaner, bowling or playing golf
Lifting or carrying groceries
Climbing several flights of stairs
Climbing one flight of stairs
Bending, kneeling or stooping
Walking more than a mile
Walking half a mile
Walking 100 vards
Bathing or dressing yourself
4. During the past week, have you had any of the following problems with your work 
or other
Yes No
Cut down on the amount of time vou spent on work or 
other activities
Accomplished less than you would like
Were limited in the kind or work or other activities
Had difficultv performing the work or other activities (for 
example, it took extra effort)
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5. During the past week, have you had any of the following problems with your work 
or other
regular daily activities as a result of any emotional problems (such as feeling
Yes No
Cut down on the amount of time vou spent on work or 
other activities
Accomplished less than you would like
Did work or other activities less carefullv than usual
6. During the past week, to what extent has your physical health or emotional 
problems interfered
with your normal social activities with family, friends, neighbours, or groups?
Not at all Slightly Moderately Quite a 
bit
Extremely
7. How much bodily pain have you had during the past week?
None Very Mild Mild Moderate Severe Very Severe
8. During the past week, how much did pain interfere with your normal work
Not at all A little Bit Moderately Quite a 
bit
Extremely
9. These questions are about how you feel and how things have been with you during 
the past week
For each question, please give the one answer that comes closest to the way you have 
been feeling.
How much of the time during the past week.......
A U of
the
time
Most o f  
the time
A good 
bit o f  
the time
Some o f  
the time
A little 
o f the 
time
None o f  
the time
Did you feel full of life?
Have you been a very nervous person?
Have you felt so down in the dumps that 
nothing could cheer you up?
Have you felt calm and peaceful?
Did you have a lot of energy?
Have you felt downhearted and low?
Did you feel worn out?
Have you been a happy person?
Did you feel tired?
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10. During the past week, how much of the time has your physical health or 
emotional problemsjnterfered with your social activities (like visiting friends.
All of the time Most of the Some of A little of None of the
time the time the time time
11. How TRUE or FALSE is each of the following statements for you?
Definitely true Mostly true Don’t
know
Mostly false Definitely false
I seem to get ill a little more easily 
than other people
I am as healthy as anybody I know
I expect my health to get worse
My health is excellent
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